<html class="gs_el_sm gs_pfcs"><head><title>‪Laurence H Patterson‬ - ‪Google Scholar‬</title><meta http-equiv="Content-Type" content="text/html;charset=UTF-8"><meta http-equiv="X-UA-Compatible" content="IE=Edge"><meta name="referrer" content="origin-when-cross-origin"><meta name="viewport" content="width=device-width,initial-scale=1,minimum-scale=1,maximum-scale=2"><meta name="format-detection" content="telephone=no"><link rel="shortcut icon" href="/favicon.ico"><link rel="canonical" href="https://scholar.google.com/citations?user=wGRCWGAAAAAJ&amp;hl=en"><meta name="description" content="‪Professor Emeritus,  Institute of Cancer Therapeutics, University of Bradford‬ - ‪‪Cited by 5,392‬‬ - ‪medicinal chemistry‬ - ‪cancer pharmacology‬ - ‪drug discovery‬"><meta property="og:description" content="‪Professor Emeritus,  Institute of Cancer Therapeutics, University of Bradford‬ - ‪‪Cited by 5,392‬‬ - ‪medicinal chemistry‬ - ‪cancer pharmacology‬ - ‪drug discovery‬"><meta property="og:title" content="Laurence H Patterson"><meta property="og:image" content="https://scholar.googleusercontent.com/citations?view_op=medium_photo&amp;user=wGRCWGAAAAAJ&amp;citpid=9"><meta property="og:type" content="website"><meta name="twitter:card" content="summary"><style>html,body,form,table,div,h1,h2,h3,h4,h5,h6,img,ol,ul,li,button{margin:0;padding:0;border:0;}table{border-collapse:collapse;border-width:0;empty-cells:show;}html,body{height:100%}#gs_top{position:relative;box-sizing:border-box;min-height:100%;min-width:964px;-webkit-tap-highlight-color:rgba(0,0,0,0);}#gs_top>*:not(#x){-webkit-tap-highlight-color:rgba(204,204,204,.5);}.gs_el_ph #gs_top,.gs_el_ta #gs_top{min-width:320px;}#gs_top.gs_nscl{position:fixed;width:100%;}body,td,input,button{font-size:13px;font-family:Arial,sans-serif;line-height:1.24;}body{background:#fff;color:#222;-webkit-text-size-adjust:100%;-moz-text-size-adjust:none;}.gs_gray{color:#777777}.gs_red{color:#dd4b39}.gs_grn{color:#006621}.gs_lil{font-size:11px}.gs_med{font-size:16px}.gs_hlt{font-weight:bold;}a:link{color:#1a0dab;text-decoration:none}a:visited{color:#660099;text-decoration:none}a:hover,a:hover .gs_lbl{text-decoration:underline}a:active,a:active .gs_lbl,a .gs_lbl:active{color:#d14836}.gs_el_tc a:hover,.gs_el_tc a:hover .gs_lbl{text-decoration:none}.gs_pfcs a:focus,.gs_pfcs button:focus,.gs_pfcs input:focus,.gs_pfcs label:focus{outline:none}.gs_a,.gs_a a:link,.gs_a a:visited{color:#006621}.gs_a a:active{color:#d14836}a.gs_fl:link,.gs_fl a:link{color:#1a0dab}a.gs_fl:visited,.gs_fl a:visited{color:#660099}a.gs_fl:active,.gs_fl a:active{color:#d14836}.gs_fl{color:#777777}.gs_ctc,.gs_ctu{vertical-align:middle;font-size:11px;font-weight:bold}.gs_ctc{color:#1a0dab}.gs_ctg,.gs_ctg2{font-size:13px;font-weight:bold}.gs_ctg{color:#1a0dab}a.gs_pda,.gs_pda a{padding:7px 0 5px 0}.gs_alrt{background:#f9edbe;border:1px solid #f0c36d;padding:0 16px;text-align:center;box-shadow:0 2px 4px rgba(0,0,0,.2);border-radius:2px;}.gs_spc{display:inline-block;width:12px}.gs_br{width:0;font-size:0}.gs_ibl{display:inline-block;}.gs_scl:after{content:"";display:table;clear:both;}.gs_ind{padding-left:8px;text-indent:-8px}.gs_ico,.gs_icm{display:inline-block;background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png);background-position:-23px -161px;background-size:169px;width:21px;height:21px;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){.gs_ico,.gs_icm{background-image:url(/intl/en/scholar/images/2x/sprite_20161020.png);}}.gs_el_ta .gs_nta,.gs_ota,.gs_el_ph .gs_nph,.gs_oph{display:none}.gs_el_ta .gs_ota,.gs_el_ph .gs_oph{display:inline}.gs_el_ta div.gs_ota,.gs_el_ph div.gs_oph{display:block}.gs_sth_g{visibility:hidden;max-height:0;}.gs_sth_vis .gs_sth_g{max-height:1000px;}.gs_sth_vis .gs_sth_b{position:fixed;top:0;}@keyframes gs_anm_spin{0%{transform:rotate(0deg);}100%{transform:rotate(360deg);}}.gs_rimg{display:block;background-color:#e5e5e5;border-radius:50%;overflow:hidden;position:relative;z-index:1;}.gs_rimg>img{position:absolute;margin:auto;left:0;top:0;bottom:0;right:0;}.gs_in_txtw{display:inline-block;vertical-align:middle;}.gs_in_txtb{display:block;}.gs_in_txt{color:#000;background-color:#fff;font-size:16px;box-sizing:border-box;height:29px;line-height:23px;border:1px solid #d9d9d9;border-top-color:#c0c0c0;padding:3px 6px 1px 8px;border-radius:1px;outline:none;-webkit-appearance:none;-moz-appearance:none;}.gs_el_tc .gs_in_txt{font-size:18px;}.gs_in_txtb .gs_in_txt{width:100%;}.gs_in_txt:hover{border-color:#b9b9b9;border-top-color:#a0a0a0;box-shadow:inset 0 1px 2px rgba(0,0,0,.1);}.gs_in_txte .gs_in_txt{border-color:#dd4b39;}.gs_in_txt:focus{border-color:#4d90fe;box-shadow:inset 0 1px 2px rgba(0,0,0,.3);}.gs_in_txt:disabled{color:#b8b8b8;border-color:#f1f1f1;box-shadow:none;}.gs_in_txtm .gs_in_txt{font-size:13px;height:24px;line-height:16px;padding:3px 6px;}.gs_el_tc .gs_in_txtm .gs_in_txt{height:29px;line-height:21px;}.gs_in_txts{font-size:13px;line-height:18px;color:#666;}.gs_in_txte .gs_in_txts{color:#dd4b39;}button{position:relative;z-index:1;box-sizing:border-box;font-size:13px;cursor:pointer;height:29px;line-height:normal;min-width:72px;padding:0 8px;color:#444;border:1px solid rgba(0,0,0,.1);border-radius:3px;text-align:center;background-color:#f5f5f5;-webkit-user-select:none;user-select:none;}button.gs_btn_rnd{border-radius:14px;padding:0 12px;}button.gs_btn_rnd.gs_btn_rndci{padding-left:4px;}button.gs_btn_lrge{height:41px;min-width:82px;padding:0 9px;}button.gs_btn_lrge.gs_btn_rnd{border-radius:20px;padding:0 16px;}button.gs_btn_lrge.gs_btn_rnd.gs_btn_rndci{padding-left:10px;}button.gs_btn_cir{border-radius:14.5px;min-width:29px;}button.gs_btn_lrge.gs_btn_cir{border-radius:20.5px;min-width:41px;}button.gs_btn_mini{padding:0;border:0;}.gs_el_ph button.gs_btn_mph,.gs_el_ta button.gs_btn_mta{height:41px;}button .gs_wr{position:relative;display:inline-block;width:100%;height:100%;}button .gs_wr:before{content:"";width:0;height:100%;}button .gs_wr:before,button .gs_ico,button .gs_rdt,button .gs_lbl,button .gs_icm{display:inline-block;vertical-align:middle;}button .gs_wr{font-size:13px;text-transform:none;}.gs_btn_lrge .gs_wr{font-size:15px;}.gs_btn_lsb .gs_wr{font-size:11px;font-weight:bold;}.gs_btn_lsu .gs_wr{font-size:11px;text-transform:uppercase;}.gs_btn_lrge.gs_btn_lsb .gs_wr,.gs_btn_lrge.gs_btn_lsu .gs_wr{font-size:13px;}.gs_btn_half,.gs_el_ta .gs_btn_hta,.gs_el_ph .gs_btn_hph{min-width:36px;}.gs_btn_lrge.gs_btn_half,.gs_el_ta .gs_btn_lrge.gs_btn_hta,.gs_el_ph .gs_btn_lrge.gs_btn_hph,.gs_el_ta .gs_btn_mta,.gs_el_ph .gs_btn_mph{min-width:41px;}.gs_btn_slt{border-radius:3px 0 0 3px;}.gs_btn_srt{margin-left:-1px;border-radius:0 3px 3px 0;}.gs_btn_smd{margin-left:-1px;border-radius:0;}button:hover{z-index:2;color:#222;border-color:rgba(0,0,0,.2);background-color:#f8f8f8;}button.gs_sel{background-color:#dcdcdc;}button:active{z-index:2;background-color:#f1f1f1;}button:focus{z-index:2;}button::-moz-focus-inner{padding:0;border:0}button:-moz-focusring{outline:1px dotted ButtonText}.gs_pfcs button:-moz-focusring{outline:none}a.gs_in_ib{position:relative;display:inline-block;line-height:16px;padding:6px 0 7px 0;-webkit-user-select:none;user-select:none;}a.gs_btn_lrge{height:40px;padding:0;}a.gs_in_ib .gs_lbl{display:inline-block;padding-left:21px;color:#222;}a.gs_in_ib .gs_lbl:not(:empty){padding-left:29px;}button.gs_in_ib .gs_lbl:not(:empty){padding-left:4px;}a.gs_in_ib:active .gs_lbl,a.gs_in_ib .gs_lbl:active,a.gs_in_ib :active~.gs_lbl{color:#d14836;}.gs_el_ta .gs_btn_hta .gs_lbl,.gs_el_ph .gs_btn_hph .gs_lbl,.gs_el_ta .gs_btn_mta .gs_lbl,.gs_el_ph .gs_btn_mph .gs_lbl,.gs_el_ta .gs_btn_cta .gs_lbl,.gs_el_ph .gs_btn_cph .gs_lbl{display:none;}a.gs_in_ib .gs_ico{position:absolute;top:3px;left:0;}.gs_in_ib.gs_md_li .gs_ico{left:14px;}.gs_el_tc .gs_in_ib.gs_md_li .gs_ico{top:11px;}.gs_in_ib.gs_md_li.gs_md_lix .gs_ico{top:10px;left:16px;}a.gs_btn_lrge .gs_ico{top:50%;left:50%;margin:-10.5px 0 0 -10.5px;}.gs_in_ib .gs_ico{opacity:.55;}.gs_in_ib:hover .gs_ico{opacity:.72;}.gs_in_ib:active .gs_ico,.gs_in_ib .gs_ico:active,.gs_in_ib :active~.gs_ico{opacity:1;}.gs_in_ib:disabled .gs_ico,.gs_in_ib.gs_dis .gs_ico{opacity:.28;}.gs_in_ib.gs_btn_act .gs_ico,.gs_in_ib.gs_btn_cre .gs_ico{opacity:1;}.gs_btn_act:disabled .gs_ico,.gs_btn_cre:disabled .gs_ico{opacity:.72;}.gs_rdt{position:relative;width:0;height:21px;}.gs_rdt:before{content:"";position:absolute;top:2px;right:1px;width:5px;height:5px;border-radius:50%;background-color:#dd4b39;}button.gs_btn_flat{border-color:transparent;background-color:transparent;}button.gs_btn_flat:hover{background-color:rgba(0,0,0,.05);}button.gs_btn_flat:active{background-color:rgba(0,0,0,.1);}button.gs_btn_flat.gs_btn_flact{color:#1a0dab;}button.gs_btn_act{color:#fff;-webkit-font-smoothing:antialiased;background-color:#4d90fe;}button.gs_btn_act:hover{color:#fff;background-color:#3983fe;}button.gs_btn_act.gs_sel{background-color:#2f6bcc;}button.gs_btn_act:active{background-color:#357ae8;}button.gs_btn_cre{color:#fff;-webkit-font-smoothing:antialiased;background-color:#d14836;}button.gs_btn_cre:hover{color:#fff;background-color:#c53727;}button.gs_btn_cre.gs_sel{background-color:#992b1e;}html:not(.gs_pfcs) .gs_btn_act:focus:not(:active){box-shadow:inset 0 0 0 1px rgba(255,255,255,.5);}button.gs_btn_cre:active{background-color:#b0281a;}button:disabled,button:disabled:hover,button:disabled:active{cursor:default;color:#b8b8b8;border-color:rgba(0,0,0,.05);background-color:transparent;z-index:0;}button.gs_btn_flat:disabled{color:#b8b8b8;border-color:transparent;}button.gs_btn_act:disabled{color:#fff;background-color:#a6c8ff;}button.gs_btn_cre:disabled{color:#fff;background-color:#e8a49b;}a.gs_in_ib.gs_dis{cursor:default;pointer-events:none}a.gs_in_ib.gs_dis .gs_lbl{color:#b8b8b8;text-decoration:none}.gs_ttp{position:absolute;top:100%;right:50%;z-index:10;pointer-events:none;visibility:hidden;opacity:0;transition:visibility 0s .13s,opacity .13s ease-out;}button:hover .gs_ttp,button:focus .gs_ttp,a:hover .gs_ttp,a:focus .gs_ttp{transition:visibility 0s .3s,opacity .13s ease-in .3s;visibility:visible;opacity:1;}.gs_md_tb.gs_sel .gs_ttp{transition:none;visibility:hidden;}button.gs_btn_lrge.gs_btn_cir .gs_ttp{top:75%;}.gs_ttp .gs_aro,.gs_ttp .gs_aru{position:absolute;top:-2px;right:-5px;width:0;height:0;line-height:0;font-size:0;border:5px solid transparent;border-top:none;border-bottom-color:#595959;z-index:1;}.gs_ttp .gs_aro{top:-3px;right:-6px;border-width:6px;border-top:none;border-bottom-color:white;}.gs_ttp .gs_txt{display:block;position:relative;top:2px;right:-50%;padding:4px 6px;background:#595959;color:white;font-size:11px;font-weight:bold;line-height:normal;white-space:nowrap;border:1px solid white;border-radius:3px;box-shadow:inset 0 1px 4px rgba(0,0,0,.2);}.gs_press,.gs_in_se,.gs_tan{touch-action:none;}.gs_in_se .gs_lbl:not(:empty){padding-right:14px;}.gs_in_se .gs_icm{position:absolute;top:50%;margin-top:-5.5px;right:0;width:7px;height:11px;background-position:-21px -88px;opacity:.55;}.gs_in_se:hover .gs_icm{opacity:.72;}.gs_in_se:active .gs_icm{opacity:1;}.gs_in_se:disabled .gs_icm{opacity:.28;}.gs_el_ta .gs_btn_hta .gs_icm,.gs_el_ph .gs_btn_hph .gs_icm,.gs_el_ta .gs_btn_mta .gs_icm,.gs_el_ph .gs_btn_mph .gs_icm,.gs_el_ta .gs_btn_cta .gs_icm,.gs_el_ph .gs_btn_cph .gs_icm{display:none;}.gs_btn_mnu .gs_icm{margin-top:-3.5px;height:7px;background-position:0 -110px;}.gs_in_se.gs_btn_act .gs_icm,.gs_in_se.gs_btn_cre .gs_icm{margin-top:-3.5px;height:7px;background-position:-42px -44px;opacity:1;}.gs_btn_act:disabled .gs_icm,.gs_btn_cre:disabled .gs_icm{opacity:.72;}button.gs_btnG .gs_ico{width:21px;height:21px;background-position:-92px -253px;}button .gs_bs{position:absolute;top:50%;left:50%;margin-top:-10px;margin-left:-10px;box-sizing:border-box;width:20px;height:20px;border-radius:50%;border:2px solid #eee;border-top-color:#4d90fe;visibility:hidden;animation:gs_anm_spin .8s linear infinite;}button.gs_bsp .gs_bs{visibility:visible;transition:visibility 0s .4s;}.gs_md_d{text-transform:none;white-space:nowrap;position:absolute;top:0;left:0;border:1px solid #ccc;border-color:rgba(0,0,0,.2);background:#fff;box-shadow:0 2px 4px rgba(0,0,0,.2);z-index:1100;text-align:left;visibility:hidden;max-height:0;margin-top:-1000px;opacity:0;transition:opacity .13s,visibility 0s .13s,max-height 0s .13s,margin-top 0s .13s;}.gs_md_d.gs_vis{visibility:visible;max-height:10000px;margin-top:0;opacity:1;transition:all 0s;}.gs_el_tc .gs_md_d{transform-origin:100% 0;transform:scale(1,0);transition:opacity .218s ease-out,transform 0s .218s,visibility 0s .218s,max-height 0s .218s,margin-top 0s .218s;}.gs_el_ios .gs_md_d{-webkit-backface-visibility:hidden;}.gs_el_tc .gs_md_d.gs_ttzi{transform-origin:50% 50%;transform:scale(0,0);}.gs_el_tc .gs_md_d.gs_ttzr{transform:scale(0,0);}.gs_el_tc .gs_md_d.gs_vis{transform:scale(1,1);transition:transform .218s ease-out;}.gs_md_r{position:relative;display:inline-block;}.gs_md_rmb>.gs_md_d{top:29px}.gs_md_rmbl>.gs_md_d{top:41px}.gs_md_ul{list-style-type:none;word-wrap:break-word;display:inline-block;vertical-align:top;}.gs_md_ul.gs_md_ul_tb{display:block;}.gs_md_li,.gs_in_cb.gs_md_li,.gs_md_li:link,.gs_md_li:visited{display:block;padding:6px 44px 6px 16px;font-size:13px;line-height:16px;color:#222;cursor:pointer;text-decoration:none;position:relative;z-index:0;}a.gs_md_li:hover .gs_lbl,a.gs_md_li:active .gs_lbl{text-decoration:none}.gs_el_tc .gs_md_li{padding-top:14px;padding-bottom:10px;}.gs_md_li.gs_md_lix{font-size:16px;line-height:20px;padding:12px 16px 8px 16px;}.gs_md_li:before{content:"";background-color:#f1f1f1;position:absolute;left:0;right:0;top:0;bottom:0;opacity:0;transition:opacity .13s;z-index:-1;}.gs_md_li:hover:before,.gs_md_li:focus:before{opacity:1;transition:all 0s;}a.gs_in_ib.gs_md_li .gs_lbl{color:#222}a.gs_in_ib.gs_md_li.gs_in_gray .gs_lbl{color:#444}.gs_md_li:active:before{background-color:#ddd}.gs_md_li.gs_sel,a.gs_in_ib.gs_md_li.gs_sel .gs_lbl{color:#d14836}.gs_md_d:focus,.gs_md_li:focus{outline:none}a.gs_md_lix .gs_lbl,a.gs_md_lix .gs_lbl:not(:empty){padding:0 0 0 40px;}a.gs_in_cb:link,a.gs_in_cb:visited,a.gs_in_cb:active,a.gs_in_cb:hover{cursor:pointer;color:#222;text-decoration:none;}.gs_in_cb,.gs_in_ra{position:relative;line-height:16px;display:inline-block;-webkit-user-select:none;user-select:none;}.gs_in_cb.gs_md_li{padding:6px 44px 6px 16px;}.gs_in_cb input,.gs_in_ra input{position:absolute;top:1px;left:1px;width:15px;height:15px;margin:0;padding:0;opacity:0;z-index:2;}.gs_in_ra input{top:0;left:0}.gs_el_tc .gs_in_cb input{top:9px}.gs_el_tc .gs_in_ra input{top:8px}.gs_in_cb.gs_in_cbj input{top:15px;left:15px}.gs_in_cb label,.gs_in_cb .gs_lbl,.gs_in_ra label{display:inline-block;padding-left:21px;min-height:16px;}.gs_in_cb label:empty:before,.gs_in_cb .gs_lbl:empty:before,.gs_in_ra label:empty:before{content:"\200b";}.gs_el_tc .gs_in_cb label,.gs_el_tc .gs_in_cb .gs_lbl,.gs_el_tc .gs_in_ra label{padding-top:8px;padding-bottom:5px;}.gs_in_cb.gs_in_cbj label,.gs_in_cb.gs_in_cbj .gs_lbl{padding:13px 0 12px 41px;}.gs_in_cbb,.gs_in_cbb label,.gs_in_cbb .gs_lbl{display:block;}.gs_in_cb .gs_cbx,.gs_in_ra .gs_cbx{position:absolute}.gs_in_cb .gs_cbx{top:2px;left:2px;width:11px;height:11px;border:1px solid #c6c6c6;border-radius:1px;}.gs_md_li .gs_cbx{top:8px;left:18px}.gs_el_tc .gs_in_cb .gs_cbx{top:10px}.gs_el_tc .gs_md_li .gs_cbx{top:16px}.gs_in_cb.gs_in_cbj .gs_cbx{top:15px;left:15px}.gs_el_tc .gs_in_ra .gs_cbx{top:8px}.gs_in_ra .gs_cbx{top:0;left:0;border:1px solid #c6c6c6;width:13px;height:13px;border-radius:7px;}.gs_in_cb:hover .gs_cbx,.gs_in_ra:hover .gs_cbx{border-color:#666;box-shadow:inset 0 1px 1px rgba(0,0,0,.1);}button.gs_in_cb:hover .gs_cbx{border-color:#c6c6c6;}.gs_in_cb :focus~label,.gs_in_ra :focus~label{outline:1px dotted #222;outline:auto -webkit-focus-ring-color;}.gs_pfcs .gs_in_cb :focus~label,.gs_pfcs .gs_in_ra :focus~label{outline:none;}.gs_in_cb:active .gs_cbx,.gs_in_ra:active .gs_cbx,.gs_in_cb .gs_cbx:active,.gs_in_ra .gs_cbx:active,.gs_in_cb :active~.gs_cbx,.gs_in_ra :active~.gs_cbx{border-color:#666;background-color:#ebebeb;}button.gs_in_cb:active .gs_cbx{border-color:#a6a6a6;}.gs_in_cb :disabled~.gs_cbx,.gs_in_ra :disabled~.gs_cbx,button.gs_in_cb:disabled .gs_cbx{border-color:#f1f1f1;box-shadow:none;}.gs_in_cb :disabled~label,.gs_in_ra :disabled~label{color:#b8b8b8;}.gs_in_cb.gs_err .gs_cbx{border-color:#eda29b;}.gs_in_cb .gs_chk,.gs_in_ra .gs_chk{position:absolute;z-index:1;top:-3px;left:-2px;width:21px;height:21px;}.gs_md_li .gs_chk{top:3px;left:14px}.gs_el_tc .gs_in_cb .gs_chk{top:5px}.gs_el_tc .gs_md_li .gs_chk{top:11px}.gs_in_cb.gs_in_cbj .gs_chk{top:10px;left:11px}.gs_in_ra .gs_chk{top:4px;left:4px;width:7px;height:7px;border-radius:4px;}.gs_el_tc .gs_in_ra .gs_chk{top:12px}.gs_in_cb input:checked~.gs_chk,.gs_in_cb.gs_sel .gs_chk{background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png) -69px -67px;opacity:.62;}.gs_in_ra input:checked~.gs_chk{background-color:#666}.gs_in_cb.gs_par .gs_chk{background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png) -21px -44px;opacity:.55;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){.gs_in_cb input:checked~.gs_chk,.gs_in_cb.gs_sel .gs_chk,.gs_in_cb.gs_par .gs_chk{background-image:url(/intl/en/scholar/images/2x/sprite_20161020.png);background-size:169px;}}.gs_in_cb input:checked:disabled~.gs_chk{opacity:.22}.gs_in_ra input:checked:disabled~.gs_chk{background-color:#f1f1f1}.gs_ico_x{background-position:-113px -22px;opacity:.55;}.gs_ico_x:hover{opacity:.72;}.gs_ico_x:active{opacity:1;}.gs_ico_X{background-position:-71px 0;opacity:.55;}.gs_ico_X:hover{opacity:.72;}.gs_ico_X:active{opacity:1;}.gs_el_tc .gs_ico_Xt{background-origin:content-box;background-clip:content-box;padding:10px 6px 10px 14px;}.gs_ico_P{background-position:0 0;opacity:.55;}.gs_ico_P:hover{opacity:.72;}.gs_ico_P:active{opacity:1;}.gs_btnP .gs_ico{background-position:-21px 0;}.gs_btnC .gs_ico{background-position:0 -66px;}.gs_btnL .gs_ico{background-position:-92px -44px;}.gs_ico_LB{background-position:-50px -44px;height:16px;}.gs_btnJ .gs_ico{background-position:-92px -22px;}.gs_btnM .gs_ico{background-position:-92px 0;}.gs_btnMW .gs_ico{background-position:-21px -22px;}.gs_btnSB .gs_ico{background-position:0 -44px;}.gs_btnTSB .gs_ico{background-position:-115px -253px;}.gs_btnPL .gs_ico{background-position:-148px -66px;}.gs_btnPR .gs_ico{background-position:-21px -66px;}.gs_btnPLW .gs_ico{background-position:-0 -230px;}.gs_btnPRW .gs_ico{background-position:-23px -230px;}.gs_btnZI .gs_ico{background-position:-148px -22px;}.gs_btnZO .gs_ico{background-position:-127px -44px;}.gs_btnDE .gs_ico{background-position:-134px 0;}.gs_btnFI .gs_ico{background-position:-50px -66px;}.gs_btnAD .gs_ico{background-position:-141px -88px;opacity:.55;}.gs_btnAD:hover .gs_ico{opacity:.72;}.gs_btnAD:active .gs_ico,.gs_btnAD .gs_ico:active,.gs_btnAD :active~.gs_ico{opacity:1;}.gs_btnBA .gs_ico{background-position:-50px -22px;}.gs_btnADD .gs_ico{background-position:-92px -66px;}.gs_btnMRG .gs_ico{background-position:-113px 0;}.gs_btnLBL .gs_ico{background-position:0 -161px;}.gs_btnCNCL .gs_ico{background-position:-71px 0;}.gs_btnDWL .gs_ico{background-position:-28px -88px;}.gs_btnMNU .gs_ico{background-position:0 -88px;}.gs_btnMNT .gs_ico{background-position:-46px -161px;}.gs_btnALT .gs_ico{background-position:-92px -161px;}.gs_btnART .gs_ico{background-position:-115px -161px;}.gs_btnGSL .gs_ico{background-position:-69px -161px;}.gs_btnCLS .gs_ico{background-position:-138px -161px;}.gs_btnXBLU .gs_ico{background-position:-138px -253px;}.gs_btnSSB .gs_ico{background-position:0 -276px;}.gs_btnSSW .gs_ico{background-position:-23px -276px;}.gs_btnFLT .gs_ico{background-position:0 -184px;}.gs_btnXT .gs_ico{background-position:-46px -184px;}.gs_btnPD .gs_ico{background-position:-69px -184px;}.gs_btnPU .gs_ico {background-position:-92px -276px;}.gs_btnCP .gs_ico{background-position:-92px -184px;}.gs_btnTP .gs_ico{background-position:-138px -184px;}.gs_btnML .gs_ico{background-position:-115px -276px;}.gs_btnCHK .gs_ico{background-position:-71px -66px;}.gs_btnDNB .gs_ico{background-position:-115px -230px;}.gs_btnDNW .gs_ico{background-position:0 -207px;}.gs_btnACA .gs_ico{background-position:-23px -207px;}.gs_btnAPT .gs_ico{background-position:-46px -207px;}.gs_btnAPTW .gs_ico{background-position:-92px -230px;}.gs_btnAFL .gs_ico{background-position:-69px -207px;}.gs_btnAN .gs_ico{background-position:-46px -276px;}.gs_btnAI .gs_ico{background-position:-69px -276px;}.gs_btnPBL .gs_ico{background-position:-92px -207px;}.gs_btnUCT .gs_ico{background-position:-115px -207px;}.gs_btnVRF .gs_ico{background-position:-138px -207px;}.gs_btnLSI .gs_ico{background-position:-46px -230px;}.gs_btnLSG .gs_ico{background-position:-69px -230px;}.gs_btnMOR .gs_ico{background-position:-23px -253px;}.gs_btnADV .gs_ico{background-position:-46px -253px;}.gs_btnPRO .gs_ico{background-position:-69px -253px;}.gs_ico_star{background-position:-71px -44px;width:13px;height:13px;}.gs_btnPLSW .gs_ico{background-position:-138px -230px;}.gs_btnPDF .gs_ico{background-position:0 -253px;}.gs_btnS .gs_ico{background-position:-138px -276px;}.gs_btnUNS .gs_ico{background-position:0 -299px;}.gs_btnMORR .gs_ico{background-position:-23px -299px;}.gs_btnTW .gs_ico{background-position:-46px -299px;}.gs_btnIN .gs_ico{background-position:-69px -299px;}.gs_btnFB .gs_ico{background-position:-92px -299px;}#gs_hdr_drs,#gs_hdr_drw{position:fixed;top:0;left:0;width:100%;height:100%;z-index:1200;visibility:hidden;}#gs_hdr_drs{opacity:0;background-color:#fff;transition:opacity .15s,visibility 0s .15s;}.gs_el_ta #gs_hdr_drs,.gs_el_ph #gs_hdr_drs{background-color:#666;}#gs_hdr_drs.gs_vis{visibility:visible;opacity:.5;transition:opacity .15s,visibility 0s;}.gs_el_tc #gs_hdr_drs{transition:opacity .218s,visibility 0s .218s;}.gs_el_tc #gs_hdr_drs.gs_vis{transition:opacity .218s,visibility 0s;}#gs_hdr_drw{overflow:auto;width:228px;background-color:#fff;box-shadow:2px 2px 4px rgba(0,0,0,.15);outline:none;transform:translate(-100%,0);transition:transform .15s ease-in-out,visibility 0s .15s;}#gs_hdr_drw.gs_vis{visibility:visible;transform:translate(0,0);transition:transform .15s ease-in-out,visibility 0s;}.gs_el_tc #gs_hdr_drw{transition:transform .3s cubic-bezier(.4,0,.6,1),visibility 0s .3s;}.gs_el_tc #gs_hdr_drw.gs_vis{transition:transform .225s cubic-bezier(0,0,.2,1),visibility 0s;}#gs_hdr_drw.gs_abt,.gs_el_tc #gs_hdr_drw.gs_abt{transition:none;}#gs_hdr_drw_in{position:relative;box-sizing:border-box;min-height:100%;padding:0 0 8px 0;}.gs_el_ta #gs_hdr_drw_in,.gs_el_ph #gs_hdr_drw_in{padding:0 0 65px 0;}#gs_hdr_drw_top{position:relative;height:63px;border-bottom:1px solid #e5e5e5;margin-bottom:8px;}.gs_el_ta #gs_hdr_drw_top,.gs_el_ph #gs_hdr_drw_top{height:57px;}#gs_hdr_drw_mnu,#gs_hdr_drw_lgo{position:absolute;top:0;height:100%;}#gs_hdr_drw_mnu{left:0;width:55px;}#gs_hdr_drw_lgo{left:56px;}.gs_hdr_drw_sec:before{display:block;content:" ";height:0;border-bottom:1px solid #e5e5e5;margin:8px 0;}.gs_hdr_drw_sec:first-child:before{display:none;}#gs_hdr_drw_bot{display:none;}.gs_el_ta #gs_hdr_drw_bot,.gs_el_ph #gs_hdr_drw_bot{display:block;position:absolute;left:0;bottom:0;width:100%;height:65px;}#gs_hdr_drw_bot .gs_md_li:before{opacity:0;}#gs_hdr_drw_bot .gs_hdr_pp{display:block;position:absolute;bottom:14px;left:15px;pointer-events:none;}#gs_hdr_drw_bot .gs_lbl{display:block;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;}#gs_hdr{position:relative;height:63px;background-color:#f5f5f5;border-bottom:1px solid #e5e5e5;display:flex;}.gs_el_ta #gs_hdr,.gs_el_ph #gs_hdr{height:57px;}#gs_hdr_mnu,#gs_hdr_bck,#gs_hdr_lgo,#gs_hdr_lgt,#gs_hdr_md,#gs_hdr_sre,#gs_hdr_act{display:inline-block;vertical-align:top;position:relative;height:100%;flex:0 0 auto;}#gs_hdr_md{flex:1 1 auto;}#gs_hdr .gs_hdr_mbo,#gs_hdr .gs_hdr_mbo,.gs_el_ta #gs_hdr .gs_hdr_dso,.gs_el_ph #gs_hdr .gs_hdr_dso{display:none;}.gs_el_ta #gs_hdr .gs_hdr_mbo,.gs_el_ph #gs_hdr .gs_hdr_mbo{display:inline-block;}#gs_hdr_mnu,#gs_hdr_bck,#gs_hdr_sre{width:55px;margin-right:1px;}#gs_hdr_lgo,#gs_hdr_drw_lgo{width:149px;background:no-repeat url('/intl/en/scholar/images/1x/scholar_logo_24dp.png') 0% 50%;background-size:149px;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){#gs_hdr_lgo,#gs_hdr_drw_lgo{background-image:url('/intl/en/scholar/images/2x/scholar_logo_24dp.png');}}#gs_hdr_lgo{margin-right:31px;}.gs_el_ph #gs_hdr_lgo{margin-right:0;}#gs_hdr_lgt{min-width:164px;margin-right:16px;}#gs_hdr_lgt:empty{display:none;}#gs_hdr_md{margin-right:16px;min-width:1px;}#gs_hdr_lgt,#gs_hdr_md h1{padding:19px 0 0 0;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;font-size:20px;line-height:25px;font-weight:normal;color:#666;max-width:100%;text-align:left;}.gs_el_ta #gs_hdr_md h1,.gs_el_ph #gs_hdr_md h1{padding:16px 0 0 0;}#gs_hdr_srch{padding:14px 0 0 0;max-width:600px;}.gs_el_ta #gs_hdr_srch,.gs_el_ph #gs_hdr_srch{padding:10px 0 0 0;max-width:none;}#gs_hdr_frm{position:relative;padding-right:39px;}#gs_hdr_tsi{height:38px;border-radius:2px 0 0 2px;}#gs_hdr_tsi::-ms-clear{display:none;}#gs_hdr_tsc{display:none;position:absolute;top:3px;right:41px;width:21px;height:21px;padding:6px 10px 7px 10px;}.gs_in_acw[dir="rtl"]~#gs_hdr_tsc{right:auto;left:1px;}#gs_hdr_tsb{position:absolute;top:0;right:0;width:40px;height:38px;border-radius:0 2px 2px 0;}#gs_hdr_frm_ac{top:37px;right:40px;}.gs_el_ph #gs_hdr_frm_ac{right:0;}.gs_el_ph .gs_hdr_ifc #gs_hdr_mnu,.gs_el_ph .gs_hdr_ifc #gs_hdr_bck,.gs_hdr_src #gs_hdr_srch,.gs_hdr_src #gs_hdr_lgt,.gs_hdr_srx #gs_hdr_sre,.gs_hdr_srx #gs_hdr_md h1,.gs_hdr_srx #gs_hdr_md h1.gs_hdr_mbo,.gs_hdr_srx #gs_hdr_md h1.gs_hdr_dso,.gs_el_ta .gs_hdr_srx #gs_hdr_lgo,.gs_el_ph .gs_hdr_srx #gs_hdr_lgo,.gs_el_ph .gs_hdr_srx #gs_hdr_mnu,.gs_el_ph .gs_hdr_srx #gs_hdr_bck{display:none;}.gs_el_ph .gs_hdr_ifc #gs_hdr_md,.gs_el_ph .gs_hdr_srx #gs_hdr_md{margin-left:16px;}.gs_el_tc .gs_hdr_tsc #gs_hdr_tsi[dir="ltr"]{padding-right:41px;}.gs_el_tc .gs_hdr_tsc #gs_hdr_tsi[dir="rtl"]{padding-left:41px;}.gs_el_tc .gs_hdr_tsc .gs_in_acw~#gs_hdr_tsc{display:block;}#gs_hdr_act{min-width:64px;max-width:200px;text-align:right;float:right;}.gs_el_ta #gs_hdr_act,.gs_el_ph #gs_hdr_act{display:none;}#gs_hdr_act_i,#gs_hdr_act_s{display:inline-block;padding:23px 24px 23px 16px;max-width:100%;box-sizing:border-box;font-size:13px;line-height:17px;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;color:#444;}#gs_hdr_act_s{text-transform:uppercase;}.gs_el_sm #gs_hdr_act_i,.gs_el_sm #gs_hdr_act_s{padding:23px 16px;}.gs_el_ta #gs_hdr_act_i,.gs_el_ta #gs_hdr_act_s,.gs_el_ph #gs_hdr_act_i,.gs_el_ph #gs_hdr_act_s{padding:20px 16px;}#gs_hdr_act_i:active,#gs_hdr_act_s:active{color:#d14836;}#gs_hdr_act_i,.gs_el_sm #gs_hdr_act_i{padding-top:15px;padding-bottom:16px;}.gs_el_ta #gs_hdr_act_i,.gs_el_ph #gs_hdr_act_i{padding-top:12px;padding-bottom:13px;}#gs_hdr_act_i .gs_hdr_pp{vertical-align:top;}#gs_hdr_act_d{top:63px;left:auto;right:24px;min-width:288px;max-width:400px;}.gs_el_sm #gs_hdr_act_d{right:16px;}.gs_el_ta #gs_hdr_act_d{top:57px;}.gs_el_ph #gs_hdr_act_d{top:57px;min-width:280px;max-width:280px;max-width:90vw;}/* Account dialog body. */#gs_hdr_act_aw,#gs_hdr_act_ap,.gs_hdr_act_am,#gs_hdr_act_ab{display:block;padding:10px 20px;word-wrap:break-word;white-space:normal;}#gs_hdr_act_aw{background-color:#fef9db;font-size:11px;}#gs_hdr_act_ap,.gs_hdr_act_am{border-bottom:1px solid #ccc;}#gs_hdr_act_ap{padding:20px;}.gs_el_ph #gs_hdr_act_ap{padding:10px;}#gs_hdr_act_apb{margin-top:12px;}#gs_hdr_act_aa:link,#gs_hdr_act_aa:visited{float:right;margin-left:8px;color:#1a0dab;}#gs_hdr_act_aa:active{color:#d14836}.gs_hdr_act_am:link,.gs_hdr_act_am:visited{color:#222;text-decoration:none;background:#fbfbfb;}.gs_hdr_act_am:hover,.gs_hdr_act_am:focus{background:#f1f1f1;}.gs_hdr_act_am:active{background:#eee;}#gs_hdr_act_ab{background:#fbfbfb;padding:10px 0;display:table;width:100%;white-space:nowrap;}#gs_hdr_act_aba,#gs_hdr_act_abs{display:table-cell;padding:0 20px;}#gs_hdr_act_abs{text-align:right;}.gs_el_ph #gs_hdr_act_aba,.gs_el_ph #gs_hdr_act_abs{display:block;padding:10px;text-align:center;}.gs_el_ph #gs_hdr_act_aba button,.gs_el_ph #gs_hdr_act_abs button{width:100%;}#gs_hdr_act_a1,#gs_hdr_act_a2{position:absolute;top:-9px;right:7.5px;width:0;height:0;z-index:1;border:8.5px solid transparent;border-top:none;border-bottom-color:#333;border-bottom-color:rgba(0,0,0,.2);}#gs_hdr_act_a2{top:-8px;border-bottom-color:#fff;}.gs_hdr_act_mw #gs_hdr_act_a2{border-bottom-color:#fef9db;}.gs_hdr_pp{border-radius:50%;overflow:hidden;}#gs_hdr_act_ap .gs_hdr_pp,.gs_hdr_act_am .gs_hdr_pp{float:left;}#gs_hdr_act_ap .gs_hdr_pm{margin-left:116px;}.gs_hdr_act_am .gs_hdr_pm{margin:6px 0 0 58px;}#gs_ab{position:relative;height:41px;border-bottom:1px solid #e5e5e5;display:flex;white-space:nowrap;background-color:#fff;z-index:1000;}.gs_el_ta #gs_ab.gs_nta,.gs_el_ph #gs_ab.gs_nph{display:none;}#gs_ab_g{height:42px;}.gs_sth_vis #gs_ab{position:fixed;}#gs_ab_ico,#gs_ab_ttl,#gs_ab_md,#gs_ab_btns{display:inline-block;vertical-align:top;position:relative;height:100%;flex:0 0 auto;}.gs_el_ph #gs_ab_md{display:block;}#gs_ab_ico{width:55px;margin-right:1px;}#gs_ab_ico .gs_ico{position:absolute;top:50%;left:50%;margin:-10.5px 0 0 -10.5px;}#gs_ab_ttl{min-width:172px;padding-right:8px;}.gs_el_sm #gs_ab_ttl{min-width:68px;}.gs_el_ta #gs_ab_ttl,.gs_el_ph #gs_ab_ttl{min-width:0;}#gs_ab_ttl,#gs_ab_ttll{font-size:18px;color:#666;text-transform:none;}.gs_el_sm #gs_ab_ttl,.gs_el_sm #gs_ab_ttll{font-size:16px;}#gs_ab_ttll{overflow:hidden;text-overflow:ellipsis;max-width:200px;}#gs_ab_md{flex:1 0 auto;}.gs_ab_st #gs_ab_md{flex:1 1 auto;font-size:13px;line-height:17px;padding:0 8px;color:#999;overflow:hidden;text-overflow:ellipsis;}.gs_el_ph .gs_ab_st #gs_ab_md{visibility:hidden;padding:0;}#gs_ab_btns{margin-right:8px;}.gs_el_sm #gs_ab_btns{margin-right:0;}.gs_el_ta #gs_ab_btns,.gs_el_ph #gs_ab_btns{margin-right:4px;}#gs_ab_ttl:before,#gs_ab_md:before,#gs_ab_btns:before{content:"";display:inline-block;width:0;height:100%;vertical-align:middle;}#gs_ab_md>button,#gs_ab_btns>button,#gs_ab_md>.gs_in_ib,#gs_ab_btns>.gs_in_ib,#gs_ab_md>.gs_md_r,#gs_ab_btns>.gs_md_r,#gs_ab .gs_ab_mdw,#gs_ab .gs_ab_btw{margin:0 8px;vertical-align:middle;}#gs_ab .gs_ab_mdw,.gs_ab_btw{display:inline-block;margin:0;}#gs_ab_btns>.gs_in_ib{margin:0 16px 0 8px;}#gs_ab .gs_ab_btw{margin:0 12px 0 16px;}.gs_el_ta .gs_ab_sel #gs_ab_ico,.gs_el_ph .gs_ab_sel #gs_ab_ico,.gs_el_ta .gs_ab_sel #gs_ab_ttl,.gs_el_ph .gs_ab_sel #gs_ab_ttl,.gs_el_ta .gs_ab_sel #gs_ab_btns,.gs_el_ph .gs_ab_sel #gs_ab_btns{display:none;}#gs_bdy{display:table;table-layout:fixed;width:100%;}#gs_bdy_sb{vertical-align:top;width:228px;word-wrap:break-word;display:none;}.gs_el_sm #gs_bdy_sb{}.gs_el_ta #gs_bdy_sb,.gs_el_ph #gs_bdy_sb{}.gs_bdy_sb_sec{margin:0 40px 0 56px;}.gs_bdy_sb_sec:before{display:block;content:" ";height:0;margin:13px 0;border-top:1px solid #eee;}.gs_bdy_sb_sec:first-child:before{margin:21px 0 0 0;border:none;}#gs_bdy_sb ul{list-style-type:none;}.gs_bdy_sb_sec a:link,.gs_bdy_sb_sec a:visited{color:#222;}.gs_bdy_sb_sec a:active{color:#d14836;}.gs_bdy_sb_sel a:link,.gs_bdy_sb_sel a:visited{color:#d14836;text-decoration:none;}.gs_el_tc .gs_bdy_sb_sec li.gs_ind,.gs_el_tc .gs_bdy_sb_sec li.gs_ind a{padding-top:8px;padding-bottom:5px;}.gs_el_tc .gs_bdy_sb_sec:first-child li.gs_ind:first-child{margin-top:-8px;}#gs_bdy_sb .gs_ind,#gs_bdy_sb .gs_inw{margin-bottom:4px;}.gs_el_tc #gs_bdy_sb .gs_ind,.gs_el_tc #gs_bdy_sb .gs_inw{margin-bottom:0;}#gs_bdy_ccl{display:table-cell;vertical-align:top;padding:0 24px 0 16px;}.gs_el_sm #gs_bdy_ccl{padding:0 16px;}.gs_el_ta #gs_bdy_ccl,.gs_el_ph #gs_bdy_ccl{padding:0 16px;}.gs_el_ph #gs_bdy_ccl{padding:0;}#gs_ftr_sp{height:62px;}.gs_el_sm #gs_ftr_sp{height:57px;}#gs_ftr{position:absolute;bottom:0;left:0;width:100%;white-space:nowrap;border-top:1px solid #e4e4e4;background-color:#f2f2f2;display:flex;}#gs_ftr_rt{box-sizing:border-box;max-width:100%;overflow-x:auto;margin-left:auto;padding:0 12px;}.gs_el_sm #gs_ftr_rt{padding:0 8px;}.gs_el_ph #gs_ftr_rt:after{content:" ";position:absolute;top:0;right:0;width:16px;height:100%;background-image:linear-gradient(to right,rgba(242,242,242,0),rgba(242,242,242,1) 80%);}#gs_ftr_rt a{display:inline-block;line-height:16px;padding:12px;white-space:nowrap;}.gs_el_sm #gs_ftr_rt a{padding:12px 8px;}#gs_ftr_rt a:link,#gs_ftr_rt a:visited{color:#666}#gs_ftr_rt a:active{color:#d14836}#gsc_a_t{width:100%;table-layout:fixed;}#gsc_a_tr0,#gsc_a_trh{box-sizing:border-box;}#gsc_a_tr0 th.gsc_a_x,#gsc_a_tr0 th.gsc_a_t,#gsc_a_tr0 th.gsc_a_c,#gsc_a_tr0 th.gsc_a_y{height:0;}#gsc_a_trh{z-index:700;background-color:#f5f5f5;height:42px;}.gs_el_ta #gsc_a_trh,.gs_el_ph #gsc_a_trh,.gs_el_ta #gsc_a_t td,.gs_el_ph #gsc_a_t td{background-color:#fff;border-bottom:1px solid #e5e5e5;}#gsc_a_t th.gsc_a_x,#gsc_a_t th.gsc_a_t,#gsc_a_t th.gsc_a_c,#gsc_a_t th.gsc_a_y{box-sizing:border-box;text-transform:uppercase;vertical-align:middle;padding-top:0;padding-bottom:0;}#gsc_x_all{z-index:1;}.gsc_a_x,.gsc_a_t,.gsc_a_c,.gsc_a_y,.gsc_a_e{font-weight:normal;padding:16px 16px 0 16px;vertical-align:top;text-align:right;}.gsc_a_c{padding:16px 8px 0 8px;}.gs_el_sm .gsc_a_x,.gs_el_sm .gsc_a_t,.gs_el_sm .gsc_a_c{padding:12px 8px 0 8px;}.gs_el_ta .gsc_a_x,.gs_el_ta .gsc_a_t,.gs_el_ta .gsc_a_c,.gs_el_ph .gsc_a_x,.gs_el_ph .gsc_a_t,.gs_el_ph .gsc_a_c{padding:12px 8px;}.gs_el_sm .gsc_a_y{padding:12px 8px 0 8px;}.gs_el_ta .gsc_a_y{padding-bottom:12px;}.gsc_a_x{width:41px;padding:4px 0 0 0;}.gs_el_sm .gsc_a_x{padding:0;}.gsc_a_t{text-align:left;}.gs_el_ph .gsc_a_t{padding-left:16px;}#gsc_a_ta{display:inline-block;vertical-align:middle;margin-right:16px;}.gs_el_ph #gsc_a_ta{display:none}.gs_el_ph .gsc_a_c{padding-right:16px;}th.gsc_a_c{width:64px;white-space:nowrap;}.gsc_art_sel #gsc_a_ta,.gsc_art_sel #gsc_a_ca,.gsc_art_sel .gsc_a_h{display:none;}.gsc_a_ac,.gsc_a_hc{margin-top:3px;}th.gsc_a_y{width:88px;white-space:nowrap;}.gs_el_sm th.gsc_a_y{width:58px;}.gs_el_ph th.gsc_a_y,.gs_el_ph td.gsc_a_y{width:0;padding:0;}.gs_el_ph .gsc_a_h{display:none}@media print{#gs_top th.gsc_a_y{width:58pt;}#gs_top #gsc_a_tr0{display:none}#gs_top #gsc_a_trh{position:static}}.gsc_a_e{padding:16px;text-align:center;}.gsc_a_a{padding:8px 0}.gsc_a_at{padding:8px 0;font-size:16px}a.gsc_a_acm{text-decoration:line-through;}a.gsc_a_acm:hover,a.gs_a_acm:active{text-decoration:underline;}.gsc_a_m{position:absolute;}.gs_el_ph .gsc_a_m{display:block;position:static;}.gsc_a_am{font-size:24px;position:absolute;top:-18px;left:-2px;padding:8px 12px 4px 8px;}.gs_el_ph .gsc_a_am{display:inline-block;position:static;padding:6px 16px;margin-bottom:-6px;}#gsc_a_sp{visibility:hidden;}#gsc_a_sp.gs_vis{visibility:visible;padding:16px 0;height:25px;border-bottom:1px solid #ccc;}#gsc_a_sp:after{display:block;height:100%;content:" ";background:url('/intl/en/scholar/images/spinner.gif') no-repeat 50% 50%;opacity:0;}#gsc_a_sp.gs_vis:after{opacity:1;transition:opacity 0s .4s;}#gsc_a_err{display:none;padding:28px 0;}#gsc_a_err.gs_vis{display:block;}#gsc_md_iad{width:800px;max-width:94%;}.gs_el_ph #gsc_md_iad{width:100%;max-width:100%;}#gsc_md_iad .gs_md_prg{min-height:400px;}.gs_el_ph #gsc_iads_res .gs_md_prg{margin:0 16px;}#gsc_iad_tart,.gsc_iad_tsel.gsc_iad_tart #gsc_iad_tart,.gsc_iad_tart #gsc_iad_tgrp,.gsc_iad_tsel #gsc_iad_tgrp,#gsc_iad_tsel,#gsc_napb_hdr #gsc_iad_tart,#gsc_napb_hdr #gsc_iad_tgrp{display:none;}#gsc_iad_tgrp,.gsc_iad_tart #gsc_iad_tart,.gsc_iad_tsel #gsc_iad_tsel,#gsc_napb_hdr #gsc_iad_tsel{display:inline-block;}#gsc_iad_t:not(.gsc_iad_tsel) #gsc_iad_tsel{pointer-events:none;color:#b5b5b5;}.gs_el_ph #gsc_napb #gsc_iads_frm{margin:0 16px;}#gsc_iads_res{position:relative;margin:8px 0 16px 0;min-height:80px;border-bottom:1px solid #e5e5e5;}.gs_el_ph #gsc_md_iad #gsc_iads_res{margin:8px -16px 16px -16px;}.gs_el_ph #gsc_napb #gsc_iads_pp{margin-right:16px;}#gsc_iadb_hdr{display:table;table-layout:fixed;width:100%;}#gsc_iadb_hdr_cb,#gsc_iadb_hdr_instr{display:table-cell;vertical-align:middle;height:41px;}#gsc_iadb_hdr_cb{width:41px;}#gsc_iadb_hdr_cb:empty{width:0;}.gs_el_ph #gsc_iadb_hdr_cb:empty{width:16px;}#gsc_iadb_hdr_instr{font-size:16px;}.gs_el_ph #gsc_iadb_hdr_instr{padding-right:16px;}.gsc_oic{position:relative;}.gsc_oic_cb{font-weight:normal;border-top:1px solid #e5e5e5;border-bottom:1px solid #e5e5e5;background-color:#fcfcfc;padding-right:16px;}.gsc_oict{display:block;overflow:hidden;}.gsc_oict_name{display:block;font-size:16px;line-height:20px;word-wrap:break-word;}.gsc_oict_inf{display:block;float:right;margin-left:16px;white-space:nowrap;}.gsc_oict_all,.gsc_oict_prf{font-size:13px;text-transform:uppercase;line-height:20px;}.gsc_oict_all[data-a]{color:#1a0dab;cursor:pointer;}.gsc_oict_all[data-a]:hover{text-decoration:underline;}.gsc_oict_all[data-a]:active{color:#d14836;}.gsc_oict_prf{padding-left:8px;margin-left:8px;border-left:1px solid #e0e0e0;}.gsc_oict_prf:empty{display:none;}.gs_el_ph .gsc_oict_all,.gs_el_ph .gsc_oict_prf{float:right;clear:both;margin:0;padding:0;border:none;}.gs_el_ph .gsc_oict_prf{margin-top:2px;}.gsc_oic_res{margin:8px 0 12px 41px;}.gs_el_ph .gsc_oic_res{margin-right:16px;}.gsc_oic_res h4{font-size:13px;font-weight:normal;}.gsc_oic_dis .gsc_oic_name,.gsc_oic_dis .gsc_oic_all,.gsc_oic_dis .gsc_oic_prf{color:#777;}.gsc_oic_dis .gsc_oict_all[data-a]{color:#1a0dab;opacity:.66;}.gsc_oic_dis .gsc_oic_res{opacity:.5;}.gsc_iadb_art{border-top:1px solid #e5e5e5;overflow:hidden;}.gsc_iadb_art_cb{float:left;}.gsc_iadb_art_added{float:right;margin:12px;font-size:11px;text-transform:uppercase;color:#777;}.gs_el_ph .gsc_iadb_art_added{display:block;float:none;text-align:right;margin:8px 16px;}.gsc_iadb_art_added:empty{display:none;}.gsc_iadb_art_body{margin:12px 0 12px 41px;}.gs_el_ph .gsc_iadb_art_body{margin:12px 16px 12px 41px;}.gsc_iadb_art_body h3{font-size:13px;font-weight:normal;}.gsc_iadb_art_dis .gsc_iadb_art_body{opacity:.5;}#gsc_md_mopt,#gsc_md_cbyd,#gsc_md_cbym{width:600px;}.gs_el_ta #gsc_md_mopt,.gs_el_ta #gsc_md_cbyd,.gs_el_ta #gsc_md_cbym{width:500px;}.gs_el_ph #gsc_md_mopt,.gs_el_ph #gsc_md_cbyd,.gs_el_ph #gsc_md_cbym{width:100%;}.gsc_mob_art{vertical-align:top;padding:8px 0;}.gs_el_tc .gsc_mob_art>.gs_in_ra{margin-top:-8px;}.gsc_mob_cby{vertical-align:top;text-align:right;padding:8px 12px;position:relative;}.gsc_mob_ttl,.gsc_mob_pub{display:block;}.gsc_mob_pub{color:#666;}.gsc_mob_cbym{text-decoration:line-through}.gsc_mob_cbm{font-size:24px;position:absolute;padding:4px 0 0 4px;line-height:16px;}.gs_fsvg line{stroke:#222222}a:link .gs_fsvg{fill:#1a0dab;}a:link .gs_fsvg line{stroke:#1a0dab;}a:visited .gs_fsvg{fill:#660099;}a:visited .gs_fsvg line{stroke:#660099;}a:active .gs_fsvg{fill:#d14836;}a:active .gs_fsvg line{stroke:#d14836;}a .gs_fsvg{border-bottom:1px solid transparent;}a:hover .gs_fsvg,a:focus .gs_fsvg{border-bottom-color:inherit;}.gs_fsml{font-size:13px}.gs_fscp{font-variant:small-caps}.gsh_clim{display:table-row}.gsh_clil,.gsh_clic{display:table-cell;padding-bottom:8px}.gsh_clil{padding-right:8px;}.gsh_lla{list-style-type:lower-alpha}.gsh_lua{list-style-type:upper-alpha}.gsh_llr{list-style-type:lower-roman}.gsh_lur{list-style-type:upper-roman}.gsh_l>li{margin-left:32px;}.gsh_h3{font-size:inherit;font-weight:normal}.gsh_h3,.gsh_csp{margin:16px 0}.gsh_h3+.gsh_csp{margin-top:-8px}.gsh_ovln{text-decoration:overline}.gsh_small .gsh_l .gsh_csp{margin:8px 0}.gsh_small .gsh_csp:first-child,.gsh_small .gsh_h3:first-child{margin-top:0}.gsh_small .gsh_csp:last-child{margin-bottom:0}.gsh_dspfr{text-align:center}.gsh_dspfr svg{margin:8px 0}.gs_pp_tn,.gs_el_ta .gs_pp_mo_tn,.gs_el_ph .gs_pp_mo_tn{width:32px;height:32px;}.gs_pp_sm,.gs_el_ta .gs_pp_mo_sm,.gs_el_ph .gs_pp_mo_sm{width:56px;height:56px;}.gs_pp_nm,.gs_el_ta .gs_pp_mo_nm,.gs_el_ph .gs_pp_mo_nm{width:128px;height:128px;}.gs_ai_pho{float:left;}.gs_ai_t{margin-left:72px;}.gs_ai_pho_pst+.gs_ai_t{margin-left:48px;}.gs_ai_t.gs_ai_pss{margin-left:64px;}.gs_ai_pho_pst+.gs_ai_t.gs_ai_pss{margin-left:40px;}.gs_ai_name{font-size:17px;font-weight:normal;margin-bottom:4px;}.gs_ai_name a{padding:6px 0 4px 0;}.gs_ai_name.gs_ai_name_nlsb{font-size:15px;}.gs_ai_name.gs_ai_name_nlsb a:link,.gs_ai_name.gs_ai_name_nlsb a:visited{padding:7px 0 5px 0; color:#222;}.gs_ai_name.gs_ai_name_nlsb a:active{color:#d14836;}.gs_ai_int{margin-top:5px;}.gs_ai_eml:empty,.gs_ai_int:empty,.gs_ai_cby:empty{display:none;}.gs_ai_one_int{vertical-align:top;font-size:13px;margin-right:8px;white-space:nowrap;display:inline-block;max-width:200px;text-overflow:ellipsis;overflow:hidden;}.gs_el_tc a.gs_ai_one_int{padding:8px 0 5px 0;}.gs_el_ph .gs_ai_eml,.gs_el_ph .gs_ai_cby{margin-top:8px;}.gs_ai_ilnl .gs_ai_int,.gs_ai_ilnl .gs_ai_cby{margin-top:8px;color:#666;}.gs_ai.gs_ai_chpr{position:relative;}.gs_ai_chpr .gs_ai_t{margin-right:276px;}.gs_el_sm .gs_ai_chpr .gs_ai_t{margin-right:156px;}.gs_el_ph .gs_ai_chpr .gs_ai_t{margin-right:0;}.gs_ai_chpr .gs_ai_cby{position:absolute;top:4px;right:0;text-align:right;}.gs_el_sm .gs_ai_chpr .gs_ai_cby,.gs_el_ta .gs_ai_chpr .gs_ai_cby{width:132px;word-wrap:break-word;}.gs_el_ph .gs_ai_chpr .gs_ai_cby{text-align:left;position:static;width:auto;}#gsc_bdy{position:relative;max-width:1200px;margin:0 auto;}.gs_el_ph #gsc_bdy,.gs_el_ta #gsc_bdy{display:flex;flex-flow:column;}.gsc_lcl{position:relative;margin:0 350px 0 0;order:3;}.gs_el_sm .gsc_lcl{margin-right:334px;}.gs_el_ta .gsc_lcl,.gs_el_ph .gsc_lcl{margin:0;}#gsc_prf_t_wrp{position:relative;order:2;overflow:hidden;}.gs_el_tc #gsc_prf_t_wrp:after{display:block;content:"";position:absolute;z-index:100;top:0;right:0;width:12px;height:100%;background-image:linear-gradient(to right,rgba(247,247,247,0),rgba(247,247,247,1) 80%);}#gsc_prf_t{width:100%;background-color:#f5f5f5;display:none;white-space:nowrap;overflow-x:auto;padding:0 4px;}.gs_el_ta #gsc_prf_t,.gs_el_ph #gsc_prf_t{display:block;}#gsc_prf_t:after{content:"\00A0";padding:0 4px;}.gsc_prf_tab,.gsc_prf_tab:link{font-size:13px;text-transform:uppercase;padding:13px 12px;display:inline-block;color:#666;cursor:pointer;}.gsc_prf_tab:hover{color:#000;text-decoration:none}.gsc_prf_tab:active{color:#4d90fe;}.gsc_prf_tab[aria-selected="true"]{border-bottom:2px solid #4d90fe;color:#0461f9;cursor:default;}.gs_el_ta #gsc_art,.gs_el_ph #gsc_art,.gs_el_ta #gsc_rsb_cit,.gs_el_ph #gsc_rsb_cit,.gs_el_ta #gsc_rsb_mnd,.gs_el_ph #gsc_rsb_mnd,.gs_el_ta #gsc_rsb_awd,.gs_el_ph #gsc_rsb_awd,.gs_el_ta #gsc_rsb_co,.gs_el_ph #gsc_rsb_co{display:none;}#gsc_bdy[data-tab="gsc_prf_t-art"] #gsc_art,#gsc_bdy[data-tab="gsc_prf_t-cit"] #gsc_rsb_cit,#gsc_bdy[data-tab="gsc_prf_t-mnd"] #gsc_rsb_mnd,#gsc_bdy[data-tab="gsc_prf_t-awd"] #gsc_rsb_awd,#gsc_bdy[data-tab="gsc_prf_t-ath"] #gsc_rsb_co{display:block;}.gsc_rsb{float:right;width:317px;order:4;border-left:1px solid #eee;margin-top:32px;}.gs_el_sm .gsc_rsb{margin-top:16px;}.gs_el_ph .gsc_rsb,.gs_el_ta .gsc_rsb{float:none;width:auto;border:none;margin:0;}.gsc_rsb_s{margin:0 0 48px 16px;position:relative;}.gs_el_sm .gsc_rsb_s{margin:0 0 32px 16px;}.gs_el_ph .gsc_rsb_s,.gs_el_ta .gsc_rsb_s{margin:0;}.gsc_rsb_s:last-child{margin-bottom:0;}.gsc_rsb_header{padding:8px 8px 12px 8px;border-bottom:1px solid #e5e5e5;font-weight:normal;font-size:15px;}.gs_el_sm .gsc_rsb_header{padding:4px 8px 9px 8px;}.gs_el_ph .gsc_rsb_header,.gs_el_ta .gsc_rsb_header{display:none;}.gsc_rsb_action{position:absolute;top:-3px;right:-2px;}.gs_el_sm .gsc_rsb_action{top:-8px;}.gsc_rsb_tap{display:block;position:absolute;right:2px;top:12px;opacity:.5;z-index:1;}.gs_el_ta .gsc_rsb_tap,.gs_el_ph .gsc_rsb_tap{top:24px;right:10px;}.gsc_rsb_hm{border-bottom:1px solid #e5e5e5;padding:3px 6px;}#gsc_rsb_gpl{display:block;margin-top:3px;padding:6px 16px;line-height:15px;color:#0461f9;border:1px solid #4d90fe;border-radius:2px;text-align:center;text-transform:uppercase;}.gs_el_sm #gsc_rsb_gpl{margin-top:0;}.gs_el_ta #gsc_rsb_gpl,.gs_el_ph #gsc_rsb_gpl{display:none;}#gsc_rsb_st{width:100%;}.gsc_rsb_std{text-align:right;padding-right:8px;}.gs_el_ta .gsc_rsb_std,.gs_el_ph .gsc_rsb_std{padding-right:16px;}.gsc_rsb_sc1{text-align:left;padding:2px 8px;}.gs_el_sm .gsc_rsb_sc1{padding:0 8px;}.gs_el_ta .gsc_rsb_sc1,.gs_el_ph .gsc_rsb_sc1{padding:4px 16px;}.gsc_rsb_sth{font-weight:normal;padding:8px 8px 8px 0;border-bottom:1px solid #e5e5e5;text-align:right;}.gs_el_sm .gsc_rsb_sth{padding:4px 8px 4px 0;}.gs_el_ta .gsc_rsb_sth,.gs_el_ph .gsc_rsb_sth{padding:16px 16px 16px 0;}#gsc_rsb_st tbody:before,#gsc_rsb_st tbody:after{content:'';display:block;height:8px;}.gs_el_sm #gsc_rsb_st tbody:before,.gs_el_sm #gsc_rsb_st tbody:after{height:4px;}.gs_el_ph #gsc_hist_opn,.gs_el_ta #gsc_hist_opn{display:none;}.gsc_rsb_f{max-width:118px;word-wrap:break-word;white-space:normal;}.gs_el_ta .gsc_rsb_f{max-width:none;}.gsc_rsb_f:link,.gsc_rsb_f:visited{color:#222;}.gsc_rsb_m_na{color:#dd4b39;}.gsc_rsb_m_a{color:#006621;float:right;position:relative;}.gsc_rsb_m_bar{width:100%;height:4px;margin:8px 0 8px 0;background:#006621;}.gsc_rsb_m_bar_na{background:#dd4b39;width:100%;height:100%;z-index:1;}.gsc_rsb_m{padding:8px;}.gs_el_ta .gsc_rsb_m,.gs_el_ph .gsc_rsb_m{padding:8px 16px;}.gsc_rsb_m_desc{padding-top:16px;color:#777;}.gsc_rsb_m_s{font-size:24px;position:absolute;line-height:0.3;}#gsc_lwp_mndt_lnk{text-transform:uppercase;margin-left:16px;margin-right:-9px;text-align:right;font-size:13px;padding:12px 9px;border-radius:3px;}#gsc_lwp_mndt_lnk:hover,#gsc_lwp_mndt_lnk:active,#gsc_lwp_mndt_lnk:visited{text-decoration:none;color:#1a0dab;}#gsc_lwp_mndt_lnk:hover{background-color:rgba(0,0,0,.05);}#gsc_lwp_mndt_lnk:active{background-color:rgba(0,0,0,.1);}.gsc_rsb_m_title{padding-bottom:12px;}.gsc_rsb_m_header{display:flex;align-items:flex-end;justify-content:space-between;padding:0 8px;}.gs_el_sm .gsc_rsb_m_header{padding:0 8px;}.gsc_rsb_hmv{text-align:center;padding-top:16px;}.gsc_rsb_a{list-style:none;}.gsc_rsb_a>li{position:relative;}.gs_el_ta .gsc_rsb_a>li,.gs_el_ph .gsc_rsb_a>li{border-bottom:1px solid #e5e5e5;}.gsc_rsb_a>li:first-child{margin-top:8px;}.gsc_rsb_a_pht{float:left;width:32px;height:32px;}.gsc_rsb_a_desc{margin:0 33px 0 48px;min-height:32px;display:block;}.gs_el_ph .gsc_rsb_a_desc,.gs_el_ta .gsc_rsb_a_desc{margin:0 33px 0 64px;min-height:56px;}.gsc_rsb_a_desc a{color:#222;}.gsc_rsb_a_ext{display:block;color:#777;font-size:13px;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;}.gs_el_ph .gsc_rsb_a_ext,.gs_el_ta .gsc_rsb_a_ext{white-space:normal;}.gsc_rsb_a_ext2{display:none;}.gs_el_ph .gsc_rsb_a_ext2,.gs_el_ta .gsc_rsb_a_ext2{display:block;}.gsc_rsb_aa{display:block;padding:8px;line-height:normal;cursor:pointer;}.gs_el_ph .gsc_rsb_aa,.gs_el_ta .gsc_rsb_aa{font-size:17px;padding:12px 16px;}.gsc_rsb_aa:hover,.gsc_rsb_aa:active{text-decoration:none;background:#f1f1f1;}.gsc_rsb_aa a:hover{text-decoration:none;}#gsc_prf_w{order:1;padding:32px 0;overflow:hidden;}.gs_el_sm #gsc_prf_w{padding:16px 0;}#gsc_prf_pu{float:left;width:128px;height:128px;text-align:center;}.gs_el_ph #gsc_prf_pu{float:none;width:100%;margin:0 0 8px 0;}#gsc_prf_pua{line-height:0;width:128px;height:128px;}.gs_el_ph #gsc_prf_pua{margin:0 auto;}#gsc_prf_pufi{width:0;height:0;overflow:hidden;}.gsc_prf_pufo #gsc_prf_pufi{width:auto;height:auto;overflow:visible;position:relative;z-index:10;}.gsc_prf_pufo #gsc_prf_pufi2{display:inline-block;background:#fcfcfc;padding:8px 8px 8px 0;}.gsc_prf_puic{position:absolute;bottom:0;width:100%;padding:8px 0;background-color:#000;opacity:.6;}.gsc_prf_pel{cursor:pointer;}#gsc_prf_i{margin:0 16px 0 160px;}.gs_el_sm #gsc_prf_i{margin:0 16px 0 144px;}.gs_el_ph #gsc_prf_i{margin:0 16px;text-align:center;}#gsc_prf_btne{vertical-align:top;margin:-9px 4px;}.gs_el_ph #gsc_prf_btne{position:absolute;top:60px;right:8px;margin:0;}#gsc_prf_btnf{float:right;margin:3px 0 16px 16px;}.gs_el_sm #gsc_prf_btnf{margin-top:0;}.gs_el_ph #gsc_prf_btnf{float:none;margin:0;position:absolute;top:8px;right:8px;border-radius:50%;}#gsc_prf_btnf .gs_lbl{padding:0 4px;}#gsc_prf_in{font-size:24px;line-height:24px;padding:3px 0 12px 0;word-wrap:break-word;}.gs_el_sm #gsc_prf_in{font-size:22px;padding:3px 0 8px 0;}.gs_el_ph #gsc_prf_in{font-size:20px;padding:0 0 2px 0;}.gsc_prf_il{font-size:15px;line-height:18px;padding:1px 0;}.gs_el_ph .gsc_prf_il{font-size:13px;line-height:16px;}.gsc_prf_ila:link,.gsc_prf_ila:visited{text-decoration:underline;color:#222;}#gsc_prf_int{margin-top:5px;}#gsc_prf_int:empty{display:none;}.gsc_prf_inta{margin-right:16px;white-space:nowrap;max-width:200px;text-overflow:ellipsis;overflow:hidden;vertical-align:top;}.gsc_prf_inta:last-child{margin:0}.gs_el_tc .gsc_prf_ila,.gs_el_tc .gsc_prf_inta{padding:8px 0 5px 0;}.gsc_md_pro_tt,.gsc_md_pro_ch #gsc_md_pro_lgtm,#gsc_md_pro_save{display:none;}.gsc_md_pro_ed #gsc_md_pro_ted,.gsc_md_pro_aa #gsc_md_pro_taa,.gsc_md_pro_ra #gsc_md_pro_tra,.gsc_md_pro_an #gsc_md_pro_tan,.gsc_md_pro_ai #gsc_md_pro_tai,.gsc_md_pro_ch #gsc_md_pro_save{display:inline-block;}.gsc_md_pro_el{color:#777;}.gsc_md_pro_ev{padding:4px 0 16px 0;}#gsc_dd_add-d,#gsc_dd_exp-d,#gsc_dd_sort-d,#gsc_dd_mor-d{top:42px;}#gsc_dd_add-d,#gsc_dd_mor-d,#gsc_dd_sort-d{white-space:normal;word-wrap:break-word;width:208px;width:-webkit-max-content;width:max-content;min-width:100px;max-width:208px;}.gs_el_ph #gsc_dd_add-d{left:-9px;}.gs_el_ph #gsc_dd_exp-d{left:auto;right:12px;}.gs_el_ph #gsc_dd_mor-d{left:-58px;}.gs_el_ph #gsc_dd_sort-d{left:10px;}.gs_el_ph #gsc_dd_sort-r{margin-left:-10px;}.gsc_dd_sec,#gsc_dd_exp-d{padding:8px 0;}.gs_el_tc .gsc_dd_sec,.gs_el_tc #gsc_dd_exp-d{padding:4px 0 8px 0;}.gsc_dd_sep{border-top:1px solid #ebebeb;}#gsc_dd_mor-s .gsc_dd_mor-sel,#gsc_dd_sort-s .gsc_dd_sort-sel{color:#dd4b39;}#gsc_dd_mor-p{padding:14px 44px 14px 16px;color:#777;}.gs_el_tc #gsc_dd_mor-p{padding:18px 44px 18px 16px;}.gsc_art_sel #gsc_dd_add-r,.gsc_art_sel #gsc_dd_mor-r,#gsc_btn_mer,#gsc_btn_del,#gsc_dd_exp-r{display:none;}#gsc_dd_mor-r,.gsc_art_sel #gsc_btn_mer,.gsc_art_sel #gsc_btn_del,.gsc_art_sel #gsc_dd_exp-r{display:inline-block;}html:not(.gs_el_ph) #gsc_dd_sort-r{display:none;}#gsc_lwp{margin:24px 0;text-align:center;}.gs_el_sm #gsc_lwp{margin:16px 0;}#gsc_bpf{display:inline-block;verticle-align:middle;}#gsc_a_nn{display:inline-block;vertical-align:middle;padding-right:16px;font-size:13px;}.gs_el_ph #gsc_a_nn{display:none;}@media print{#gs_top #gs_md_s,#gs_top #gs_md_w,#gs_top #gs_hdr,#gs_top #gs_hdr_drs,#gs_top #gs_hdr_drw,#gs_top #gs_ftr,#gs_top #gsc_nag,#gs_top #gsc_prf_nbar_btns,#gs_top #gsc_prf_btne,#gs_top #gsc_prf_btnf,#gs_top #gsc_prf_ivh,#gs_top #gsc_prf_puf,#gs_top #gsc_rsb_co,#gs_top #gsc_bdy #gsc_rsb_co,#gs_top .gsc_g_hist_wrp,#gs_top #gsc_prf_t_wrp,#gs_top .gsc_rsb_header,#gs_top .gsc_a_tb,#gs_top .gsc_a_x,#gs_top #gsc_lwp,#gs_top .gsc_prf_puic,#gs_top #gsc_dd_add-r,#gs_top #gsc_dd_mor-r,#gs_top #gsc_dd_sort-r{display:none;}#gs_top,#gs_top #gsc_bdy,#gs_top #gsc_prf_w,#gs_top #gsc_prf,#gs_top #gsc_prf_pu,#gs_top #gsc_prf_pua,#gs_top #gsc_prf_i,#gs_top .gsc_rsb_s,#gs_top .gsc_lcl,#gs_top .gsc_rsb,#gs_top #gsc_a_tw,#gs_top #gsc_a_t,#gs_top .gsc_prf_il,#gs_top .gsc_prf_ila,#gs_top .gsc_prf_inta,#gs_top #gsc_rsb_st{background:none;border:none;padding:0;margin:0;height:auto;width:auto;min-width:0;max-width:none;float:none;display:block;position:static;color:black;font-weight:normal;font-size:12pt;text-decoration:none;}#gs_top .gsc_a_ac,#gs_top .gsc_a_a,#gs_top #gsc_a_ca,#gs_top .gsc_a_at,#gs_top .gsc_rsb_sc1,#gs_top .gsc_rsb_sth,#gs_top .gsc_rsb_std,#gs_top #gsc_bdy .gsc_a_x,#gs_top #gsc_bdy .gsc_a_t,#gs_top #gsc_bdy .gsc_a_c,#gs_top #gsc_bdy .gsc_a_y,#gs_top #gsc_a_trh,#gs_top .gsc_a_m,#gs_top .gsc_a_am{color:black;font-weight:normal;font-size:12pt;padding:0;margin:0;background:none;border:none;}#gs_top #gsc_a_trh,#gs_top #gsc_a_trh th{height:0;}#gs_top #gsc_a_ta,#gs_top #gsc_a_ca,#gs_top #gsc_a_ha,#gs_top .gsc_a_a{font-size:11pt;}#gs_top .gsc_a_ac{font-size:10pt}#gs_top #gsc_prf_pu{width:80pt;height:auto;float:left;margin:0 7pt 7pt 0;}#gs_top #gsc_prf_pua{left:auto;transform:none;border-radius:0;}#gs_top #gsc_prf_pua>img{position:static;}#gs_top #gsc_prf_i{margin:0 7pt 7pt 87pt;text-align:left;}#gs_top #gsc_prf_in{font-size:18pt;line-height:18pt;padding:0 0 4pt 0;}#gs_top .gsc_prf_il{padding:2pt 0;}#gs_top #gsc_prf_w{float:left;width:64%;}#gs_top .gsc_rsb{float:right;width:35%;}#gs_top #gsc_art{clear:both;}#gs_top #gsc_rsb_st{display:table;width:100%;max-width:none;margin-top:3pt;}#gs_top .gsc_rsb_sc1,#gs_top .gsc_rsb_sth,#gs_top .gsc_rsb_std{font-size:10pt;}#gs_top th.gsc_rsb_sc1,#gs_top .gsc_rsb_sth{border-bottom:1pt solid #ccc;}#gs_top .gsc_rsb_f{max-width:60pt;}#gs_top .gsc_rsb_sth{padding-left:14pt;}#gs_top #gsc_bdy .gsc_a_x,#gs_top #gsc_bdy .gsc_a_t,#gs_top #gsc_bdy .gsc_a_c,#gs_top #gsc_bdy .gsc_a_y,#gs_top #gsc_a_trh{padding:6pt 0;}#gs_top #gsc_a_trh{border-bottom:1pt solid #ccc;}#gs_top #gsc_a_ca{display:block;width:auto;}#gs_top #gsc_a_ta{display:inline-block;vertical-align:middle;margin-right:12pt;}#gs_top .gsc_a_h{display:inline;font-size:10pt;}#gs_top .gsc_a_at{color:#008;}#gs_top .gsc_a_m,#gs_top .gsc_a_am{display:inline;position:absolute;}#gs_top .gsc_a_am{padding: 11pt 0 0 8pt;}#gs_top .gsc_a_t .gs_gray{color:black;font-size:10pt;}}.gsc_lwpds_frm{position:relative;height:29px;}.gsc_lwpds_tsiw{position:absolute;top:0;left:0;right:38px;}.gsc_lwpds_tsiw input{border-radius:3px 0 0 3px;}.gsc_lwpds_tsbw{position:absolute;top:0;right:0;}.gsc_lwpds_tsbw button{border-radius:0 3px 3px 0;}.gsc_pgn{text-align:right;font-weight:bold;line-height:29px;}.gsc_pgn_ppn{margin:0 8px;}.gsc_ccb_ck{padding:11px 10px 9px 10px;}.gsc_ccb_svg{stroke:#666;stroke-width:2px;fill:#fff;width:21px;height:21px;vertical-align:top;}.gsc_ccb_lim .gsc_ccb_svg,.gsc_ccb_dis .gsc_ccb_svg{fill:#e2e2e2;stroke:#fff;}.gsc_ccb_lim .gsc_ccb_svg>circle,.gsc_ccb_dis .gsc_ccb_svg>circle{stroke:#e2e2e2;}.gsc_ccb_on .gsc_ccb_svg{fill:#4d90fe;stroke:#fff;}.gsc_ccb_on .gsc_ccb_svg>circle{stroke:#4d90fe;}.gsc_ccb_del:active .gsc_ccb_svg>circle,.gsc_ccb_add:active .gsc_ccb_svg>circle{fill:#2f6de1;}#gsc_md_cod{width:800px;max-width:94%;}.gs_el_ph #gsc_md_cod{width:100%;max-width:100%;}#gsc_md_cod .gs_md_prg{min-height:400px;}.gsc_codb_instr{font-size:16px;margin:1em 0;}#gsc_cods_res{position:relative;margin-bottom:24px;min-height:80px;border-bottom:1px solid #e5e5e5;}.gs_el_ph #gsc_cods_res{margin-bottom:16px;}.gsc_cods_hide,.gsc_cod_sugg #gsc_cod_tedit,.gsc_cod_sugg #gsc_cods_frm,.gsc_cod_sugg #gsc_cods_pp,.gsc_cod_lc #gsc_cod_tadd,.gsc_cod_changed #gsc_cod_tedit,.gsc_cod_changed #gsc_cod_tadd,.gsc_cod_lim #gsc_cod_tedit,.gsc_cod_lim #gsc_cod_tadd{display:none;}#gsc_cods_frm{margin:0 0 24px 0;}.gs_el_ph #gsc_cods_frm{margin:0 0 16px 0;}.gsc_ucoar{padding:24px 0;border-bottom:1px solid #eee;}.gs_el_ph .gsc_ucoar{padding:16px 0px;}.gsc_ucoar:first-child{padding-top:0;}.gsc_ucoar:last-child{border-bottom:none;}.gsc_ucoar_cb{float:right;margin-top:-8px;}#gsc_cod_trev{display:none;color:#666;pointer-events:none;}.gsc_cod_changed #gsc_cod_trev,.gsc_cod_lim #gsc_cod_trev{display:inline-block;}.gsc_cod_changed #gsc_cod_trev{color:#1a0dab;pointer-events:auto;}.gsc_fol_cr{margin:0 0 8px 0;}.gs_el_tc .gsc_fol_cr{margin:0;}.gs_el_tc .gsc_fol_cr:first-child{margin-top:-8px;}#gsc_fol_ml{display:block;color:#777;padding:12px 0 4px 0;}</style><script>!function(GSP){/*

 Copyright The Closure Library Authors.
 SPDX-License-Identifier: Apache-2.0
*/
var aa="function"==typeof Object.create?Object.create:function(a){var b=function(){};b.prototype=a;return new b},ba;if("function"==typeof Object.setPrototypeOf)ba=Object.setPrototypeOf;else{var da;a:{var ea={a:!0},fa={};try{fa.__proto__=ea;da=fa.a;break a}catch(a){}da=!1}ba=da?function(a,b){a.__proto__=b;if(a.__proto__!==b)throw new TypeError(a+" is not extensible");return a}:null}
var ha=ba,ia=function(a,b){a.prototype=aa(b.prototype);a.prototype.constructor=a;if(ha)ha(a,b);else for(var c in b)if("prototype"!=c)if(Object.defineProperties){var d=Object.getOwnPropertyDescriptor(b,c);d&&Object.defineProperty(a,c,d)}else a[c]=b[c];a.na=b.prototype},ja=function(){},ka=function(a,b){var c=Array.prototype.slice.call(arguments,1);return function(){var d=c.slice();d.push.apply(d,arguments);return a.apply(this,d)}};var g=function(){this.o=this.o;this.F=this.F};g.prototype.o=!1;g.prototype.isDisposed=function(){return this.o};g.prototype.T=function(){this.o||(this.o=!0,this.H())};g.prototype.H=function(){if(this.F)for(;this.F.length;)this.F.shift()()};function la(a){var b=[],c=0,d;for(d in a)b[c++]=d;return b};function l(a,b){a.classList.add(b)}function n(a,b){a.classList.remove(b)}function p(a,b){return a.classList?a.classList.contains(b):!1}function q(a,b,c){c=void 0!==c?c:!p(a,b);(c?l:n)(a,b)};function r(a){return 0<=(navigator.userAgent||"").indexOf(a)}var ma=r("iPhone")||r("iPad")||r("iPod"),na=r("iPhone")||r("Android")&&r("Mobile");function oa(){if(void 0===b){var a=window.screen;a={width:window.innerWidth,height:window.innerHeight,ma:a.width,la:a.height}}else a=b;var b=a;a=b.width;var c=b.height,d=b.ma;b=b.la;var e=4;if(600>a||48E4>d*b||na)e=1;else if(982>a)e=2;else if(1136>a||590>c)e=3;return e}var pa,qa=/[?&]tc=([01])/.exec(location.search||"");
pa=qa?0<+qa[1]:r("Android")?!0:window.matchMedia&&window.matchMedia("(pointer)").matches?window.matchMedia("(pointer:coarse)").matches:!r("Firefox")||r("Mobile")||r("Tablet")?ma||"ontouchstart"in window||0<(navigator.msMaxTouchPoints||0):!1;function ra(){if(void 0==sa){sa=!1;try{var a=Object.defineProperty({},"passive",{get:function(){sa=!0}});window.addEventListener("testPassive",ja,a);window.removeEventListener("testPassive",ja,a)}catch(b){}}return sa}var sa;var ta=function(a){this.Y=a},ua=new ta("INPUT"),va=new ta("TABLE");function t(a){return document.getElementById(a)}function x(a){return a.id||(a.id="gs_id"+wa++)}function xa(a){a=(void 0===a?null:a)||document.body;return"rtl"==(a?window.getComputedStyle(a,null):null).direction}
function ya(a){var b=[];a=a.elements;for(var c=a.length,d=0;d<c;d++){var e=a[d],f=encodeURIComponent(e.name||""),h=e.type;!f||e.disabled||!("checkbox"!=h&&"radio"!=h||e.checked)||b.push(f+"="+encodeURIComponent(e.value||""))}return b.join("&")}function za(a,b){var c=a.elements[b];c||(c=document.createElement(ua.Y),c.type="hidden",c.name=b,a.appendChild(c));return c}function Aa(a){t("gsc_md_cbyd_c").href=a&&a.match(Ba)?a:"javascript:void(0)"}function Ca(a){a.match(Ba)&&(window.location.href=a)}
var wa=100,Da=/\S+/g,Ba=/^(?:https?:|[^:/?#]*(?:[/?#]|$))/i,Ea=/^(?:#|\/[a-z0-9_-]*(?:[?].*)?$)/i;function y(a){return a.hasOwnProperty("gs_uid")?a.gs_uid:a.gs_uid=++Fa}var Fa=0;var z=function(){this.i=[];this.A={};this.O=this.v=0};z.prototype.add=function(a){var b=y(a);this.A[b]||(this.i.push(a),this.A[b]=this.i.length,++this.v)};z.prototype.remove=function(a){a=y(a);var b=this.A[a];b&&(this.i[b-1]=null,delete this.A[a],2*--this.v<this.i.length&&!this.O&&Ga(this))};z.prototype.notify=function(a){var b=this.i;try{++this.O;for(var c=0;c<b.length;c++){var d=b[c];d&&d.apply(null,arguments)}}finally{!--this.O&&2*this.v<b.length&&Ga(this)}};
var Ga=function(a){var b=a.i,c=b.length;a=a.A;for(var d=0,e=0;e<c;e++){var f=b[e];f&&(b[d]=f,a[y(f)]=++d)}b.length=d};function B(a,b,c,d,e){Ha(a,b,c,void 0===d?!1:d,void 0===e?!1:e,Ia)}function C(a,b,c,d){Ha(a,b,c,void 0===d?!1:d,!1,Ja)}function Ka(a,b,c,d){function e(h){C(f,a,e,c);b(h)}var f=document;c=void 0===c?!1:c;B(f,a,e,c,void 0===d?!1:d)}function D(a){La?La.add(a):a()}var Ma=window.requestAnimationFrame?function(a){window.requestAnimationFrame(a)}:function(a){setTimeout(a,33)};function Na(a){a.stopPropagation();a.preventDefault()}
function Oa(a){return(a.ctrlKey?1:0)|(a.altKey?2:0)|(a.metaKey?4:0)|(a.shiftKey?8:0)}function Ia(a,b,c,d,e){var f=a.addEventListener;e=e&&ra();f.call(a,b,c,e?{passive:e,capture:d}:d)}function Ja(a,b,c,d){a.removeEventListener(b,c,d)}function Ha(a,b,c,d,e,f){if("string"===typeof b)f(a,b,c,d,e);else for(var h=b.length,k=0;k<h;k++)f(a,b[k],c,d,e)}function Pa(){La.notify();La=null}function Qa(){"complete"==document.readyState&&(C(document,"readystatechange",Qa),Pa())}
var La,Ra=!!document.attachEvent,Sa=document.readyState;if(Ra?"complete"!=Sa:"loading"==Sa)La=new z,Ra?B(document,"readystatechange",Qa):Ka("DOMContentLoaded",Pa);function Ta(){Ka(["mousedown","touchstart"],function(){q(document.documentElement,"gs_pfcs",!0);B(document,"keydown",Ua,!0)},!0,!0)}function Ua(a){9==a.keyCode&&(q(document.documentElement,"gs_pfcs",!1),C(document,"keydown",Ua,!0),Ta())}Ta();function Va(a,b,c,d,e){var f=t(a);Wa(f,function(){l(f,"gs_vis");b&&b()},function(){n(f,"gs_vis");c&&c()},d,e)}function Wa(a,b,c,d,e){var f=x(a);if(!E[f]){var h=document.activeElement;Xa(Ya(a),!0);b&&b();G.push(function(k){delete E[f];try{k||(e||h).focus()}catch(m){}c&&c()});E[f]=G.length;h&&a.contains(h)||setTimeout(function(){var k=d,m=k&&"text"==k.type;if(!k||m&&pa)k=a;try{k.focus(),m&&(k.value=k.value)}catch(w){}},0)}}function H(a){Xa((E[a]||1E6)-1,!1)}
function Za(a){a=void 0===a?!1:a;G.pop()(a)}function Xa(a,b){for(b=void 0===b?!1:b;G.length>a;)Za(b||G.length>a+1)}function Ya(a){for(var b=0;a&&!(b=E[a.id]||0);)a=a.parentNode;return b}var G=[],E={};B(document,"click",function(a){var b=G.length;b&&!Oa(a)&&b>Ya(a.target)&&Za(!0)});B(document,"keydown",function(a){27==a.keyCode&&!Oa(a)&&G.length&&Za()});
B(document,"focus",function(a){var b=G.length;if(b)for(var c=Ya(a.target);c<b;){var d="",e;for(e in E)if(E[e]==b){d=e;break}a:{d=(t(d).getAttribute("data-wfc")||"").match(Da)||[];for(var f=0;f<d.length;f++){var h=t(d[f]);if(h&&h.offsetWidth){d=h;break a}}d=void 0}if(d){Na(a);d.focus();break}else Za(!0),--b}},!0);var $a={},ab={},bb;try{bb=window.sessionStorage}catch(a){};function J(a){return"object"==typeof a?a:null}function cb(a,b){b=db(b);a=eb(a);a=fb(a)||"#";gb=J(b);hb?window.history.pushState(b,"",a):window.location.assign(a)}function ib(a,b){b=db(b);a=eb(a);a=fb(a)||"#";gb=J(b);hb?window.history.replaceState(b,"",a):window.location.replace(a)}function fb(a){var b=[],c;for(c in a)b.push(encodeURIComponent(c)+"="+encodeURIComponent(a[c]));return(a=b.sort().join("&"))?"#"+a:""}
function jb(a){var b={};a=a.split("&");for(var c=0;c<a.length;c++){var d=a[c],e=d.indexOf("=");if(e+1){var f=d.substr(0,e);d=d.substr(e+1)}else f=d,d="";f&&(b[decodeURIComponent(f)]=decodeURIComponent(d))}return b}function kb(a){var b=a.indexOf("#")+1;return jb(b?a.substr(b):"")}function lb(a){var b=a.indexOf("?")+1;a=b?a.substr(b):"";b=a.indexOf("#");return jb(b+1?a.substr(0,b):a)}function mb(a,b){for(var c in b){var d=b[c];void 0!==d?a[c]=d:delete a[c]}}
function eb(a){var b=kb(window.location.hash);mb(b,a);return b}function db(a){var b=gb||J(window.history.state),c={},d;for(d in b)c[d]=b[d];mb(c,a);return c}function nb(){setTimeout(function(){if(!ob){var a=window.history.state;ob=!0;gb=J(a);rb.notify()}sb=!1},0)}var rb=new z,gb,ob=!1,sb=!0,hb="pushState"in window.history,tb;
if("undefined"==typeof GSP)tb=!1;else{var ub=.001*Date.now(),vb=GSP.eventId,wb=!1,K,xb=bb;if(!("nh"in $a)){var yb=xb&&xb.getItem("nh"),zb;if(yb)try{zb=JSON.parse(yb)}catch(a){}ab.nh=zb}K=ab.nh;K instanceof Array||(K=[]);for(var Ab=K.length,Bb=0,Cb=0;Cb<Ab;Cb++){var Db=K[Cb];if(Db instanceof Array&&2==Db.length){var Eb=Db[1]==vb;wb=wb||Eb;10>=Ab-Cb&&+Db[0]>ub-86400&&!Eb&&(K[Bb++]=Db)}}K.length=Bb;K.push([ub,vb]);var Fb=K,Gb=bb;ab.nh=Fb;try{Gb&&Gb.setItem("nh",JSON.stringify(Fb))}catch(a){}tb=wb}
var Hb=tb;"onpageshow"in window?B(window,"pageshow",nb):D(nb);B(window,hb?"popstate":"hashchange",function(a){"loading"!=document.readyState&&(a=a.state,ob=!0,gb=J(a),rb.notify())});function Ib(){Jb&&(C(t("gs_alrt_l"),"click",Jb),Jb=void 0)}function Kb(){var a=Lb();l(a,"gs_anm");l(a,"gs_vis");B(document,"click",Mb);clearTimeout(Nb);Nb=setTimeout(Mb,4E3);++Ob;setTimeout(Pb,0)}function Mb(){Ob||(C(document,"click",Mb),clearTimeout(Nb),Nb=void 0,Ib(),n(Lb(),"gs_vis"))}function Lb(){return t("gs_alrt")}function Pb(){Ob=0}var Nb,Ob=0,Jb;D(function(){var a=t("gs_alrt_m");a&&(a.innerHTML&&!Hb&&Kb(),B(window,"pagehide",function(){Ob=0;Mb();n(Lb(),"gs_anm")}))});function Qb(a,b,c){var d=new XMLHttpRequest;d.onreadystatechange=function(){if(4==d.readyState){var e=d.status,f=d.responseText,h=d.responseURL,k=window.location,m=k.protocol;k="//"+k.host+"/";h&&h.indexOf(m+k)&&h.indexOf("https:"+k)&&(e=0,f="");c(e,f)}};d.open(b?"POST":"GET",a,!0);d.setRequestHeader("X-Requested-With","XHR");b&&d.setRequestHeader("Content-Type","application/x-www-form-urlencoded");b?d.send(b):d.send();return d}function Rb(a){a&&(a.onreadystatechange=ja,a.abort())};var Sb=function(a,b,c){this.type=a;this.currentTarget=this.target=b;this.g=void 0===c?null:c;this.P=!1};Sb.prototype.stopPropagation=function(){this.g&&this.g.stopPropagation();this.P=!0};var L=function(a){a.g&&Na(a.g);a.P=!0};var M=function(a,b){this.R=a;this.ka=b},Tb=function(a,b,c){this.R=a;this.types=b;this.listener=c};function Ub(a,b){var c=b.length;if(c){var d=y(a),e=Vb[d];if(!e){e=Vb[d]=[];d=Wb(b[0].R);for(var f in d){var h=Xb[f];h||(h=Xb[f]=Object.create(null));for(var k in d[f]){var m=h[k];m||(m=h[k]=[]);m.push(a)}}Yb(a,e,b[0],Zb);for(f=1;f<c;f++)Yb(a,e,b[f],$b)}}}function O(a,b,c){ac(new Sb(a,b,void 0===c?null:c))}
function P(a,b,c){var d=bc;"string"===typeof b&&(cc[0]=b,b=cc);var e=b.length;a=Wb(a);for(var f in a)for(var h in a[f])for(var k=0;k<e;k++)d(f,h,b[k],c)}function Wb(a){"string"===typeof a&&(dc[0]=a,a=dc);for(var b=a.length,c=Object.create(null),d=0;d<b;d++){var e=a[d],f=e.charAt(0),h=e.substr(1);if("#"!=f&&"."!=f||!h)throw Error("bad selector: "+e);(e=c[f])||(e=c[f]=Object.create(null));e[h]=!0}return c}
function bc(a,b,c,d){var e=ec[c];e||("touchstart"!=c&&"mouseover"!=c&&"mouseout"!=c&&B(document,c,fc,"focus"==c||"blur"==c),e=ec[c]=Object.create(null));(c=e[a])||(c=e[a]=Object.create(null));(a=c[b])||(a=c[b]=new z);a.add(d)}function fc(a){var b=a.target;b&&3==b.nodeType&&(b=b.parentNode);ac(new Sb(a.type,b,a))}
function ac(a){for(var b=a.target;b&&b!=document&&!b.disabled&&!p(b,"gs_dis");){a.currentTarget=b;var c=b.id;if(c&&!gc("#",c,a))break;c=b.classList||[];for(var d=c.length,e=0;e<d;e++)if(!gc(".",c[e],a))return;b=b.parentNode}}function gc(a,b,c){var d=ec[c.type];(b=(a=d&&d[a])&&a[b])&&b.notify(c);return!c.P}function Yb(a,b,c,d){var e=c.R;c=c.ka;for(var f in c){var h=ka(d,a,c[f]);P(e,f,h);b.push(new Tb(e,f,h))}}function Zb(a,b,c){var d=c.currentTarget;a=hc(a,d)||a;a=ic(a,d);b.call(a,c)}
function $b(a,b,c){a:{for(var d=c.currentTarget;d&&d!=document;){var e=hc(a,d);if(e){a=ic(e,d);break a}d=d.parentNode}a=void 0}a&&b.call(a,c)}function ic(a,b){var c=jc(b),d=kc[c];d||(d=kc[c]=[]);for(var e=d.length,f=0;f<e;f++){var h=d[f];if(h instanceof a)return h}b=new a(b);d.push(b);a=y(a);(d=lc[a])||(d=lc[a]=[]);d.push(c);return b}function hc(a,b){var c,d=b.id;d&&(c=mc(a,c,"#",d));b=b.classList||[];d=b.length;for(var e=0;e<d;e++)c=mc(a,c,".",b[e]);return c}
function mc(a,b,c,d){c=(d=(c=Xb[c])&&c[d])?d.length:0;for(var e=0;e<c;e++){var f=d[e];!(f===a||f.prototype instanceof a)||b&&!(f===b||f.prototype instanceof b)||(b=f)}return b}function jc(a){var b=a.getAttribute("data-duid");b||a.setAttribute("data-duid",b=""+nc++);return b}var ec=Object.create(null),dc=[""],cc=[""],Xb=Object.create(null),Vb=Object.create(null),lc=Object.create(null),kc=Object.create(null),nc=100;window.gs_evt_dsp=fc;function oc(){var a=".gs_md_li";if("string"===typeof a){var b=a.charAt(0),c=a.slice(1);if("#"==b)a=function(d){return d.id==c&&0<d.offsetWidth};else if("."==b)a=function(d){return p(d,c)&&0<d.offsetWidth};else throw Error("bad selector: "+a);}return a}function pc(a,b){return a&&((void 0===b?0:b)?a.lastElementChild:a.firstElementChild)}function qc(a,b){return a&&((void 0===b?0:b)?a.previousElementSibling:a.nextElementSibling)}function rc(a,b,c){c=void 0===c?!1:c;return sc(a,b,oc(),c,!1)}
function sc(a,b,c,d,e){for(var f;b&&a;){if(c(b)){if(e)return b}else for(f=pc(b,d);f;f=qc(f,d))if(e=sc(f,f,c,d,!0))return e;for(e=!0;;){if(b==a)return null;f=b.parentNode;if(b=qc(b,d))break;b=f}}return null};function tc(a){return!!p(a,"gs_sel")+2*!!p(a,"gs_par")}function uc(a){return+a.getAttribute("data-s")}function vc(a,b,c){c=void 0===c?!1:c;q(a,"gs_sel",1==b);q(a,"gs_par",2==b);a.setAttribute("aria-checked",wc[b]);c||a.setAttribute("data-s",""+b)}var wc=["false","true","mixed"];var Q=function(){this.j=Object.create(null);this.l=0};Q.prototype.clear=function(){this.j=Object.create(null);this.l=0};Q.prototype.has=function(a){return a in this.j};Q.prototype.get=function(a){return this.j[a]};Q.prototype.set=function(a,b){this.has(a)||this.l++;this.j[a]=b};Q.prototype.delete=function(a){this.has(a)&&(delete this.j[a],this.l--)};var xc=function(a){var b=window,c=this;this.i=new z;this.V=0;this.S=[b,a,function(){c.V++||Ma(d)},!1];var d=function(){c.V=0;c.i.notify()}};xc.prototype.addListener=function(a){this.i.v||B.apply(null,this.S);this.i.add(a)};xc.prototype.removeListener=function(a){this.i.remove(a);this.i.v||C.apply(null,this.S)};var yc=new xc("scroll"),zc=new xc("resize");var Ac=new z;function Bc(){var a=document.documentElement,b=oa();b={gs_el_ph:1==b,gs_el_ta:2==b,gs_el_sm:4!=b,gs_el_tc:pa||1==b};var c;for(c in b){var d=b[c];if(p(a,c)!=d){var e=!0;q(a,c,d)}}e&&Ac.notify()}q(document.documentElement,"gs_el_ios",ma);Bc();zc.addListener(Bc);B(window,["pageshow","load"],Bc);function R(a,b,c,d){function e(){var u=ca&&p(h,"gs_el_ph");q(F,"gs_vis",!u);h.style.overflowY=Yd&&!u?"scroll":""}function f(){var u=h.clientHeight,I=+A.getAttribute("data-h");I||(w.style.maxHeight="none",I=m.offsetHeight);I=Math.max((u-I)/2,10);u=Math.max(u-48-2*I,10);var Jc=ca&&p(h,"gs_el_ph");m.style.top=Jc?"auto":I+"px";w.style.maxHeight=Jc?"none":u+"px";Cc(w)}b=void 0===b?"":b;c=void 0===c?"":c;d=void 0===d?"":d;var h=document.documentElement,k=t("gs_top"),m=t(a),w=t(a+"-bdy"),v=t(m.getAttribute("data-cid")||
m.id+"-bdy")||m,F=t(m.getAttribute("data-shd")||"gs_md_s"),A=Dc(m),ca=!!A&&p(A,"gs_md_wmw"),N=window.pageYOffset,Yd=k.scrollHeight>h.clientHeight,pb=!!E[a],qb=pb?"":S,Lc=b&&"#"!=b[0]&&!d,$d=a==S&&b==Ec&&c==T;Fc=b;Lc?(pb?q(v,"gs_md_ldg",!0):Gc(m,v,'<div class="gs_md_prg">'+t("gs_md_ldg").innerHTML+"</div>"),O("gs-md-ldin",v)):(d&&Gc(m,v,d),O("gs-md-lded",v));qb&&(++Hc,H(qb),--Hc);S=a;Ec=b;T=c;Ic=d;$d||Hc||(Kc+=1,(qb?ib:cb)(Mc(),Nc()));pb||Wa(m,function(){A&&l(A,"gs_vis");l(m,"gs_vis");q(m,"gs_abt",
sb);Oc(a);Ac.add(e);e();A&&w&&(f(),zc.addListener(f));l(k,"gs_nscl");k.style.top=-N+"px"},function(){Ac.remove(e);zc.removeListener(f);A&&n(A,"gs_vis");n(m,"gs_vis");n(m,"gs_abt");n(F,"gs_vis");h.style.overflowY="";n(k,"gs_nscl");k.style.top="auto";Rb(U);U=null;window.scrollTo(0,N);S=Ec=T=Ic="";var u=Kc;Kc=0;Hc||(0<u?window.history.go(-u):ib(Mc(),Nc()))},Pc(m),Qc(m));Lc&&(Rb(U),U=null,U=Qb(b,c,function(u,I){U=null;u=200==u;Gc(m,v,u?I:Rc());u&&a==S&&b==Ec&&c==T&&(Ic=I,ib(Mc(),Nc()));O("gs-md-lded",
v)}))}function Dc(a){a=a.parentNode;return p(a,"gs_md_wnw")?a:null}function Pc(a){return(a=a.getAttribute("data-ifc"))?t(a):null}function Qc(a){return(a=a.getAttribute("data-cfc"))?t(a):null}
function Gc(a,b,c){q(b,"gs_md_ldg",!1);for(var d=b.querySelectorAll("[data-duid]"),e=d.length,f={},h=0;h<e;h++){for(var k=jc(d[h]),m=kc[k],w=m?m.length:0,v=0;v<w;v++){var F=m[v],A=y(F.constructor),ca=f[A];ca||(ca=f[A]={});ca[k]=!0;F&&"function"==typeof F.T&&F.T()}delete kc[k]}for(var N in f){N=+N;d=f[N];h=(e=lc[N])?e.length:0;for(m=k=0;m<h;m++)w=e[m],w in d||(e[k++]=w);k?e.length=k:delete lc[N]}b.innerHTML=c;Oc(a.id);Rb(U);U=null}
function Oc(a){if(a=document.querySelector("#"+a+">.gs_md_bdy"))a.scrollTop=a.scrollLeft=0,Cc(a)}function Cc(a){var b=a.style,c="padding"+(xa(a)?"Left":"Right");b[c]="";var d=a.offsetWidth-a.clientWidth;2<d&&(a=parseInt(window.getComputedStyle(a,null)[c],10)||0,b[c]=Math.max(a-d,0)+"px")}function Rc(){return'<div class="gs_md_prg"><div class="gs_alrt">'+t("gs_md_err").innerHTML+"</div></div>"}function Mc(){return{d:S||void 0,u:Ec||void 0,p:T?"1":void 0}}function Nc(){return{n:Kc,p:T,h:Ic}}
var U=null,Fc="",S="",Ec="",T="",Ic="",Kc=0,Hc=0;rb.add(function(){var a=kb(window.location.hash),b=a.d||"",c=b?t(b):null;++Hc;if(c){c=a.u||"";a=0<+a.p;var d=gb||J(window.history.state)||{},e=+d.n||0,f=""+(d.p||"");d=""+(d.h||"");c.match(Ea)||(c="");a!=!!f?R(b,"","",Rc()):b==S&&c==Ec&&f==T&&d==Ic||R(b,c,f,d);Kc=e}else S&&H(S);--Hc});var Sc=function(a){g.call(this);this.D=a;this.K=Object.create(null);this.C=null;a=a.querySelectorAll(".gs_in_txtw>input[type=text]");for(var b=a.length;b--;){var c=a[b],d=c.parentNode.querySelector(".gs_in_txts");c=c.name;d&&c&&(this.K[c]=d.innerHTML)}};ia(Sc,g);Sc.prototype.H=function(){Rb(this.C);this.D=this.C=null;g.prototype.H.call(this)};
Sc.prototype.ga=function(a){var b=this;L(a);if((a=this.D)&&!this.C){var c="json=&"+ya(a);Tc(this,!0);this.C=Qb(a.action,c,function(d,e){b.C=null;Tc(b,!1);var f=b.D,h=f.getAttribute("data-alrt");if(h=h?t(h):null)h.innerHTML="";try{var k=200==d&&JSON.parse(e)}catch(A){}k&&"object"==typeof k||(Uc(h,t("gs_md_err").innerHTML),k={});if(d=k.L)Ca(""+d);else{(d=k.M)&&Uc(h,d);d=1E6;if(h&&h.innerHTML){var m=h;d=h.getBoundingClientRect().top}f=f.elements;k=k.E;"object"==typeof k||(k=Object.create(null));for(var w in b.K){h=
f[w];e=void 0;var v=""+(k[w]||""),F=h.parentNode.querySelector(".gs_in_txts");q(h.parentNode,"gs_in_txte",!!v);F&&(F.innerHTML=v||b.K[w]||"");v&&(e=h.getBoundingClientRect().top)<d&&(m=h,d=e)}m&&m.scrollIntoView&&(0>d||d+20>window.innerHeight)&&m.scrollIntoView()}})}};
var Tc=function(a,b){a=a.D;var c=a.getAttribute("data-bsel");a=c?document.querySelectorAll(c):a.querySelectorAll("button");for(c=a.length;c--;){var d=a[c];d.disabled=b;q(d,"gs_bsp",b)}},Uc=function(a,b){if(a)a.innerHTML=b;else{var c=void 0===c?"":c;var d=void 0===d?"":d;var e=void 0===e?[]:e;t("gs_alrt_m").innerHTML=b;Lb().action=d.match(Ba)?d:"";a=t("gs_alrt_l");a.textContent=c;c=t("gs_alrt_h");c.innerHTML="";for(var f in e)b=document.createElement("input"),b.type="hidden",b.name=f,b.value=e[f],
c.appendChild(b);Ib();q(a,"gs_fm_s",!0);Kb()}};Ub(Sc,[new M(".gs_ajax_frm",{submit:Sc.prototype.ga})]);var Vc=[[1,0,1],[2,0,1]];P(".gs_cb_gen","click",function(a){var b=a.currentTarget,c=tc(b),d=2==+b.getAttribute("data-s");vc(b,Vc[+d][c],!0);O("gs-change",b,a.g)});P(".gs_cb_gen",["keydown","keyup"],function(a){var b=a.currentTarget,c=a.g.keyCode;"BUTTON"!=b.tagName||13!=c&&32!=c||(L(a),"keydown"==a.type&&b.click())});P([".gs_cb_gen",".gs_md_li"],"keydown",function(a){var b=a.currentTarget,c=b.tagName,d=a.g.keyCode;"BUTTON"!=c&&(32==d||13==d&&"A"!=c)&&(L(a),b.click())});var Wc=["click","contextmenu","mouseup"].concat(navigator.sendBeacon?[]:["mousedown","touchstart"]),Xc="",Yc=null;function Zc(){Yc=null}function $c(a){navigator.sendBeacon?navigator.sendBeacon(a):Yc&&a==Yc.src||((Yc=new Image).src=a,setTimeout(Zc,1E3))}function ad(){var a=lb(document.location.href).hl||"";a="/scholar_bfnav?url="+encodeURIComponent(document.location.href)+"&hl="+encodeURIComponent(a)+"&ei="+GSP.eventId;$c(a)}D(function(){Xc=Hb?"&bn=1":"";Hb&&ad()});
B(window,"pageshow",function(a){a.persisted&&(Xc="&bn=1",ad())});
B(document,Wc,function(a){if(!("click"==a.type&&a.button||"mouseup"==a.type&&1!=a.button)){var b,c;a:{for(a=a.target;a;){var d=a.nodeName;if("A"==d)break a;if("SPAN"==d||"B"==d||"I"==d||"EM"==d||"IMG"==d)a=a.parentNode;else break}a=null}a&&(b=a.getAttribute("href"))&&(c=a.getAttribute("data-clk"))&&(b="/scholar_url?url="+encodeURIComponent(b)+"&"+c+"&ws="+window.innerWidth+"x"+window.innerHeight+"&at=",c=encodeURIComponent,a=(a=a.getAttribute("data-clk-atid"))&&t(a),b=b+c(a&&a.innerText||"")+Xc,$c(b))}},
!1,!0);P(".gs_fm_s","click",function(a){a=a.currentTarget.getAttribute("data-fm")||"";(a=t(a))&&a.submit()});var V=function(a){this.m=x(a.querySelector(".gs_md_d"));this.G=x(a.querySelector(".gs_md_tb"))};V.prototype.I=function(a){var b=t(this.m);return void 0!==a?rc(b,b,a):null};V.prototype.open=function(a){a=this.I(a);if(p(t(this.G),"gs_sel"))try{a&&a.focus()}catch(c){}else{var b=t(this.G);Va(this.m,function(){l(b,"gs_sel")},function(){n(b,"gs_sel")},a,b)}};V.prototype.close=function(){H(this.m)};V.prototype.Z=function(a){L(a);p(t(this.G),"gs_sel")?this.close():this.open("keydown"==a.g.type?!1:void 0)};
V.prototype.U=function(a){var b=a.g.keyCode;if(38==b||40==b)L(a),this.open(38==b)};V.prototype.aa=function(a){a.target.id==this.m&&this.U(a)};Ub(V,[new M(".gs_md_rmb",{}),new M(".gs_md_tb",{"gs-press":V.prototype.Z,keydown:V.prototype.U}),new M(".gs_md_d",{keydown:V.prototype.aa})]);var W=function(a){V.call(this,a);this.ia=x(a.querySelector(".gs_md_in"));this.ja=x(a.querySelector(".gs_md_tb .gs_lbl"))};ia(W,V);W.prototype.I=function(){return t(this.m).querySelector(".gs_md_li[aria-selected]")};W.prototype.ba=function(a){bd(this,a)};W.prototype.J=function(a){var b=a.g.keyCode;13!=b&&32!=b||bd(this,a)};
var bd=function(a,b){var c=b.currentTarget,d=t(a.ia),e=a.I();c!=e&&(d.value=c.getAttribute("data-v"),t(a.ja).innerHTML=c.innerHTML,e&&cd(e,!1),cd(c,!0));L(b);a.close();O("gs-change",d,b.g)},cd=function(a,b){q(a,"gs_sel",b);b?a.setAttribute("aria-selected","true"):a.removeAttribute("aria-selected")};Ub(W,[new M(".gs_md_ris",{}),new M(".gs_md_li",{click:W.prototype.ba,keydown:W.prototype.J})]);P("#gs_lp","click",function(a){L(a);R("gs_lp_d")});P("#gs_lp_cur","click",function(a){L(a);H("gs_lp_d")});var dd=function(a){this.W=x(a)};dd.prototype.J=function(a){var b=a.currentTarget,c=a.g.keyCode;if(38==c||40==c){var d=t(this.W);d=rc(d,b,38==c)||rc(d,d,38==c)}else if(37==c||39==c)a:{c=!!(37==c^xa(b.parentNode));d=b.parentNode;var e=d.children,f=e.length;if(d.id!=this.W){for(;e[--f]!=b;);d=qc(d,c)||pc(d.parentNode,c);e=d.children;if(f=Math.min(f+1,e.length))if(d=e[f-1],p(d,"gs_md_li")&&d.offsetLeft!=b.offsetLeft)break a}d=void 0}d&&(L(a),d.focus())};
Ub(dd,[new M(".gs_md_ulr",{}),new M(".gs_md_li",{keydown:dd.prototype.J})]);P("#gs_hdr_mnu","click",function(a){L(a);R("gs_hdr_drw")});P("#gs_hdr_drw_mnu","click",function(a){L(a);H("gs_hdr_drw")});P("#gs_hdr_act_i","click",function(a){L(a);1==oa()?Ca(document.querySelector("#gs_hdr_drw_bot>a").href):Va("gs_hdr_act_d")});P("#gs_hdr_drw","keydown",function(a){var b=a.g.keyCode;if(38==b||40==b){var c=a.currentTarget;if(b=rc(c,c,38==b))L(a),b.focus()}});
P("#gs_hdr_tsi",["focus","blur"],function(a){function b(){var h=d.getBoundingClientRect().top-10;10<Math.abs(h)&&window.scrollBy(0,h);clearTimeout(e);c()}function c(){C(window,f,b)}var d=a.target;a="focus"==a.type;q(t("gs_hdr"),"gs_hdr_ifc",a);if(a&&pa&&!(749<window.innerHeight)){var e=setTimeout(c,1E3),f=["scroll","resize"];B(window,f,b)}});P("#gs_hdr_tsi",["input","gs-change"],function(a){q(t("gs_hdr_frm"),"gs_hdr_tsc",!!a.currentTarget.value)});
P("#gs_hdr_tsc","mousedown",function(a){L(a);var b=t("gs_hdr_tsi");b.value="";b.focus();O("input",b,a.g)});P("#gs_hdr_sre","click",function(a){L(a);var b=t("gs_hdr");Va("gs_hdr_frm",function(){n(b,"gs_hdr_src");l(b,"gs_hdr_srx")},function(){l(b,"gs_hdr_src");n(b,"gs_hdr_srx")},t("gs_hdr_tsi"))});P(".gs_md_x","click",function(a){(a=a.currentTarget.getAttribute("data-mdx"))&&H(a)});var X=function(){},ed,fd;X.prototype.$=function(a){a.g.button||(L(a),gd(a))};X.prototype.ca=function(a){hd(a)&&(L(a),gd(a))};X.prototype.da=function(a){hd(a)&&L(a)};X.prototype.ea=function(a){if(!a.g.button){L(a);var b=a.g;b&&(id=b.clientX||0,jd=b.clientY||0,B(document,kd,ld,!0),clearTimeout(ed),ed=setTimeout(md,2E3));gd(a)}};X.prototype.ha=function(a){L(a);if(nd){var b=a.g;if(b=(b=b&&b.touches)&&1==b.length&&b[0])od=b.clientX,pd=b.clientY,B(document,qd,rd,!0),clearTimeout(fd),fd=setTimeout(sd,2E3)}gd(a)};
var hd=function(a){a=a.g.keyCode;return 32==a||13==a},gd=function(a){O("gs-press",a.currentTarget,a.g)},md=function(){C(document,kd,ld,!0);clearTimeout(ed);ed=void 0},ld=function(a){"mousedown"!=a.type&&10>Math.abs(a.clientX-id)&&10>Math.abs(a.clientY-jd)?(Na(a),"click"==a.type&&md()):md()},sd=function(){C(document,qd,rd,!0);clearTimeout(fd);fd=void 0},rd=function(a){"touchstart"!=a.type&&10>Math.abs(a.clientX-od)&&10>Math.abs(a.clientY-pd)?(Na(a),"click"==a.type&&sd()):sd()},id=0,jd=0,kd=["mousedown",
"mouseup","click"],nd=r("Android")&&!r("Chrome"),od=0,pd=0,qd=["touchstart","mousedown","mouseup","click"];Ub(X,[new M(".gs_press",{click:X.prototype.$,keydown:X.prototype.ca,keyup:X.prototype.da,mousedown:X.prototype.ea,touchstart:X.prototype.ha})]);function td(){var a=0>ud.getBoundingClientRect().top;vd!=a&&(vd=a,q(wd,"gs_sth_vis",a),a?xd():(yd.style.left="",yd.style.width="",zd()))}function xd(){if(vd){var a=ud.getBoundingClientRect();yd.style.left=a.left+"px";yd.style.width=a.width+"px";zd()}}function zd(){O("gs-sth-change",t("gs_sth"))}var wd,ud,yd,vd=!1;D(function(){if(wd=t("gs_sth"))ud=wd.querySelector(".gs_sth_g"),yd=wd.querySelector(".gs_sth_b"),yc.addListener(td),zc.addListener(xd),td()});function Ad(){var a=t("gsc_rsb_co");if(a){a=a.querySelectorAll("img.gs_pp_df");for(var b=0;b<a.length;b++){var c=a[b];c.getAttribute("data-srcset")&&(c.setAttribute("srcset",c.getAttribute("data-srcset")),c.removeAttribute("data-srcset"));c.getAttribute("data-src")&&(c.setAttribute("src",c.getAttribute("data-src")),c.removeAttribute("data-src"))}}};var Bd=/\S+@\S+\.\S+/;function Cd(a){return p(a,"gsc_ccb_dis")||p(a,"gsc_ccb_lim")}function Dd(){for(var a=0>=Ed(),b=t("gsc_cods_res").querySelectorAll(".gsc_ccb_add"),c=b.length;c--;){var d=b[c];p(d,"gsc_ccb_on")||q(d,"gsc_ccb_lim",a)}};var Fd=function(a){this.X=a};Fd.prototype.fa=function(a){L(a);a=a.currentTarget.getAttribute("data-a");this.X.setAttribute("data-a",a||"");O("gsc-navigate",this.X)};var Gd=[new M(".gsc_pgn",{}),new M([".gsc_pgn_ppr",".gsc_pgn_pnx"],{click:Fd.prototype.fa})];function Hd(a,b){b=void 0===b?"":b;var c=t("gsc_md_cod");a+=fb({t:Id});R(c.id,a,"",b)}function Jd(a){if(Id!=a){var b=t("gsc_md_cod");n(b,Id);l(b,a);Id=a}}function Kd(){var a=kb(Fc).t;"gsc_cod_sugg"!=a&&"gsc_cod_lc"!=a||Jd(a)}function Ld(){var a=Md();a=a?a.value:"";var b=(t("gsc_cods_urls").getAttribute("data-sa")||"").replace(Nd,"$1"+encodeURIComponent(a));a=a?b:t("gsc_cods_urls").getAttribute("data-lc")||"";Hd(a)}
function Od(a){var b=t("gsc_cods_frm");if(b){b=b.elements;var c=b[1];b[0].disabled=c.disabled=a;q(c,"gs_bsp",a)}a=a?null:t("gsc_codb_data");if(c=t("gsc_cods_pp")){var d=a&&a.getAttribute("data-prev");b=a&&a.getAttribute("data-next");var e=a&&a.getAttribute("data-start"),f=a&&a.getAttribute("data-end");c.querySelector(".gsc_pgn_ppn").textContent=e&&f?e+" - "+f:"";e=c.querySelector(".gsc_pgn_ppr");e.disabled=!d;e.setAttribute("data-a",d||"");c=c.querySelector(".gsc_pgn_pnx");c.disabled=!b;c.setAttribute("data-a",
b||"")}a&&(Pd=+a.getAttribute("data-max")||0,za(t("gsc_cods_save"),"xsrf").value=a.getAttribute("data-xsrf")||"")}function Qd(){var a=0<Y.l||0<Z.l,b=Ed(),c=0>=b;t("gsc_cod_done").disabled=!a||0>b;q(t("gsc_cod_t"),"gsc_cod_changed",a);a=t("gsc_cod_trev");a.textContent=a.getAttribute(c?"data-lim":"data-txt")||"";q(t("gsc_cod_t"),"gsc_cod_lim",c)}function Ed(){return Pd-Y.l+("gsc_cod_sugg"==Id?0:Z.l)}function Md(){return t("gsc_cods_tsi")}
function Rd(a){for(var b="",c=la(a.j),d=c.length;d--;)b+=a.get(c[d]);return b}var Id="gsc_cod_lc",Pd=0,Nd=/([?&]mauthors=)([^&]*)/,Y=new Q,Z=new Q;function Sd(a){q(t("gsc_a_sp"),"gs_vis",0==a);q(t("gsc_a_err"),"gs_vis",2==a)}function Td(){return document.querySelectorAll("#gsc_a_t input[type=checkbox]")}function Ud(){O("gsc-works-change",t("gsc_a_t"))}function Vd(){var a=t("gsc_x_all");if(a){var b=document.querySelectorAll("#gsc_a_t input[type=checkbox]:checked");var c=b.length;var d=Td().length;c=c?c==d?1:2:0;vc(a,c);2==c&&(Wd=b)}Ud()}var Wd=[];var Xd="",Zd=0,ae=0;function be(a){for(var b=[!1,!1,!1],c=0;c<b.length;c++){var d=t(ce[c]);d&&(b[c]=!!a(d))}return b}function de(){var a=t("gsc_fol_m");if(a){var b=t("gsc_fol_b");if(!(a=!Bd.test(a.value))){a:{a=be(tc);for(var c=be(uc),d=0;d<a.length;d++)if(a[d]!=c[d]){a=!0;break a}a=!1}a=!a}b.disabled=a}}var ce=["gsc_fol_a","gsc_fol_c","gsc_fol_r"],ee=["follow_articles_btn","follow_citations_btn","follow_related_btn"];function fe(){p(document.documentElement,"gs_el_ph")||p(document.documentElement,"gs_el_ta")||Ad()};function ge(a){if(a){a.id&&a.removeAttribute("id");for(var b=0;b<a.children.length;b++)ge(a.children[b])}};function he(){var a=t("gsc_prf_pufii");if(r("MSIE ")){var b=t("gsc_prf_puf");Va("gsc_prf_pufi",function(){l(b,"gsc_prf_pufo")},function(){n(b,"gsc_prf_pufo")},a)}else a.click()};function ie(){var a=document.querySelectorAll(".gsc_prf_pnl"),b=document.documentElement;b=p(b,"gs_el_ph")||p(b,"gs_el_ta");for(var c=0;c<a.length;c++)a[c].setAttribute("role",b?"tabpanel":"region")};var je=kb(window.location.hash),ke=je.u||"";"gs_md_cita-d"==je.d&&ke.match(Ea)&&0<=ke.indexOf("view_citation")&&Ca(ke);P("#gsc_md_cod","gs-md-ldin",function(){Kd();Od(!0)});P("#gsc_md_cod","gs-md-lded",function(){Kd();Od(!1);for(var a=t("gsc_cods_res").querySelectorAll(".gsc_ccb_ck"),b=a.length;b--;){var c=a[b];if(!Cd(c)){var d=c.getAttribute("data-authorid")||"";d=(p(c,"gsc_ccb_add")?Y:Z).has(d);q(c,"gsc_ccb_on",d)}}Dd();Qd();a=lb(Fc);(b=Md())&&(b.value=a.mauthors||"")});
P("#gsc_cods_frm","gsc-lwpds-submit",Ld);P("#gsc_cods_pp","gsc-navigate",function(a){(a=a.currentTarget.getAttribute("data-a"))&&Hd(a)});
P([".gsc_ccb_add",".gsc_ccb_del"],"click",function(a){a=a.currentTarget;if(!Cd(a)){var b=!p(a,"gsc_ccb_on");q(a,"gsc_ccb_on",b);var c=p(a,"gsc_ccb_add")?".gsc_ccb_del":".gsc_ccb_add",d=a.parentNode;(c=d&&d.querySelector(c))&&n(c,"gsc_ccb_on");c=a.getAttribute("data-authorid")||"";Y.delete(c);Z.delete(c);b&&(p(a,"gsc_ccb_add")?Y:Z).set(c,t("gsc_ucoar-"+c).outerHTML);Dd();Qd()}});
P("#gsc_cod_trev","click",function(){var a=t("gsc_cods_res").cloneNode(!0),b=a.querySelector("#gsc_codb_content");b||(b=document.createElement("div"),b.id="gsc_codb_content",a.appendChild(b));var c=Rd(Y)+Rd(Z);b.innerHTML=c;(b=Md())&&(b.value="");Hd("",a.innerHTML)});P("#gsc_cod_done","click",function(){var a=t("gsc_cods_save");za(a,"colleague_add").value=la(Y.j).join(",");za(a,"colleague_del").value=la(Z.j).join(",");a.submit()});
P(["#gsc_coauth_opn",".gsc_rsb_btne",".gsc_rsb_btnv"],"click",function(){Jd("gsc_cod_lc");Pd=0;Y.clear();Z.clear();var a=Md();a&&(a.value="");Ld()});P(".gsc_rsb_aa",["click","keydown"],function(a){if("keydown"!=a.type||a.g&&!Oa(a.g)&&13==a.g.keyCode)a.g&&Na(a.g),(a=(a=a.currentTarget.querySelector("a"))?a.getAttribute("href"):"")&&Ca(a)});P("#gsc_prf_t-ath","click",function(){Ad()});D(function(){Ac.add(fe);fe()});P(".gsc_lwpds_frm","submit",function(a){L(a);O("gsc-lwpds-submit",a.target)});
var le=window.location.href.split("#")[0];Xd=le.replace(/([?&])(cstart|pagesize)=[^&]*/g,"$1");Zd=Math.max(+le.replace(/.*[?&]cstart=([^&]*).*/,"$1")||0,0);ae=+le.replace(/.*[?&]pagesize=([^&]*).*/,"$1")||0;ae=Math.max(Math.min(ae,100),20);
P("#gsc_bpf_more","click",function(a){var b=a.currentTarget,c=ae,d=100>c?100-c:100;a=(Xd+"&cstart="+(Zd+c)+"&pagesize="+d).replace(/([?&])&+/g,"$1");Sd(0);b.disabled=!0;Qb(a,"json=1",function(e,f){b.disabled=!1;try{var h=200==e&&JSON.parse(f)}catch(m){}if(h&&"object"==typeof h){ae=c+=d;Sd(1);e=t("gsc_a_b");f=document.createElement(va.Y);f.innerHTML=""+h.B;f=Array.prototype.slice.call(f.rows);for(var k=0;k<f.length;k++)e.appendChild(f[k]);Vd();if(e=t("gsc_a_nn"))f=e.innerHTML.replace(/[0-9]+$/,""+
t("gsc_a_b").rows.length),e.innerHTML=f;b.disabled=!h.N}else Sd(2)})});P(["#gsc_fol_a","#gsc_fol_c","#gsc_fol_r"],"gs-change",de);P("#gsc_fol_m","input",de);P("#gsc_fol_f","submit",function(a){a.g&&a.g.preventDefault();a=t("gsc_fol_f");var b=t("gsc_fol_inp");b.innerHTML="";for(var c=be(tc),d=be(uc),e=0;e<c.length;e++)if(c[e]!=d[e]){var f=ee[e],h=document.createElement("input");h.type="hidden";h.name=c[e]?f:"un"+f;b.appendChild(h)}O("gsc-fol-submit",a)});P("#gsc_fol_f","gsc-fol-submit",function(a){a.currentTarget.submit()});
P("#gsc_md_hist","gs-md-lded",function(){var a=t("gsc_md_hist_c");if(!a.innerHTML){var b=document.getElementsByClassName("gsc_g_hist_wrp");1==b.length&&(a.appendChild(b[0].cloneNode(!0)),ge(a.lastChild))}});P(["#gsc_hist_opn",".gsc_md_hist_b"],"click",function(){var a=document.documentElement;!t("gsc_hist_opn")||p(a,"gs_el_ph")||p(a,"gs_el_ta")||R("gsc_md_hist")});
P("#gsc_lwp_mndt_lnk","click",function(a){var b=a.currentTarget.getAttribute("href")+"&tzom="+(new Date).getTimezoneOffset();window.location.assign(b);a.g.preventDefault()});P("#gsc_prf_btne","click",function(){var a=t("gsc_md_pro-d");a.setAttribute("data-ifc","");R(a.id,fb({t:"gsc_md_pro_ed"}))});P("#gsc_prf_btnf","click",function(){R("gsc_md_fol")});P("#gsc_md_fol_pub","click",function(){t("gsc_fol_mpf").submit()});P("#gsc_prf_iv_tg","click",function(){q(t("gsc_prf_w"),"gsc_prf_why")});
P(".gsc_prf_pel",["click","keydown"],function(a){("keydown"!=a.type||13==a.g.keyCode&&a.g&&!Oa(a.g))&&he()});P("#gsc_prf_pufii","change",function(){t("gsc_prf_puf").submit()});P(".gsc_prf_tab","click",function(a){var b=t("gsc_bdy");b.setAttribute("data-tab",a.currentTarget.id);b=b.querySelectorAll(".gsc_prf_tab");for(var c=0;c<b.length;c++){var d=b[c];d.setAttribute("aria-selected",""+(d==a.currentTarget))}});D(function(){Ac.add(ie);ie()});
P("#gsc_md_cbyd","gs-md-ldin",function(){var a=t("gsc_md_cbyd_merge");a&&(a.disabled=!0);Aa("")});P("#gsc_md_cbyd","gs-md-lded",function(){var a=t("gsc_md_cbyd_f"),b=t("gsc_md_cbyd_merge"),c=Fc,d=lb(c).s||"";c=kb(c).c||"";a.elements.s.value=d;Aa(c);b&&a.elements.choose&&(b.disabled=!1,b.getBoundingClientRect().bottom<window.innerHeight&&b.focus())});
P("#gsc_md_cbym",["gs-md-ldin","gs-md-lded"],function(){var a=lb(Fc).s||"",b=t("gsc_md_cbym_e");b&&a&&0>a.indexOf("&")&&b.setAttribute("data-href",(b.getAttribute("data-href")||"").replace(/(&citation_for_view=)[^&]*/,"$1"+a))});P("#gsc_md_cbym_e","click",function(a){a=a.currentTarget.getAttribute("data-href")||"";R("gs_md_cita-d",a)});Ub(Fd,Gd);D(function(){return setTimeout(Vd,0)});P(".gsc_a_x","change",Vd);
P("#gsc_x_all","gs-change",function(a){a=tc(a.currentTarget);for(var b=2==a?Wd:Td(),c=b.length;c--;)b[c].checked=0!=a;Ud()});P(".gsc_a_acm","click",function(a){L(a);var b=a.currentTarget;a=b.href;var c=b.getAttribute("data-eid")||"";b=b.getAttribute("data-eud")||"";a=t("gsc_md_cbyd_f").action+"&update_op=merge_options&s="+(b+","+c)+fb({c:a});R("gsc_md_cbyd",a)});
P(".gsc_a_am","click",function(a){a=a.currentTarget.getAttribute("data-eid")||"";a=(t("gsc_md_cbym_l").getAttribute("data-act")||"")+"&update_op=merge_options&s="+a;R("gsc_md_cbym",a)});P("#gs_sth","gs-sth-change",function(a){var b=t("gsc_a_tr0"),c=t("gsc_a_trh"),d=b.querySelector(".gsc_a_t"),e=c.querySelector(".gsc_a_t");p(a.currentTarget,"gs_sth_vis")?(e.style.width=d.offsetWidth+"px",b.style.height=c.offsetHeight+"px"):e.style.width=b.style.height="auto"});
P("#gs_md_cita-b-save","click",function(){var a=t("gsc_ecd_form");za(a,"continue").value=window.location.pathname+window.location.search;O("submit",a)});P(".gsc_ecd_form_tsel","click",function(a){var b=t("gsc_ecd_table"),c=za(t("gsc_ecd_form"),"articletype");a=a.currentTarget;c.value=a.getAttribute("data-type")||"";b.className=a.getAttribute("data-class")||"";b=document.querySelectorAll("#gsc_ecd_citation_type button");for(c=b.length;c--;)q(b[c],"gs_sel",b[c]==a)});
}({"customAC":2,"eventId":"NB5AYcWYM8i1mwGW7rLoCQ"});</script></head><body><div id="gs_top" onclick=""><style>#gs_md_s,.gs_md_wnw{z-index:1200;position:fixed;top:0;left:0;width:100%;height:100%;visibility:hidden;}#gs_md_s{background-color:#fff;opacity:.5;}.gs_el_ta #gs_md_s,.gs_el_ph #gs_md_s{background-color:#666;}.gs_md_wnw{transition:all 0s .218s;}#gs_md_s.gs_vis,.gs_md_wnw.gs_vis{visibility:visible;transition:all 0s;}.gs_md_wnw>.gs_md_d{position:relative;margin:0 auto;width:464px;box-shadow:2px 2px 8px rgba(0,0,0,.2);white-space:normal;}.gs_el_ta .gs_md_wnw>.gs_md_d,.gs_el_ph .gs_md_wnw>.gs_md_d{box-shadow:2px 2px 8px rgba(0,0,0,.65);}.gs_el_ph .gs_md_wnw>.gs_md_d{width:80%;max-width:440px;}.gs_el_ph .gs_md_wmw>.gs_md_d{width:100%;height:100%;max-width:none;border:none;box-shadow:none;transform:translate(0,100%);transform:translate(0,100vh);transition:transform .27s cubic-bezier(.4,0,.6,1),opacity 0s .27s,visibility 0s .27s,max-height 0s .27s;}.gs_el_ph .gs_md_wmw>.gs_md_d.gs_vis{transform:translate(0,0);transition:transform .3s cubic-bezier(0,0,.2,1);}.gs_md_wmw>.gs_md_d.gs_abt,.gs_el_ph .gs_md_wmw>.gs_md_d.gs_abt{transition:none;}.gs_md_hdr{display:flex;align-items:center;height:47px;border-bottom:1px solid #e0e0e0;border-bottom-color:rgba(0,0,0,.12);background-color:#f5f5f5;}.gs_md_hdr>a,.gs_md_hdr>a.gs_btn_lrge{flex:0 0 auto;width:41px;height:47px;}.gs_el_ph .gs_md_hdr>a{margin:0 2px 0 0;}.gs_el_ph a.gs_md_hdr_c{margin:0 0 0 2px;}.gs_md_hdr_b{margin:0 41px 0 16px;}.gs_el_ph .gs_md_hdr_b{margin:0 16px;}.gs_md_hdr_t:empty~.gs_md_hdr_b{margin-left:0;}.gs_md_hdr_b:empty{width:41px;margin:0;}.gs_el_ph .gs_md_hdr_b:empty{margin-right:2px;}.gs_md_hdr_b:empty:not(:last-child){display:none;}.gs_md_hdr_b>button{min-width:51px;height:33px;}.gs_md_hdr_t{flex:1 1 auto;font-size:18px;font-weight:normal;color:#666;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;text-align:center;}.gs_md_bdy{overflow-y:auto;box-sizing:border-box;padding:24px 41px 0 41px;}.gs_md_bdy:after{display:block;content:"";clear:both;padding-bottom:24px;}.gs_el_ph .gs_md_bdy{padding:16px 16px 0 16px;}.gs_el_ph .gs_md_bdy:after{padding-bottom:16px;}.gs_el_ph .gs_md_wmw .gs_md_bdy{position:absolute;width:100%;top:48px;bottom:0;}.gs_md_lbl{display:block;font-size:16px;margin:0 0 16px 0;word-wrap:break-word;}.gs_md_btns{margin:24px 0 0 0;white-space:nowrap;}.gs_el_ph .gs_md_btns{margin:16px 0 0 0;}.gs_md_btns button{margin-right:16px;}.gs_md_btns button:last-child{margin-right:0;}.gs_md_prg{margin:24px 0;text-align:center;}.gs_md_prg .gs_alrt{padding:4px 16px;}.gs_md_ldg:before{content:"";position:absolute;top:0;left:0;bottom:0;right:0;background-color:#fff;opacity:.5;z-index:100;}</style><div id="gs_md_ldg" style="display:none">Loading...</div><div id="gs_md_err" style="display:none">The system can't perform the operation now. Try again later.</div><div id="gs_md_s"></div><div data-h="0" class="gs_md_wnw"><div id="gsc_md_hist" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_hist-t" data-wfc="gsc_md_hist-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_hist-x" role="button" aria-label="Cancel" data-mdx="gsc_md_hist" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_hist-t" class="gs_md_hdr_t">Citations per year</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_hist-bdy" class="gs_md_bdy"><style>#gsc_md_hist{width:80%;max-width:386px;}#gsc_md_hist_c{position:relative;width:100%;}</style><div id="gsc_md_hist_c"></div></div></div></div><div data-h="600" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cbyd" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cbyd-t" data-cid="gsc_md_cbyd_l" data-wfc="gsc_md_cbyd-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cbyd-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cbyd" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cbyd-t" class="gs_md_hdr_t">Duplicate citations</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_cbyd-bdy" class="gs_md_bdy"><form id="gsc_md_cbyd_f" action="/citations?hl=en&amp;user=wGRCWGAAAAAJ&amp;view_op=list_works" method="post"><input type="hidden" name="s" value=""><div class="gs_md_lbl">The following articles are merged in Scholar. Their <a id="gsc_md_cbyd_c" href="javascript:void(0)">combined citations</a> are counted only for the first article.</div><div id="gsc_md_cbyd_l"></div></form></div></div></div><div data-h="600" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cbym" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cbym-t" data-cid="gsc_md_cbym_l" data-wfc="gsc_md_cbym-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cbym-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cbym" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cbym-t" class="gs_md_hdr_t">Merged citations</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_cbym-bdy" class="gs_md_bdy"><div class="gs_md_lbl">This "Cited by" count includes citations to the following articles in Scholar. The ones marked <span id="gsc_md_cbym_s">*</span> may be different from the article in the profile.</div><div id="gsc_md_cbym_l" data-act="/citations?hl=en&amp;user=wGRCWGAAAAAJ&amp;view_op=list_works"></div></div></div></div><div data-h="900" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cod" class="gs_md_d gs_ttzi gsc_cod_lc" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cod-t" data-cid="gsc_cods_res" data-wfc="gsc_md_cod-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cod-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cod" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cod-t" class="gs_md_hdr_t"><span id="gsc_cod_t"><span id="gsc_cod_tadd">Add co-authors</span><span id="gsc_cod_tedit">Co-authors</span><a id="gsc_cod_trev" href="javascript:void(0)" data-txt="Review" data-lim="Limit reached"></a></span></h2><div class="gs_md_hdr_b"><button type="button" id="gsc_cod_done" aria-label="Add co-authors" disabled="" class="gs_btnDNW gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></div></div><div id="gsc_md_cod-bdy" class="gs_md_bdy"><div id="gsc_cods_urls" class="gsc_cods_hide" data-ls="" data-lc="/citations?view_op=list_colleagues&amp;hl=en&amp;json=&amp;user=wGRCWGAAAAAJ" data-sa=""></div><form id="gsc_cods_save" action="" method="POST"><input type="hidden" name="colleague_add"><input type="hidden" name="colleague_del"></form><div id="gsc_cods_res"></div></div></div></div><div data-h="800" class="gs_md_wnw gs_md_wmw"><div id="gs_md_cita-d" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gs_md_cita-d-t" data-cid="gs_md_cita-l" data-wfc="gs_md_cita-d-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gs_md_cita-d-x" role="button" aria-label="Cancel" data-mdx="gs_md_cita-d" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gs_md_cita-d-t" class="gs_md_hdr_t"></h2><div class="gs_md_hdr_b"><button type="button" id="gs_md_cita-b-save" aria-label="Save" class="gs_btnDNW gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></div></div><div id="gs_md_cita-d-bdy" class="gs_md_bdy"><style>#gs_md_cita-d{width:90%;max-width:1000px;}.gs_el_ph #gs_md_cita-d{width:100%;max-width:none;}#gs_md_cita-d .gs_md_prg{min-height:600px;}</style><div id="gs_md_cita-l" aria-live="assertive"></div></div></div></div><div data-h="0" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_fol" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_fol-t" data-wfc="gsc_md_fol-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_fol-x" role="button" aria-label="Cancel" data-mdx="gsc_md_fol" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_fol-t" class="gs_md_hdr_t">Follow this author</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_fol-bdy" class="gs_md_bdy"><form method="post" id="gsc_fol_f" action="/citations?hl=en&amp;user=wGRCWGAAAAAJ&amp;view_op=list_works"><input type="hidden" name="xsrf" value="AMD79ooAAAAAYUFvtJWqYqrXxQXT_LRsh56iixZProA0"><input type="hidden" name="user" value="wGRCWGAAAAAJ"><div id="gsc_fol_inp"></div><div id="gsc_fol_cb"><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_a" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New articles by this author</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_c" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New citations to this author</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_r" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New articles related to this author's research</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div></div><div id="gsc_fol_email"><label id="gsc_fol_ml" for="gsc_fol_m">Email address for updates</label><div class="gs_in_txtw gs_in_txtb"><input type="text" class="gs_in_txt" name="email_for_op" value="" id="gsc_fol_m" maxlength="100" autocapitalize="off" autocorrect="off"></div></div><div class="gs_md_btns"><button type="submit" id="gsc_fol_b" disabled="" class=" gs_btn_act gs_btn_lrge gs_btn_lsu"><span class="gs_wr"><span class="gs_lbl">Done</span></span></button></div></form></div></div></div><!--[if lte IE 9]><div class="gs_alrt" style="padding:16px"><div>Sorry, some features may not work in this version of Internet Explorer.</div><div>Please use <a href="//www.google.com/chrome/">Google Chrome</a> or <a href="//www.mozilla.com/firefox/">Mozilla Firefox</a> for the best experience.</div></div><![endif]--><div id="gs_hdr_drs"></div><div id="gs_hdr_drw" class="gs_md_ulr" role="dialog" tabindex="-1" data-shd="gs_hdr_drs" data-wfc="gs_hdr_drw_mnu" data-cfc="gs_hdr_mnu"><div id="gs_hdr_drw_in"><div id="gs_hdr_drw_top"><a href="javascript:void(0)" id="gs_hdr_drw_mnu" role="button" aria-controls="gs_hdr_drw" aria-label="Options" class="gs_btnMNT gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><a id="gs_hdr_drw_lgo" href="/schhp?hl=en" aria-label="Homepage"></a></div><div><div class="gs_hdr_drw_sec"><a href="/citations?hl=en" role="menuitem" class="gs_btnPRO gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">My profile</span></a><a href="/scholar?scilib=1&amp;hl=en" role="menuitem" class="gs_btnL gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">My library</span></a><a href="/citations?view_op=metrics_intro&amp;hl=en" role="menuitem" class="gs_btnJ gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Metrics</span></a><a href="/scholar_alerts?view_op=list_alerts&amp;hl=en" role="menuitem" class="gs_btnM gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Alerts</span></a></div><div class="gs_hdr_drw_sec"><a href="/scholar_settings?hl=en" role="menuitem" class="gs_btnP gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Settings</span></a></div></div><div id="gs_hdr_drw_bot" class="gs_hdr_drw_sec"><a href="https://accounts.google.com/Login?hl=en&amp;continue=https://scholar.google.com/schhp%3Fhl%3Den" class=" gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Sign in</span></a></div></div></div><div id="gs_hdr" role="banner" class="gs_hdr_src"><a href="javascript:void(0)" id="gs_hdr_mnu" role="button" aria-controls="gs_hdr_drw" class="gs_btnMNT gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><a id="gs_hdr_lgo" class="" href="/schhp?hl=en" aria-label="Homepage"></a><div id="gs_hdr_md"><div id="gs_hdr_srch"><form id="gs_hdr_frm" action="/citations"><input type="hidden" name="view_op" value="search_authors"><input type="hidden" name="hl" value="en"><div class="gs_in_txtw gs_in_txtb"><input type="text" class="gs_in_txt" name="mauthors" value="" id="gs_hdr_tsi" placeholder="Search profiles" size="50" maxlength="2048" autocapitalize="off" aria-label="Search"></div><span id="gs_hdr_tsc"><span class="gs_ico gs_ico_X"></span></span><button type="submit" id="gs_hdr_tsb" name="btnG" aria-label="Search" class="gs_btnG gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></form></div></div><a href="javascript:void(0)" id="gs_hdr_sre" role="button" aria-controls="gs_hdr_frm" aria-label="Search" class="gs_btnTSB gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><div id="gs_hdr_act"><a id="gs_hdr_act_s" href="https://accounts.google.com/Login?hl=en&amp;continue=https://scholar.google.com/schhp%3Fhl%3Den">Sign in</a></div></div><style>#gs_alrt{position:fixed;bottom:48px;left:16px;max-width:384px;z-index:1250;display:flex;justify-content:space-between;align-items:center;font-size:13px;line-height:16px;color:#e2e2e2;background:#333;text-align:left;border-radius:3px;box-shadow:0 3px 5px -1px rgba(0,0,0,.2),0 6px 10px 0 rgba(0,0,0,.14),0 1px 18px 0 rgba(0,0,0,.12);visibility:hidden;transform-origin:center;transform:scale(0.8,0.8) translate(0,100%);}.gs_el_ph #gs_alrt{bottom:0;left:0;width:100%;max-width:none;border-radius:0;box-shadow:none;transform:scale(1,1) translate(0,100%);}#gs_alrt.gs_vis{visibility:visible;transform:scale(1,1) translate(0,0);}#gs_alrt.gs_anm{transition:transform .067s cubic-bezier(.4,0,1,1),visibility 0s .067s;}#gs_alrt.gs_vis.gs_anm{transition:transform .067s cubic-bezier(0,0,.2,1);}.gs_el_ph #gs_alrt.gs_anm{transition:transform .084s cubic-bezier(.4,0,1,1),visibility 0s .084s;}.gs_el_ph #gs_alrt.gs_vis.gs_anm{transition:transform .1s cubic-bezier(0,0,.2,1);}#gs_alrt_m{display:block;padding:16px;}#gs_alrt_l{display:block;padding:8px;margin:0 8px 0 -8px;border-radius:3px;color:#fcc934;text-transform:uppercase;text-decoration:none;}#gs_alrt_l:hover{background-color:rgba(255,255,255,.05)}#gs_alrt_l:active{background-color:rgba(255,255,255,.1)}#gs_alrt_l:empty{display:none}#gs_alrt_m a{padding:8px 0;color:#e2e2e2;text-decoration:underline;}#gs_alrt_m a:active{color:#f6aea9}</style><form action="" method="post" id="gs_alrt"><span id="gs_alrt_m"></span><span id="gs_alrt_h"></span><a id="gs_alrt_l" href="javascript:void(0)" class="gs_fm_s" data-fm="gs_alrt"></a></form><div id="gs_bdy"><div id="gs_bdy_sb" role="navigation"><div id="gs_bdy_sb_in"></div></div><div id="gs_bdy_ccl" role="main"><div id="gsc_bdy" class="gs_scl" data-tab="gsc_prf_t-art"><div class="gsc_rsb" role="navigation"><a id="gsc_rsb_gpl" class="gsc_rsb_s" href="/citations?hl=en">Get my own profile</a><div class="gsc_rsb_s gsc_prf_pnl" id="gsc_rsb_cit" role="region" aria-labelledby="gsc_prf_t-cit"><h3 class="gsc_rsb_header"><span class="gsc_rsb_title">Cited by</span><button type="button" id="gsc_hist_opn" class=" gs_btn_flat gs_btn_flact gs_btn_lrge gs_btn_half gs_btn_lsu gsc_rsb_action"><span class="gs_wr"><span class="gs_lbl">View all</span></span></button></h3><table id="gsc_rsb_st"><thead><tr><th class="gsc_rsb_sth"></th><th class="gsc_rsb_sth">All</th><th class="gsc_rsb_sth">Since 2016</th></tr></thead><tbody><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="This is the number of citations to all publications. The second column has the &quot;recent&quot; version of this metric which is the number of new citations in the last 5 years to all publications.">Citations</a></td><td class="gsc_rsb_std">5392</td><td class="gsc_rsb_std">1453</td></tr><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="h-index is the largest number h such that h publications have at least h citations. The second column has the &quot;recent&quot; version of this metric which is the largest number h such that h publications have at least h new citations in the last 5 years.">h-index</a></td><td class="gsc_rsb_std">43</td><td class="gsc_rsb_std">21</td></tr><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="i10-index is the number of publications with at least 10 citations. The second column has the &quot;recent&quot; version of this metric which is the number of publications that have received at least 10 new citations in the last 5 years.">i10-index</a></td><td class="gsc_rsb_std">97</td><td class="gsc_rsb_std">43</td></tr></tbody></table><style>.gsc_g_t{position:absolute;bottom:0;color:#777;font-size:11px;}.gsc_g_a{position:absolute;bottom:13px;width:15px;background:#777;}.gsc_g_a:hover,.gsc_g_a:focus,.gsc_g_a:active{text-decoration:none;cursor:default;}.gsc_g_al{position:absolute;bottom:15px;left:7px;color:#222;background:white;font-size:11px;padding:1px;border:1px solid #777;border-radius:1px;visibility:hidden;opacity:0;transition:opacity .218s,visibility 0s .218s;}.gsc_g_a:hover .gsc_g_al,.gsc_g_a:focus .gsc_g_al,.gsc_g_a:active .gsc_g_al{visibility:visible;opacity:1;transition:all 0s;}#gsc_md_hist{max-width:1250px;}.gsc_md_hist_w{position:relative;overflow:hidden;margin-right:43px;}.gs_md_bdy .gsc_md_hist_w,.gs_el_ph .gsc_md_hist_w,.gs_el_ta .gsc_md_hist_w{overflow-x:auto;padding-bottom:16px;}.gsc_md_hist_b{position:relative;height:174px;width:100%;}.gsc_md_hist_b .gsc_g_a{bottom:auto;}.gsc_md_hist_b .gsc_g_t{bottom:auto;top:161px;}.gsc_md_hist_b:after{position:absolute;right:1208px;content:"\00A0";}.gsc_g_hist_x{position:relative;margin-right:45px;}.gsc_g_hist_xl{position:absolute;right:8px;width:35px;}.gs_el_ta .gsc_g_hist_xl,.gs_el_ph .gsc_g_hist_xl{right:16px;}.gsc_g_hist_wrp{padding-top:32px;position:relative;}.gs_el_ta .gsc_g_hist_wrp,.gs_el_ph .gsc_g_hist_wrp{padding-right:8px;}.gs_md_bdy .gsc_g_hist_wrp{border-top:0;}.gs_el_tc .gs_md_bdy .gsc_g_hist_wrp:after,.gs_el_tc.gs_el_ph .gsc_g_hist_wrp:after,.gs_el_tc.gs_el_ta .gsc_g_hist_wrp:after{display:block;content:"";position:absolute;z-index:100;top:0;left:0;width:20px;height:100%;background-image:linear-gradient(to left,rgba(255,255,255,0),rgba(255,255,255,1) 80%);}.gsc_g_x,.gsc_g_xt{position:absolute;left:0;border-bottom:1px solid #eee;width:100%;text-align:right;}.gsc_g_x{border-bottom:1px solid #eee;}.gsc_g_xtl{position:absolute;color:#777;}.gsc_g_gtr{position:absolute;}.gsc_g_a:last-child .gsc_g_al{right:0;left:auto;}</style><div class="gsc_g_hist_wrp" dir="rtl"><div class="gsc_g_hist_x"><div class="gsc_g_x" style="top:160px;"></div><div class="gsc_g_xt" style="top:0px;"></div><div class="gsc_g_xt" style="top:80px;"></div><div class="gsc_g_xt" style="top:120px;"></div><div class="gsc_g_xt" style="top:40px;"></div></div><div class="gsc_g_hist_xl"><div class="gsc_g_xtl" style="top:153px;">0</div><div class="gsc_g_xtl" style="top:-7px;">300</div><div class="gsc_g_xtl" style="top:73px;">150</div><div class="gsc_g_xtl" style="top:113px;">75</div><div class="gsc_g_xtl" style="top:33px;">225</div></div><div class="gsc_md_hist_w"><div class="gsc_md_hist_b"><span class="gsc_g_t" style="right:1155px">1985</span><span class="gsc_g_t" style="right:1123px">1986</span><span class="gsc_g_t" style="right:1091px">1987</span><span class="gsc_g_t" style="right:1059px">1988</span><span class="gsc_g_t" style="right:1027px">1989</span><span class="gsc_g_t" style="right:995px">1990</span><span class="gsc_g_t" style="right:963px">1991</span><span class="gsc_g_t" style="right:931px">1992</span><span class="gsc_g_t" style="right:899px">1993</span><span class="gsc_g_t" style="right:867px">1994</span><span class="gsc_g_t" style="right:835px">1995</span><span class="gsc_g_t" style="right:803px">1996</span><span class="gsc_g_t" style="right:771px">1997</span><span class="gsc_g_t" style="right:739px">1998</span><span class="gsc_g_t" style="right:707px">1999</span><span class="gsc_g_t" style="right:675px">2000</span><span class="gsc_g_t" style="right:643px">2001</span><span class="gsc_g_t" style="right:611px">2002</span><span class="gsc_g_t" style="right:579px">2003</span><span class="gsc_g_t" style="right:547px">2004</span><span class="gsc_g_t" style="right:515px">2005</span><span class="gsc_g_t" style="right:483px">2006</span><span class="gsc_g_t" style="right:451px">2007</span><span class="gsc_g_t" style="right:419px">2008</span><span class="gsc_g_t" style="right:387px">2009</span><span class="gsc_g_t" style="right:355px">2010</span><span class="gsc_g_t" style="right:323px">2011</span><span class="gsc_g_t" style="right:291px">2012</span><span class="gsc_g_t" style="right:259px">2013</span><span class="gsc_g_t" style="right:227px">2014</span><span class="gsc_g_t" style="right:195px">2015</span><span class="gsc_g_t" style="right:163px">2016</span><span class="gsc_g_t" style="right:131px">2017</span><span class="gsc_g_t" style="right:99px">2018</span><span class="gsc_g_t" style="right:67px">2019</span><span class="gsc_g_t" style="right:35px">2020</span><span class="gsc_g_t" style="right:3px">2021</span><a href="javascript:void(0)" class="gsc_g_a" style="right:1160px;top:153px;height:7px;z-index:37"><span class="gsc_g_al">14</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:1128px;top:150px;height:10px;z-index:36"><span class="gsc_g_al">19</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:1096px;top:147px;height:13px;z-index:35"><span class="gsc_g_al">25</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:1064px;top:150px;height:10px;z-index:34"><span class="gsc_g_al">20</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:1032px;top:146px;height:14px;z-index:33"><span class="gsc_g_al">28</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:1000px;top:144px;height:16px;z-index:32"><span class="gsc_g_al">30</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:968px;top:149px;height:11px;z-index:31"><span class="gsc_g_al">21</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:936px;top:144px;height:16px;z-index:30"><span class="gsc_g_al">30</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:904px;top:144px;height:16px;z-index:29"><span class="gsc_g_al">31</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:872px;top:142px;height:18px;z-index:28"><span class="gsc_g_al">34</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:840px;top:146px;height:14px;z-index:27"><span class="gsc_g_al">27</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:808px;top:122px;height:38px;z-index:26"><span class="gsc_g_al">72</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:776px;top:144px;height:16px;z-index:25"><span class="gsc_g_al">31</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:744px;top:134px;height:26px;z-index:24"><span class="gsc_g_al">49</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:712px;top:120px;height:40px;z-index:23"><span class="gsc_g_al">75</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:680px;top:103px;height:57px;z-index:22"><span class="gsc_g_al">108</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:648px;top:109px;height:51px;z-index:21"><span class="gsc_g_al">97</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:616px;top:94px;height:66px;z-index:20"><span class="gsc_g_al">124</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:584px;top:72px;height:88px;z-index:19"><span class="gsc_g_al">165</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:552px;top:35px;height:125px;z-index:18"><span class="gsc_g_al">235</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:520px;top:58px;height:102px;z-index:17"><span class="gsc_g_al">192</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:488px;top:42px;height:118px;z-index:16"><span class="gsc_g_al">223</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:456px;top:5px;height:155px;z-index:15"><span class="gsc_g_al">291</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:424px;top:4px;height:156px;z-index:14"><span class="gsc_g_al">293</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:392px;top:30px;height:130px;z-index:13"><span class="gsc_g_al">245</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:360px;top:44px;height:116px;z-index:12"><span class="gsc_g_al">219</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:328px;top:57px;height:103px;z-index:11"><span class="gsc_g_al">194</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:296px;top:58px;height:102px;z-index:10"><span class="gsc_g_al">192</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:264px;top:26px;height:134px;z-index:9"><span class="gsc_g_al">253</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:232px;top:12px;height:148px;z-index:8"><span class="gsc_g_al">278</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:200px;top:32px;height:128px;z-index:7"><span class="gsc_g_al">240</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:168px;top:3px;height:157px;z-index:6"><span class="gsc_g_al">295</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:136px;top:11px;height:149px;z-index:5"><span class="gsc_g_al">281</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:104px;top:11px;height:149px;z-index:4"><span class="gsc_g_al">280</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:72px;top:44px;height:116px;z-index:3"><span class="gsc_g_al">219</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:40px;top:64px;height:96px;z-index:2"><span class="gsc_g_al">181</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:8px;top:56px;height:104px;z-index:1"><span class="gsc_g_al">195</span></a></div></div></div></div><div class="gsc_rsb_s gsc_prf_pnl" id="gsc_rsb_mnd" role="region" aria-labelledby="gsc_prf_t-mnd"><div class="gsc_rsb_header gsc_rsb_m_header"><div class="gsc_rsb_m_title">Public access</div><a href="/citations?view_op=list_mandates&amp;hl=en&amp;user=wGRCWGAAAAAJ" id="gsc_lwp_mndt_lnk">View all</a></div><div class="gsc_rsb_hm gs_ota gs_oph"><button type="button" onclick="window.location='/citations?view_op\x3dlist_mandates\x26hl\x3den\x26user\x3dwGRCWGAAAAAJ'" class=" gs_btn_flat gs_btn_flact gs_btn_lrge gs_btn_half gs_btn_lsu"><span class="gs_wr"><span class="gs_lbl">View all</span></span></button></div><div class="gsc_rsb_m"><div class="gsc_rsb_m_a"><span>15 articles</span></div><div class="gsc_rsb_m_na"><div>2 articles</div></div><div class="gsc_rsb_m_bar"><div class="gsc_rsb_m_bar_na" style="width:12%"></div></div><div class="gsc_rsb_m_a"><span>available</span></div><div class="gsc_rsb_m_na"><span>not available</span></div><div class="gsc_rsb_m_desc">Based on funding mandates</div></div></div></div><div class="gsc_lcl" role="main" id="gsc_prf_w"><div id="gsc_prf"><button type="button" id="gsc_prf_btnf" class="gs_btnMW gs_in_ib gs_btn_act gs_btn_lsu gs_btn_mph"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl">Follow</span></span></button><div id="gsc_prf_pu"><div id="gsc_prf_pua" class="gs_rimg"><style>#gsc_prf_pup-img{width:102px;height:128px;}@media print{#gs_top #gsc_prf_pup-img{width:63pt;height:80pt;}}</style><img alt="Laurence H Patterson" sizes="print 63px,102px" src="https://scholar.googleusercontent.com/citations?view_op=view_photo&amp;user=wGRCWGAAAAAJ&amp;citpid=9" id="gsc_prf_pup-img" srcset="https://scholar.googleusercontent.com/citations?view_op=view_photo&amp;user=wGRCWGAAAAAJ&amp;citpid=9 102w,https://scholar.googleusercontent.com/citations?view_op=medium_photo&amp;user=wGRCWGAAAAAJ&amp;citpid=9 205w"></div></div><div id="gsc_prf_i"><div id="gsc_prf_in">Laurence H Patterson</div><div class="gsc_prf_il">Professor Emeritus,  Institute of Cancer Therapeutics, <a href="/citations?view_op=view_org&amp;hl=en&amp;org=4189814768881843562" class="gsc_prf_ila">University of Bradford</a></div><div class="gsc_prf_il" id="gsc_prf_ivh">Verified email at bradford.ac.uk - <a href="http://www.cancer.brad.ac.uk/" rel="nofollow" class="gsc_prf_ila">Homepage</a></div><div class="gsc_prf_il" id="gsc_prf_int"><a href="/citations?view_op=search_authors&amp;hl=en&amp;mauthors=label:medicinal_chemistry" class="gsc_prf_inta gs_ibl">medicinal chemistry</a><a href="/citations?view_op=search_authors&amp;hl=en&amp;mauthors=label:cancer_pharmacology" class="gsc_prf_inta gs_ibl">cancer pharmacology</a><a href="/citations?view_op=search_authors&amp;hl=en&amp;mauthors=label:drug_discovery" class="gsc_prf_inta gs_ibl">drug discovery</a></div></div></div></div><div id="gsc_prf_t_wrp" role="navigation"><div id="gsc_prf_t" role="tablist"><a id="gsc_prf_t-art" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_art" aria-selected="true">Articles</a><a id="gsc_prf_t-cit" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_rsb_cit">Cited by</a><a id="gsc_prf_t-mnd" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_rsb_mnd">Public access</a></div></div><div class="gsc_lcl gsc_prf_pnl" id="gsc_art" role="region" aria-labelledby="gsc_prf_t-art"><form method="post" action="/citations?hl=en&amp;user=wGRCWGAAAAAJ&amp;view_op=list_works"><input type="hidden" name="xsrf" value="AMD79ooAAAAAYUFvtJWqYqrXxQXT_LRsh56iixZProA0"><div id="gsc_a_tw"><table id="gsc_a_t"><thead><tr id="gsc_a_tr0" aria-hidden="true"><th class="gsc_a_t"></th><th class="gsc_a_c"></th><th class="gsc_a_y"></th></tr><tr id="gsc_a_trh"><th class="gsc_a_t" scope="col"><span id="gsc_a_ta"><a href="/citations?hl=en&amp;user=wGRCWGAAAAAJ&amp;view_op=list_works&amp;sortby=title" class="gsc_a_a">Title</a></span><div id="gsc_dd_sort-r" class="gs_md_r gs_md_rmb gs_md_rmbl"><button type="button" id="gsc_dd_sort-b" aria-controls="gsc_dd_sort-d" aria-haspopup="true" ontouchstart="gs_evt_dsp(event)" class=" gs_in_se gs_btn_mnu gs_btn_flat gs_btn_lrge gs_btn_half gs_btn_lsu gs_press gs_md_tb"><span class="gs_wr"><span class="gs_lbl">Sort</span><span class="gs_icm"></span></span></button><div id="gsc_dd_sort-d" class="gs_md_d gs_md_ulr" role="menu" tabindex="-1"><div id="gsc_dd_sort-s" class="gs_oph gsc_dd_sec gsc_dd_sep"><a role="menuitem" href="/citations?hl=en&amp;user=wGRCWGAAAAAJ&amp;view_op=list_works" tabindex="-1" class="gs_md_li gsc_dd_sort-sel">Sort by citations</a><a role="menuitem" href="/citations?hl=en&amp;user=wGRCWGAAAAAJ&amp;view_op=list_works&amp;sortby=pubdate" tabindex="-1" class="gs_md_li">Sort by year</a><a role="menuitem" href="/citations?hl=en&amp;user=wGRCWGAAAAAJ&amp;view_op=list_works&amp;sortby=title" tabindex="-1" class="gs_md_li">Sort by title</a></div></div></div></th><th class="gsc_a_c" scope="col" dir="rtl"><span id="gsc_a_ca"><div class="gs_nph">Cited by</div><div class="gs_oph">Cited by</div></span></th><th class="gsc_a_y" scope="col"><span class="gsc_a_h" id="gsc_a_ha"><a href="/citations?hl=en&amp;user=wGRCWGAAAAAJ&amp;view_op=list_works&amp;sortby=pubdate" class="gsc_a_a">Year</a></span></th></tr></thead><tbody id="gsc_a_b"><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;citation_for_view=wGRCWGAAAAAJ:Tyk-4Ss8FVUC" class="gsc_a_at">The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1</a><div class="gs_gray">GA Potter, LH Patterson, E Wanogho, PJ Perry, PC Butler, T Ijaz, ...</div><div class="gs_gray">British journal of cancer 86 (5), 774-778<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2853497965547891359" class="gsc_a_ac gs_ibl">459</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;citation_for_view=wGRCWGAAAAAJ:-_dYPAW6P2MC" class="gsc_a_at">Characteristics of a novel deep red/infrared fluorescent cell‐permeant DNA probe, DRAQ5, in intact human cells analyzed by flow cytometry, confocal and multiphoton microscopy</a><div class="gs_gray">PJ Smith, N Blunt, M Wiltshire, T Hoy, P Teesdale‐Spittle, MR Craven, ...</div><div class="gs_gray">Cytometry: The Journal of the International Society for Analytical Cytology&nbsp;…<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5038707261586116227" class="gsc_a_ac gs_ibl">201</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;citation_for_view=wGRCWGAAAAAJ:fEOibwPWpKIC" class="gsc_a_at">Tumour cytochrome P450 and drug activation</a><div class="gs_gray">LH Patterson, GI Murray</div><div class="gs_gray">Current pharmaceutical design 8 (15), 1335-1347<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11920565043609401422" class="gsc_a_ac gs_ibl">181</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;citation_for_view=wGRCWGAAAAAJ:uJ-U7cs_P_0C" class="gsc_a_at">AQ4N: a new approach to hypoxia-activated cancer chemotherapy</a><div class="gs_gray">LH Patterson, SR McKeown</div><div class="gs_gray">British journal of cancer 83 (12), 1589-1593<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16715558700726609301" class="gsc_a_ac gs_ibl">176</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;citation_for_view=wGRCWGAAAAAJ:j8SEvjWlNXcC" class="gsc_a_at">Rationale for the use of aliphatic N-oxides of cytotoxic anthraquinones as prodrug DNA binding agents: a new class of bioreductive agent</a><div class="gs_gray">LH Patterson</div><div class="gs_gray">Cancer and Metastasis Reviews 12 (2), 119-134<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16232089055385718715" class="gsc_a_ac gs_ibl">159</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;citation_for_view=wGRCWGAAAAAJ:VLnqNzywnoUC" class="gsc_a_at">Enzymology of tirapazamine metabolism: a review</a><div class="gs_gray">AV Patterson, MP Saunders, EC Chinje, LH Patterson, IJ Stratford</div><div class="gs_gray">Anti-cancer drug design 13 (6), 541-573<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10899612630643213557" class="gsc_a_ac gs_ibl">117</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;citation_for_view=wGRCWGAAAAAJ:z_wVstp3MssC" class="gsc_a_at">Antitumour prodrug development using cytochrome P450 (CYP) mediated activation.</a><div class="gs_gray">LH Patterson, SR McKeown, T Robson, R Gallagher, SM Raleigh, S Orr</div><div class="gs_gray">Anti-cancer drug design 14 (6), 473-486<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17484151468921312548" class="gsc_a_ac gs_ibl">111</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;citation_for_view=wGRCWGAAAAAJ:uc_IGeMz5qoC" class="gsc_a_at">Examination of the distribution of the bioreductive drug AQ4N and its active metabolite AQ4 in solid tumours by imaging matrix‐assisted laser desorption/ionisation mass&nbsp;…</a><div class="gs_gray">SJ Atkinson, PM Loadman, C Sutton, LH Patterson, MR Clench</div><div class="gs_gray">Rapid Communications in Mass Spectrometry: An International Journal Devoted&nbsp;…<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9645413553257638156" class="gsc_a_ac gs_ibl">109</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;citation_for_view=wGRCWGAAAAAJ:9Nmd_mFXekcC" class="gsc_a_at">A novel cell permeant and far red-fluorescing DNA probe, DRAQ5, for blood cell discrimination by flow cytometry</a><div class="gs_gray">PJ Smith, M Wiltshire, S Davies, LH Patterson, T Hoy</div><div class="gs_gray">Journal of immunological methods 229 (1-2), 131-139<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12388794203856423608" class="gsc_a_ac gs_ibl">109</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;citation_for_view=wGRCWGAAAAAJ:t7zJ5fGR-2UC" class="gsc_a_at">Comparative computer graphics and solution studies of the DNA interaction of substituted anthraquinones based on doxorubicin and mitoxantrone</a><div class="gs_gray">SA Islam, S Neidle, BM Gandecha, M Partridge, LH Patterson, JR Brown</div><div class="gs_gray">Journal of medicinal chemistry 28 (7), 857-864<span class="gs_oph">, 1985</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5662470695219372321" class="gsc_a_ac gs_ibl">105</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1985</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;citation_for_view=wGRCWGAAAAAJ:hkOj_22Ku90C" class="gsc_a_at">Enhancement of chemotherapy and radiotherapy of murine tumours by AQ4N, a bioreductively activated anti-tumour agent</a><div class="gs_gray">LH Patterson, SR McKeown, K Ruparelia, JA Double, MC Bibby, S Cole, ...</div><div class="gs_gray">British journal of cancer 82 (12), 1984-1990<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5712457907769902251" class="gsc_a_ac gs_ibl">102</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;citation_for_view=wGRCWGAAAAAJ:XD-gHx7UXLsC" class="gsc_a_at">AQ4N: an alkylaminoanthraquinone N-oxide showing bioreductive potential and positive interaction with radiation in vivo</a><div class="gs_gray">SR McKeown, MV Hejmadi, IA McIntyre, JJA McAleer, LH Patterson</div><div class="gs_gray">British journal of cancer 72 (1), 76-81<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3197129077911530219" class="gsc_a_ac gs_ibl">102</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;citation_for_view=wGRCWGAAAAAJ:nrtMV_XWKgEC" class="gsc_a_at">BIOREDUCTIVELY ACTIVATED ANTITUMOR <i>N</i>-OXIDES: THE CASE OF AQ4N, A UNIQUE APPROACH TO HYPOXIA-ACTIVATED CANCER CHEMOTHERAPY</a><div class="gs_gray">LH Patterson</div><div class="gs_gray">Drug metabolism reviews 34 (3), 581-592<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11085892739266196539" class="gsc_a_ac gs_ibl">100</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;citation_for_view=wGRCWGAAAAAJ:YOwf2qJgpHMC" class="gsc_a_at">Involvement of human cytochromes P450 (CYP) in the reductive metabolism of AQ4N, a hypoxia activated anthraquinone di-N-oxide prodrug</a><div class="gs_gray">SM Raleigh, E Wanogho, MD Burke, SR McKeown, LH Patterson</div><div class="gs_gray">International Journal of Radiation Oncology* Biology* Physics 42 (4), 763-767<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1671667623320654189" class="gsc_a_ac gs_ibl">95</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;citation_for_view=wGRCWGAAAAAJ:0N-VGjzr574C" class="gsc_a_at">Function and Antagonism of β</a><div class="gs_gray">HM Sheldrake, LH Patterson</div><div class="gs_gray">Current cancer drug targets 9 (4), 519-540<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5713239949090568385" class="gsc_a_ac gs_ibl">94</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;citation_for_view=wGRCWGAAAAAJ:OcBU2YAGkTUC" class="gsc_a_at">Polysialyltransferase: a new target in metastatic cancer</a><div class="gs_gray">R A Falconer, R J Errington, S D Shnyder, P J Smith, L H Patterson</div><div class="gs_gray">Current cancer drug targets 12 (8), 925-939<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5042223074366459280" class="gsc_a_ac gs_ibl">86</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;citation_for_view=wGRCWGAAAAAJ:PkcyUWeTMh0C" class="gsc_a_at">Strategies to inhibit tumor associated integrin receptors: rationale for dual and multi-antagonists: miniperspective</a><div class="gs_gray">HM Sheldrake, LH Patterson</div><div class="gs_gray">Journal of medicinal chemistry 57 (15), 6301-6315<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=393036563408115604" class="gsc_a_ac gs_ibl">81</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;citation_for_view=wGRCWGAAAAAJ:yB1At4FlUx8C" class="gsc_a_at">DNA topoisomerase II-dependent cytotoxicity of alkylaminoanthraquinones and their N-oxides</a><div class="gs_gray">PJ Smith, NJ Blunt, R Desnoyers, Y Giles, LH Patterson</div><div class="gs_gray">Cancer chemotherapy and pharmacology 39 (5), 455-461<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8575127416566809982" class="gsc_a_ac gs_ibl">80</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;citation_for_view=wGRCWGAAAAAJ:EkHepimYqZsC" class="gsc_a_at">Evidence for human liver mediated free-radical formation by doxorubicin and mitozantrone.</a><div class="gs_gray">J Basra, CR Wolf, JR Brown, LH Patterson</div><div class="gs_gray">Anti-cancer drug design 1 (1), 45-52<span class="gs_oph">, 1985</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13638635376930480790" class="gsc_a_ac gs_ibl">74</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1985</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;citation_for_view=wGRCWGAAAAAJ:0KyAp5RtaNEC" class="gsc_a_at">Tertiary amine N-oxides as bioreductive drugs: DACA N-oxide, nitracrine N-oxide and AQ4N.</a><div class="gs_gray">WR Wilson, WA Denny, SM Pullen, KM Thompson, AE Li, LH Patterson, ...</div><div class="gs_gray">The British journal of cancer. Supplement 27, S43<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11278477440442763514" class="gsc_a_ac gs_ibl">68</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:AvfA0Oy_GE0C" class="gsc_a_at">Advanced microscopy solutions for monitoring the kinetics and dynamics of drug–DNA targeting in living cells</a><div class="gs_gray">RJ Errington, SM Ameer-Beg, B Vojnovic, LH Patterson, M Zloh, PJ Smith</div><div class="gs_gray">Advanced drug delivery reviews 57 (1), 153-167<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17064827796157442726" class="gsc_a_ac gs_ibl">67</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:epqYDVWIO7EC" class="gsc_a_at">Bioreductive GDEPT using cytochrome P 450 3A4 in combination with AQ4N</a><div class="gs_gray">HO McCarthy, A Yakkundi, V McErlane, CM Hughes, G Keilty, M Murray, ...</div><div class="gs_gray">Cancer gene therapy 10 (1), 40-48<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9638707077409775797" class="gsc_a_ac gs_ibl">66</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:kVjdVfd2voEC" class="gsc_a_at">RGD-binding integrins in prostate cancer: expression patterns and therapeutic prospects against bone metastasis</a><div class="gs_gray">M Sutherland, A Gordon, SD Shnyder, LH Patterson, HM Sheldrake</div><div class="gs_gray">Cancers 4 (4), 1106-1145<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=296250195645843431" class="gsc_a_ac gs_ibl">63</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:86PQX7AUzd4C" class="gsc_a_at">Development of a novel tumor-targeted vascular disrupting agent activated by membrane-type matrix metalloproteinases</a><div class="gs_gray">JM Atkinson, RA Falconer, DR Edwards, CJ Pennington, CS Siller, ...</div><div class="gs_gray">Cancer research 70 (17), 6902-6912<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7021443758599245458" class="gsc_a_ac gs_ibl">62</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:lmc2jWPfTJgC" class="gsc_a_at">Multiple-approaches to the identification and quantification of cytochromes P450 in human liver tissue by mass spectrometry</a><div class="gs_gray">C Seibert, BR Davidson, BJ Fuller, LH Patterson, WJ Griffiths, Y Wang</div><div class="gs_gray">Journal of proteome research 8 (4), 1672-1681<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7138500093532738094" class="gsc_a_ac gs_ibl">61</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:NyGDZy8z5eUC" class="gsc_a_at">Characterization of changes in the proteome in different regions of 3D multicell tumor spheroids</a><div class="gs_gray">KM McMahon, M Volpato, HY Chi, P Musiwaro, K Poterlowicz, Y Peng, ...</div><div class="gs_gray">Journal of proteome research 11 (5), 2863-2875<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15419600685829166765" class="gsc_a_ac gs_ibl">58</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:URolC5Kub84C" class="gsc_a_at">Enhancement of the anti-tumour effect of cyclophosphamide by the bioreductive drugs AQ4N and tirapazamine</a><div class="gs_gray">OP Friery, R Gallagher, MM Murray, CM Hughes, ES Galligan, IA McIntyre, ...</div><div class="gs_gray">British journal of cancer 82 (8), 1469-1473<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5697808253688474009" class="gsc_a_ac gs_ibl">57</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:ipzZ9siozwsC" class="gsc_a_at">Evidence for a therapeutic gain when AQ4N or tirapazamine is combined with radiation.</a><div class="gs_gray">SR McKeown, OP Friery, IA McIntyre, MV Hejmadi, LH Patterson, DG Hirst</div><div class="gs_gray">The British journal of cancer. Supplement 27, S39<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10518989537277257190" class="gsc_a_ac gs_ibl">57</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:Z5m8FVwuT1cC" class="gsc_a_at">Comparative Cytochrome P450 Proteomics in the Livers of Immunodeficient Mice Using 18O Stable Isotope Labeling* S</a><div class="gs_gray">CS Lane, Y Wang, R Betts, WJ Griffiths, LH Patterson</div><div class="gs_gray">Molecular &amp; Cellular Proteomics 6 (6), 953-962<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13234446449018530978" class="gsc_a_ac gs_ibl">56</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:zLWjf1WUPmwC" class="gsc_a_at">The chemopotentiation of cisplatin by the novel bioreductive drug AQ4N</a><div class="gs_gray">R Gallagher, CM Hughes, MM Murray, OP Friery, LH Patterson, DG Hirst, ...</div><div class="gs_gray">British journal of cancer 85 (4), 625-629<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12571302552827994985" class="gsc_a_ac gs_ibl">54</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:e_rmSamDkqQC" class="gsc_a_at">Spectral analysis of the DNA targeting bisalkylaminoanthraquinone DRAQ5 in intact living cells</a><div class="gs_gray">KL Njoh, LH Patterson, M Zloh, M Wiltshire, J Fisher, S Chappell, ...</div><div class="gs_gray">Cytometry Part A: The Journal of the International Society for Analytical&nbsp;…<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17739530954400160927" class="gsc_a_ac gs_ibl">52</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:vDijr-p_gm4C" class="gsc_a_at">Flow cytometric analysis and confocal imaging of anticancer alkylaminoanthraquinones and their n‐oxides in intact human cells using 647‐nm krypton laser excitation</a><div class="gs_gray">PJ Smith, R Desnoyers, N Blunt, Y Giles, LH Patterson, JV Watson</div><div class="gs_gray">Cytometry: The Journal of the International Society for Analytical Cytology&nbsp;…<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2184384656747514620" class="gsc_a_ac gs_ibl">52</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:uWiczbcajpAC" class="gsc_a_at">Glutathione S-transferase (GST) expression in the human hookworm Necator americanus: potential roles for excretory-secretory forms of GST</a><div class="gs_gray">PM Brophy, LH Patterson, A Brown, DI Pritchard</div><div class="gs_gray">Acta tropica 59 (3), 259-263<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12136784914187145442" class="gsc_a_ac gs_ibl">52</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:owLR8QvbtFgC" class="gsc_a_at">Colon Cancer–Specific Cytochrome P450 2W1 Converts Duocarmycin Analogues into Potent Tumor Cytotoxins</a><div class="gs_gray">S Travica, K Pors, PM Loadman, SD Shnyder, I Johansson, MN Alandas, ...</div><div class="gs_gray">Clinical Cancer Research 19 (11), 2952-2961<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15595253743830407569" class="gsc_a_ac gs_ibl">51</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:vbGhcppDl1QC" class="gsc_a_at">Tumor-selective drug activation: a GDEPT approach utilizing cytochrome P450 1A1 and AQ4N</a><div class="gs_gray">A Yakkundi, V McErlane, M Murray, HO McCarthy, C Ward, CM Hughes, ...</div><div class="gs_gray">Cancer gene therapy 13 (6), 598-605<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8938803280141151283" class="gsc_a_ac gs_ibl">50</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:kWvqk_afx_IC" class="gsc_a_at">Pharmacological inhibition of polysialyltransferase ST8SiaII modulates tumour cell migration</a><div class="gs_gray">YMJ Al-Saraireh, M Sutherland, BR Springett, F Freiberger, ...</div><div class="gs_gray">PLoS One 8 (8), e73366<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17786341933495416652" class="gsc_a_ac gs_ibl">49</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:L7CI7m0gUJcC" class="gsc_a_at">A novel deep red/low infrared fluorescent flow cytometric probe, DRAQ5NO, for the discrimination of intact nucleated cells in apoptotic cell populations</a><div class="gs_gray">M Wiltshire, LH Patterson, PJ Smith</div><div class="gs_gray">Cytometry: The Journal of the International Society for Analytical Cytology&nbsp;…<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=488332571888178328" class="gsc_a_ac gs_ibl">48</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:S16KYo8Pm5AC" class="gsc_a_at">Synthesis of DNA-directed pyrrolidinyl and piperidinyl confined alkylating chloroalkylaminoanthraquinones: potential for development of tumor-selective N-oxides</a><div class="gs_gray">K Pors, SD Shnyder, PH Teesdale-Spittle, JA Hartley, M Zloh, M Searcey, ...</div><div class="gs_gray">Journal of medicinal chemistry 49 (24), 7013-7023<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8157379841778640970" class="gsc_a_ac gs_ibl">47</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:BwyfMAYsbu0C" class="gsc_a_at">The effect of the anthrapyrazole antitumour agent CI941 on rat liver microsome and cytochrome P-450 reductase mediated free radical processes: Inhibition of doxorubicin&nbsp;…</a><div class="gs_gray">MA Graham, DR Newell, J Butler, B Hoey, LH Patterson</div><div class="gs_gray">Biochemical pharmacology 36 (20), 3345-3351<span class="gs_oph">, 1987</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6226646377690239147" class="gsc_a_ac gs_ibl">46</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1987</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:p__nRnzSRKYC" class="gsc_a_at">Involvement of NADPH: cytochrome P450 reductase in the activation of indoloquinone EO9 to free radical and DNA damaging species</a><div class="gs_gray">SM Bailey, AD Lewis, LH Patterson, GR Fisher, RJ Knox, P Workman</div><div class="gs_gray">Biochemical pharmacology 62 (4), 461-468<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1644499056614882227" class="gsc_a_ac gs_ibl">45</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:BUYA1_V_uYcC" class="gsc_a_at">DNA damage following combination of radiation with the bioreductive drug AQ4N: possible selective toxicity to oxic and hypoxic tumour cells</a><div class="gs_gray">MV Hejmadi, SR McKeown, OP Friery, IA McIntyre, LH Patterson, DG Hirst</div><div class="gs_gray">British journal of cancer 73 (4), 499-505<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14226180749433783558" class="gsc_a_ac gs_ibl">45</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:ML0RJ9NH7IQC" class="gsc_a_at">Aliphatic amine N-oxides of DNA binding agents as bioreductive drugs</a><div class="gs_gray">LH Patterson, MR Craven, GR Fisher, P Teesdale-Spittle</div><div class="gs_gray">Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 6&nbsp;…<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11729733432782080995" class="gsc_a_ac gs_ibl">45</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:KUbvn5osdkgC" class="gsc_a_at">NAD (P) H (quinone acceptor) oxidoreductase (DT-diaphorase)-mediated two-electron reduction of anthraquinone-based antitumour agents and generation of hydroxyl radicals</a><div class="gs_gray">GR Fisher, PL Gutierrez, MA Oldcorne, LH Patterson</div><div class="gs_gray">Biochemical pharmacology 43 (3), 575-585<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14042424880013326193" class="gsc_a_ac gs_ibl">44</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:v1_lew4L6wgC" class="gsc_a_at">Antitumor activity of a duocarmycin analogue rationalized to be metabolically activated by cytochrome P450 1A1 in human transitional cell carcinoma of the bladder</a><div class="gs_gray">M Sutherland, JH Gill, PM Loadman, JP Laye, HM Sheldrake, ...</div><div class="gs_gray">Molecular cancer therapeutics 12 (1), 27-37<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12616942295041132581" class="gsc_a_ac gs_ibl">43</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:MLfJN-KU85MC" class="gsc_a_at">The use of pharmacokinetic and pharmacodynamic end points to determine the dose of AQ4N, a novel hypoxic cell cytotoxin, given with fractionated radiotherapy in a phase I study</a><div class="gs_gray">WP Steward, M Middleton, A Benghiat, PM Loadman, C Hayward, ...</div><div class="gs_gray">Annals of oncology 18 (6), 1098-1103<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1746588837845253011" class="gsc_a_ac gs_ibl">42</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:4MWp96NkSFoC" class="gsc_a_at">DNA mismatch repair deficiency, resistance to cancer chemotherapy and the development of hypersensitive agents</a><div class="gs_gray">K Pors, LH Patterson</div><div class="gs_gray">Current topics in medicinal chemistry 5 (12), 1133-1149<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16841275589188423901" class="gsc_a_ac gs_ibl">42</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:kuK5TVdYjLIC" class="gsc_a_at">A proteomic approach to the identification of cytochrome P450 isoforms in male and female rat liver by nanoscale liquid chromatography-electrospray ionization-tandem mass&nbsp;…</a><div class="gs_gray">S Nisar, CS Lane, AF Wilderspin, KJ Welham, WJ Griffiths, LH Patterson</div><div class="gs_gray">Drug metabolism and disposition 32 (4), 382-386<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17160065310589620647" class="gsc_a_ac gs_ibl">41</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:ILKRHgRFtOwC" class="gsc_a_at">Identification of cytochrome P450 enzymes in human colorectal metastases and the surrounding liver: a proteomic approach</a><div class="gs_gray">CS Lane, S Nisar, WJ Griffiths, BJ Fuller, BR Davidson, J Hewes, ...</div><div class="gs_gray">European journal of cancer 40 (14), 2127-2134<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1750208678865406366" class="gsc_a_ac gs_ibl">40</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:tYavs44e6CUC" class="gsc_a_at">Lack of involvement of reactive oxygen in the cytotoxicity of mitoxantrone, CI941 and ametantrone in MCF-7 cells: comparison with doxorubicin</a><div class="gs_gray">GR Fisher, LH Patterson</div><div class="gs_gray">Cancer chemotherapy and pharmacology 30 (6), 451-458<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6313432511237875751" class="gsc_a_ac gs_ibl">39</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:tuHXwOkdijsC" class="gsc_a_at">Involvement of hydroxyl radical formation and DNA strand breakage in the cytotoxicity of anthraquinone antitumour agents</a><div class="gs_gray">GR Fisher, JR Brown, LH Patterson</div><div class="gs_gray">Free radical research communications 11 (1-3), 117-125<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11993715791822169912" class="gsc_a_ac gs_ibl">38</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:TIZ-Mc8IlK0C" class="gsc_a_at">DNA strand breakage by peroxidase-activated mitoxantrone</a><div class="gs_gray">GR Fisher, LH Patterson</div><div class="gs_gray">Journal of pharmacy and pharmacology 43 (1), 65-68<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9524713345758284545" class="gsc_a_ac gs_ibl">37</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:g3aElNc5_aQC" class="gsc_a_at">A cytochrome P450 2B6 meditated gene therapy strategy to enhance the effects of radiation or cyclophosphamide when combined with the bioreductive drug AQ4N</a><div class="gs_gray">V McErlane, A Yakkundi, HO McCarthy, CM Hughes, LH Patterson, ...</div><div class="gs_gray">The Journal of Gene Medicine: A cross‐disciplinary journal for research on&nbsp;…<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5002659021700450821" class="gsc_a_ac gs_ibl">35</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:EYYDruWGBe4C" class="gsc_a_at">Electron paramagnetic resonance spectrometry evidence for bioreduction of tirapazamine to oxidising free radicals under anaerobic conditions</a><div class="gs_gray">LH Patterson, FA Taiwo</div><div class="gs_gray">Biochemical pharmacology 60 (12), 1933-1935<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15192839735671702118" class="gsc_a_ac gs_ibl">35</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:4xDN1ZYqzskC" class="gsc_a_at">Modification of the duocarmycin pharmacophore enables CYP1A1 targeting for biological activity</a><div class="gs_gray">K Pors, PM Loadman, SD Shnyder, M Sutherland, HM Sheldrake, ...</div><div class="gs_gray">Chemical Communications 47 (44), 12062-12064<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16282630586246725181" class="gsc_a_ac gs_ibl">34</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:UHK10RUVsp4C" class="gsc_a_at">Effects of the potential chemopreventive agent DMU-135 on adenoma development in the Apc Min+ mouse</a><div class="gs_gray">S Sale, RG Tunstall, KC Ruparelia, PC Butler, GA Potter, WP Steward, ...</div><div class="gs_gray">Investigational new drugs 24 (6), 459-464<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7734774653463779088" class="gsc_a_ac gs_ibl">34</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:gsN89kCJA0AC" class="gsc_a_at">Peroxidase activation of 1-naphthol to naphthoxy or naphthoxy-derived radicals and their reaction with glutathione</a><div class="gs_gray">MA Doherty, I Wilson, P Wardman, J Basra, LH Patterson, GM Cohen</div><div class="gs_gray">Chemico-biological interactions 58, 199-215<span class="gs_oph">, 1986</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4708864008821148335" class="gsc_a_ac gs_ibl">34</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1986</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:1Ye0OR6EYb4C" class="gsc_a_at">Re-engineering of the duocarmycin structural architecture enables bioprecursor development targeting CYP1A1 and CYP2W1 for biological activity</a><div class="gs_gray">HM Sheldrake, S Travica, I Johansson, PM Loadman, M Sutherland, ...</div><div class="gs_gray">Journal of medicinal chemistry 56 (15), 6273-6277<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10859828525601925772" class="gsc_a_ac gs_ibl">32</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:hMsQuOkrut0C" class="gsc_a_at">A preclinical pharmacokinetic study of the bioreductive drug AQ4N</a><div class="gs_gray">PM Loadman, DJ Swaine, MC Bibby, KJ Welham, LH Patterson</div><div class="gs_gray">Drug metabolism and disposition 29 (4), 422-426<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4198426157720887200" class="gsc_a_ac gs_ibl">32</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:LI9QrySNdTsC" class="gsc_a_at">Reduction of the indoloquinone anticancer drug EO9 by purified DT-diaphorase: a detailed kinetic study and analysis of metabolites</a><div class="gs_gray">SM Bailey, AD Lewis, RJ Knox, LH Patterson, GR Fisher, P Workman</div><div class="gs_gray">Biochemical pharmacology 56 (5), 613-621<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=916779468016433029" class="gsc_a_ac gs_ibl">30</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:VaXvl8Fpj5cC" class="gsc_a_at">Alchemix: a novel alkylating anthraquinone with potent activity against anthracycline-and cisplatin-resistant ovarian cancer</a><div class="gs_gray">K Pors, Z Paniwnyk, P Teesdale-Spittle, JA Plumb, E Willmore, CA Austin, ...</div><div class="gs_gray">Molecular cancer therapeutics 2 (7), 607-610<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11178703043441923974" class="gsc_a_ac gs_ibl">29</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:2KloaMYe4IUC" class="gsc_a_at">Rat cytochromes P450 (CYP) specifically contribute to the reductive bioactivation of AQ4N, an alkylaminoanthraquinone-di-N-oxide anticancer prodrug</a><div class="gs_gray">SM Raleigh, E Wanogho, MD Burke, LH Patterson</div><div class="gs_gray">Xenobiotica 29 (11), 1115-1122<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13235567778948401181" class="gsc_a_ac gs_ibl">29</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:foquWX3nUaYC" class="gsc_a_at">Improved preparation and detection of cytochrome P450 isoforms using MS methods</a><div class="gs_gray">CW Sutton, M Sutherland, S Shnyder, LH Patterson</div><div class="gs_gray">Proteomics 10 (2), 327-331<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=192086608366195983" class="gsc_a_ac gs_ibl">27</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:nRpfm8aw39MC" class="gsc_a_at">Anthraquinone and its derivatives</a><div class="gs_gray">PJ Smith, LH Patterson</div><div class="gs_gray">US Patent 7,060,427<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6362487580320957061,4404461469536768723" class="gsc_a_ac gs_ibl">26</a><span class="gsc_a_m"><a href="javascript:void(0)" class="gsc_a_am" data-eid="wGRCWGAAAAAJ:nRpfm8aw39MC">*</a></span></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:k8Z6L05lTy4C" class="gsc_a_at">Secretory nematode SOD—offensive or defensive?</a><div class="gs_gray">PM Brophy, LH Patterson, DL Pritchard</div><div class="gs_gray">International journal for parasitology 25 (7), 865-866<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11762162389097803511" class="gsc_a_ac gs_ibl">26</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:rbm3iO8VlycC" class="gsc_a_at">Tumor-targeted prodrug ICT2588 demonstrates therapeutic activity against solid tumors and reduced potential for cardiovascular toxicity</a><div class="gs_gray">JH Gill, PM Loadman, SD Shnyder, P Cooper, JM Atkinson, ...</div><div class="gs_gray">Molecular pharmaceutics 11 (4), 1294-1300<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5020312989116329490" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:ruyezt5ZtCIC" class="gsc_a_at">Design and synthesis of a DNA-crosslinking azinomycin analogue</a><div class="gs_gray">MA Casely-Hayford, K Pors, CH James, LH Patterson, JA Hartley, ...</div><div class="gs_gray">Organic &amp; biomolecular chemistry 3 (19), 3585-3589<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11149761120566328535,15488668095260189403" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:M7yex6snE4oC" class="gsc_a_at">Thin-layer chromatographic separatio and identification of tertiary aromatic amines and their n-oxides</a><div class="gs_gray">LA Damani, LH Patterson, JW Gorrod</div><div class="gs_gray">Journal of Chromatography A 155 (2), 337-348<span class="gs_oph">, 1978</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10005219904840064756" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1978</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:b1wdh0AR-JQC" class="gsc_a_at">Cu/Zn superoxide dismutase in excretory–secretory products of the human hookworm <i>Necator americanus</i> An electron paramagnetic spectrometry study</a><div class="gs_gray">FA Taiwo, PM Brophy, DI Pritchard, A Brown, A Wardlaw, LH Patterson</div><div class="gs_gray">European journal of biochemistry 264 (2), 434-438<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5262991370065177765" class="gsc_a_ac gs_ibl">24</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:-FonjvnnhkoC" class="gsc_a_at">1, 4-Bis {2-[(2-hydroxyethyl) amino] ethylamino}-9, 10-anthracenedione, an anthraquinone antitumour agent that does not cause lipid peroxidation in vivo; Comparison with&nbsp;…</a><div class="gs_gray">LH Patterson, BM Gandecha, JR Brown</div><div class="gs_gray">Biochemical and biophysical research communications 110 (2), 399-405<span class="gs_oph">, 1983</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11537831642028682888" class="gsc_a_ac gs_ibl">24</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1983</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:BJbdYPG6LGMC" class="gsc_a_at">An agarose spot chemotaxis assay for chemokine receptor antagonists</a><div class="gs_gray">V Vinader, Y Al-Saraireh, HL Wiggins, JZ Rappoport, SD Shnyder, ...</div><div class="gs_gray">Journal of pharmacological and toxicological methods 64 (3), 213-216<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12584595972169626471" class="gsc_a_ac gs_ibl">23</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:2ywjKiB__4kC" class="gsc_a_at">Microstructural investigation using synchrotron radiation X-ray microtomography reveals taste-masking mechanism of acetaminophen microspheres</a><div class="gs_gray">Z Guo, X Yin, C Liu, L Wu, W Zhu, Q Shao, P York, L Patterson, J Zhang</div><div class="gs_gray">International journal of pharmaceutics 499 (1-2), 47-57<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14182413322115220686" class="gsc_a_ac gs_ibl">22</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:oNZyr7d5Mn4C" class="gsc_a_at">Stereoselectivity, sequence specificity and mechanism of action of the azinomycin epoxide</a><div class="gs_gray">MH David‐Cordonnier, M Casely‐Hayford, M Kouach, G Briand, ...</div><div class="gs_gray">ChemBioChem 7 (11), 1658-1661<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14625910645515882295" class="gsc_a_ac gs_ibl">22</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:xtoqd-5pKcoC" class="gsc_a_at">Anti-cancer compounds</a><div class="gs_gray">LH Patterson</div><div class="gs_gray">US Patent 5,132,327<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4684554700983388139,16313484863547028233" class="gsc_a_ac gs_ibl">22</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:dQ2og3OwTAUC" class="gsc_a_at">Synthesis and biological evaluation of novel chloroethylaminoanthraquinones with potent cytotoxic activity against cisplatin-resistant tumor cells</a><div class="gs_gray">K Pors, Z Paniwnyk, KC Ruparelia, PH Teesdale-Spittle, JA Hartley, ...</div><div class="gs_gray">Journal of medicinal chemistry 47 (7), 1856-1859<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15774271023875027035" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:i2xiXl-TujoC" class="gsc_a_at">Redox cycling in MCF-7 human breast cancer cells by antitumor agents based on mitozantrone</a><div class="gs_gray">GR Fisher, JR Brown, LH Patterson</div><div class="gs_gray">Free radical research communications 7 (3-6), 221-226<span class="gs_oph">, 1989</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11400538407070365931" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1989</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:Dip1O2bNi0gC" class="gsc_a_at">Truncated azinomycin analogues intercalate into DNA</a><div class="gs_gray">MA Casely-Hayford, K Pors, LH Patterson, C Gerner, S Neidle, M Searcey</div><div class="gs_gray">Bioorganic &amp; medicinal chemistry letters 15 (3), 653-656<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6578275921794678726" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:PoWvk5oyLR8C" class="gsc_a_at">The disposition of FPL 55712 acid (7-[3-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-2-hydroxypropoxy)-4-oxo-8 propyl-4H-benzopyran-2-carboxylic acid) in rat and dog</a><div class="gs_gray">B Mead, LH Patterson, DA Smith</div><div class="gs_gray">The Journal of pharmacy and pharmacology 33 (10), 682-684<span class="gs_oph">, 1981</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=875143093074923211" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1981</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:AzKEL7Gb_04C" class="gsc_a_at">RGD-binding integrins in head and neck cancers</a><div class="gs_gray">HT Ahmedah, LH Patterson, SD Shnyder, HM Sheldrake</div><div class="gs_gray">Cancers 9 (6), 56<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2600468420658991914" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:kz9GbA2Ns4gC" class="gsc_a_at">High-performance liquid chromatographic analysis of AQ4N, an alkylaminoanthraquinone N-oxide</a><div class="gs_gray">DJ Swaine, PM Loadman, MC Bibby, MA Graham, LH Patterson</div><div class="gs_gray">Journal of Chromatography B: Biomedical Sciences and Applications 742 (2&nbsp;…<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16097576666815829124" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:MIg0yeAD4ggC" class="gsc_a_at">Targeting hypoxic prostate tumors using the novel hypoxia-activated prodrug OCT1002 inhibits expression of genes associated with malignant progression</a><div class="gs_gray">H Nesbitt, NM Byrne, SN Williams, L Ming, J Worthington, RJ Errington, ...</div><div class="gs_gray">Clinical Cancer Research 23 (7), 1797-1808<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9653258825419040383,9024158671139145469" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:WZBGuue-350C" class="gsc_a_at">A comparison of free radical formation by quinone anti-tumour agents in MCF-7 cells and the role of NAD (P) H (quinone-acceptor) oxidoreductase (DT-diaphorase)</a><div class="gs_gray">GR Fisher, LH Patterson, PL Gutierrez</div><div class="gs_gray">Chemico-biological interactions 88 (2-3), 137-153<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7745545205186466258" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:FPJr55Dyh1AC" class="gsc_a_at">Development of nonsymmetrical 1, 4-disubstituted anthraquinones that are potently active against cisplatin-resistant ovarian cancer cells</a><div class="gs_gray">K Pors, JA Plumb, R Brown, P Teesdale-Spittle, M Searcey, PJ Smith, ...</div><div class="gs_gray">Journal of medicinal chemistry 48 (21), 6690-6695<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8268873104425099341" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:HbR8gkJAVGIC" class="gsc_a_at">Evidence for p-hydroxylation of N-ethyl-N-methylaniline</a><div class="gs_gray">JW Gorrod, LH Patterson</div><div class="gs_gray">Xenobiotica 10 (7-8), 603-610<span class="gs_oph">, 1980</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13816014550950609987" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1980</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:-yGd096yOn8C" class="gsc_a_at">Host-guest kinetic interactions between HP-β-cyclodextrin and drugs for prediction of bitter taste masking</a><div class="gs_gray">Z Guo, F Wu, V Singh, T Guo, X Ren, X Yin, Q Shao, P York, LH Patterson, ...</div><div class="gs_gray">Journal of pharmaceutical and biomedical analysis 140, 232-238<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9508635545406287286" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:1tZ8xJnm2c8C" class="gsc_a_at">A novel Lozenge gene in silkworm, Bombyx mori regulates the melanization response of hemolymph</a><div class="gs_gray">M Xu, X Wang, J Tan, K Zhang, X Guan, LH Patterson, H Ding, H Cui</div><div class="gs_gray">Developmental &amp; Comparative Immunology 53 (1), 191-198<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2253487787530378674" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:HJSXoJQnj-YC" class="gsc_a_at">Synthesis of a pseudo-disaccharide library and its application to the characterisation of the heparanase catalytic site</a><div class="gs_gray">V Vinader, MH Haji-Abdullahi, LH Patterson, K Afarinkia</div><div class="gs_gray">PloS one 8 (11), e82111<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12185434116455826221" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:Ug5p-4gJ2f0C" class="gsc_a_at">The metabolism of 4-substituted N-ethyl-N-methylanilines: III. Effect of various potential inhibitors, activators and inducers on α-C-and N-oxidation</a><div class="gs_gray">JW Gorrord, LH Patterson</div><div class="gs_gray">Xenobiotica 13 (9), 521-529<span class="gs_oph">, 1983</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14688616079725486554" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1983</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:wE-fMHVdjMkC" class="gsc_a_at">Protein deregulation associated with breast cancer metastasis</a><div class="gs_gray">KK Chan, KB Matchett, PM McEnhill, MF McMullin, Y El-Tanani, ...</div><div class="gs_gray">Cytokine &amp; growth factor reviews 26 (4), 415-423<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1378803079557910568" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:EPG8bYD4jVwC" class="gsc_a_at">CYP2W1 polymorphism: functional aspects and relation to risk for colorectal cancer</a><div class="gs_gray">K Stenstedt, S Travica, J Guo, I Barragan, K Pors, L Patterson, D Edler, ...</div><div class="gs_gray">Pharmacogenomics 14 (13), 1615-1622<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4027596808532291229" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:SpbeaW3--B0C" class="gsc_a_at">Reductive Metabolism: its Application in Prodrug Application</a><div class="gs_gray">LH Patterson, SM Raleigh</div><div class="gs_gray">Drug metabolism: Towards the next millennium, 72-80<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10443467621226960091" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:XoXfffV-tXoC" class="gsc_a_at">Offensive Secretory SODs?</a><div class="gs_gray">PM Brophy, LH Patterson, DI Pritchard</div><div class="gs_gray">Parasitology today (Personal ed.) 11 (3), 112; author reply 112-112; author&nbsp;…<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4568191111579790234" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:PaBasH6fAo0C" class="gsc_a_at">Analyzing cells immobilized in block copolymers</a><div class="gs_gray">P Smith, L Patterson, RJ Errington</div><div class="gs_gray">US Patent 7,723,085<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18146160409894824577,15879869755951496503,3390797514178044312" class="gsc_a_ac gs_ibl">12</a><span class="gsc_a_m"><a href="javascript:void(0)" class="gsc_a_am" data-eid="wGRCWGAAAAAJ:PaBasH6fAo0C">*</a></span></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:hCrLmN-GePgC" class="gsc_a_at">The metabolism of 4-substituted-N-ethyl-N-methyl-anilines: II. Some factors influencing α-C-and N-oxidation</a><div class="gs_gray">JW Gorrod, LH Patterson</div><div class="gs_gray">Xenobiotica 13 (9), 513-520<span class="gs_oph">, 1983</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15670383204048984255" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1983</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:q3CdL3IzO_QC" class="gsc_a_at">Resistance in cancer: a target for drug discovery</a><div class="gs_gray">M Searcey, LH Patterson</div><div class="gs_gray">Current Medicinal Chemistry-Anti-Cancer Agents 4 (5), 457-460<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=268332330004585051" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:zwpXiJ37cpgC" class="gsc_a_at">Nipple aspirate fluid—a liquid biopsy for diagnosing breast health</a><div class="gs_gray">S Shaheed, C Tait, K Kyriacou, J Mullarkey, W Burrill, LH Patterson, ...</div><div class="gs_gray">PROTEOMICS–Clinical Applications 11 (9-10), 1700015<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18380732621990109611" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:rmuvC79q63oC" class="gsc_a_at">Free radicals in irradiated drugs: an EPR study</a><div class="gs_gray">FA Taiwo, LH Patterson, E Jaroszkiewicz, B Marciniec, M Ogrodowczyk</div><div class="gs_gray">Free radical research 31 (3), 231-235<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9504854896900773431" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:ClCfbGk0d_YC" class="gsc_a_at">Targetting of daunorubicin to trypanosomes by carrier macromolecules: Should the linkage be labile?</a><div class="gs_gray">MA HARDMAN, LH PATTERSON, J WILLIAMSON, JR BROWN</div><div class="gs_gray">Biochemical Society Transactions 11 (2), 182-182<span class="gs_oph">, 1983</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14385102112250932001,12059002443006480652" class="gsc_a_ac gs_ibl">10</a><span class="gsc_a_m"><a href="javascript:void(0)" class="gsc_a_am" data-eid="wGRCWGAAAAAJ:ClCfbGk0d_YC">*</a></span></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1983</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:An6A6Jpfc1oC" class="gsc_a_at">Discovery and computer aided potency optimization of a novel class of small molecule CXCR4 antagonists</a><div class="gs_gray">V Vinader, DS Ahmet, MS Ahmed, LH Patterson, K Afarinkia</div><div class="gs_gray">PloS one 8 (10), e78744<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12215123092026213197" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:dAp6zn-oMfAC" class="gsc_a_at">Anthraquinone and its derivatives</a><div class="gs_gray">PJ Smith, LH Patterson</div><div class="gs_gray">US Patent 7,605,280<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6156300138811190309" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=wGRCWGAAAAAJ:IaI1MmNe2tcC" class="gsc_a_at">Anthraquinone anticancer drugs</a><div class="gs_gray">GA Potter, LH Patterson, P Teesdale-Spittle, Z Paniwynk</div><div class="gs_gray">US Patent 6,465,522<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10547113714577176423" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:FiytvqdAVhgC" class="gsc_a_at">Compounds</a><div class="gs_gray">R Falconer, J Gill, J Atkinson, P Loadman, M Bibby, L Patterson</div><div class="gs_gray">US Patent 8,927,486<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1360123026917107013" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:edDO8Oi4QzsC" class="gsc_a_at">Phase 1 dose escalation study of AQ4N, a selective hypoxic cell cytotoxin, with fractionated radiotherapy (RT): First report</a><div class="gs_gray">A Benghiat, WP Steward, PM Loadman, M Middleton, D Talbot, ...</div><div class="gs_gray">Journal of clinical oncology 22 (14_suppl), 2091-2091<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17111529248338820593" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:W5xh706n7nkC" class="gsc_a_at">Anthraquinone-peptides as inhibitors of AP-1 transcription factor</a><div class="gs_gray">T Ijaz, P Tran, KC Ruparelia, PH Teesdale-Spittle, S Orr, LH Patterson</div><div class="gs_gray">Bioorganic &amp; medicinal chemistry letters 11 (3), 351-353<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5669512282310072652" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:6ZxmRoH8BuwC" class="gsc_a_at">Doxorubicin-3'-NH-oestrone-17-oxime-ethyl-carbonyl, a doxorubicin-oestrone conjugate that does not redox cycle in rat liver microsomes.</a><div class="gs_gray">NG Hartman, LH Patterson, P Workman, A Suarato, F Angelucci</div><div class="gs_gray">Biochemical pharmacology 40 (5), 1164-1167<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17824505632891588594" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:z8nqeaKD1nsC" class="gsc_a_at">Recent advances in the analysis of polysialic acid from complex biological systems</a><div class="gs_gray">X Guo, SM Elkashef, PM Loadman, LH Patterson, RA Falconer</div><div class="gs_gray">Carbohydrate polymers 224, 115145<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11854224803371041599" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:X0DADzN9RKwC" class="gsc_a_at">NLG919/cyclodextrin complexation and anti-cancer therapeutic benefit as a potential immunotherapy in combination with paclitaxel</a><div class="gs_gray">J Xu, X Ren, T Guo, X Sun, X Chen, LH Patterson, H Li, J Zhang</div><div class="gs_gray">European Journal of Pharmaceutical Sciences 138, 105034<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12340491068672686702" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:JP7YXuLIOvAC" class="gsc_a_at">The unidirectional hypoxia‐activated prodrug OCT1002 inhibits growth and vascular development in castrate‐resistant prostate tumors</a><div class="gs_gray">H Nesbitt, J Worthington, RJ Errington, LH Patterson, PJ Smith, ...</div><div class="gs_gray">The Prostate 77 (15), 1539-1547<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17099428838993247996" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:HtEfBTGE9r8C" class="gsc_a_at">Use of the hollow fiber assay for the evaluation of DNA damaging agents</a><div class="gs_gray">JP Veiga, PA Cooper, K Pors, LH Patterson, MC Bibby, SD Shnyder</div><div class="gs_gray">Journal of pharmacological and toxicological methods 64 (3), 226-232<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8979717924594329379" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:_axFR9aDTf0C" class="gsc_a_at">Effects of AQ4N and its reduction product on radiation-mediated DNA strand breakage</a><div class="gs_gray">MM Ali, MCR Symons, FA Taiwo, LH Patterson</div><div class="gs_gray">Chemico-biological interactions 123 (1), 1-10<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14111501680787350170" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:5qfkUJPXOUwC" class="gsc_a_at">In-vitro metabolism of lignocaine to its <i>N</i>-oxide</a><div class="gs_gray">LH Patterson, G Hall, BS Nijjar, PK Khatra, DA Cowan</div><div class="gs_gray">Journal of pharmacy and pharmacology 38 (4), 326-326<span class="gs_oph">, 1986</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15677239391240306369" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1986</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:cK4Rrx0J3m0C" class="gsc_a_at">Targeting of Hypoxia in AQ4N-treated Tumour Xenografts by MALDIIon Mobility Separation-Mass Spectrometry Imaging</a><div class="gs_gray">MC Djidja, S Francese, E Claude, P Loadman, C Sutton, S Shynder, ...</div><div class="gs_gray">Current Analytical Chemistry 9 (2), 212-225<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13207488153205155935" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:kh2fBNsKQNwC" class="gsc_a_at">Metabolism of 4‐substituted‐<i>N</i>‐ethyl‐<i>N</i>‐methylanilines: Chromatographic and mass spectrometric identification of <i>N</i>‐oxidation metabolic products formed <i>in vitro</i></a><div class="gs_gray">DA Cowan, LH Patterson, LA Damani, JW Gorrod</div><div class="gs_gray">Biomedical mass spectrometry 9 (6), 233-240<span class="gs_oph">, 1982</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6932143334718739470" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1982</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:D_tqNUsBuKoC" class="gsc_a_at">The use of thermographic imaging to evaluate therapeutic response in human tumour xenograft models</a><div class="gs_gray">N Hussain, D Connah, H Ugail, PA Cooper, RA Falconer, LH Patterson, ...</div><div class="gs_gray">Scientific reports 6 (1), 1-6<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7380769889245475553" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:SjuI4pbJlxcC" class="gsc_a_at">NCAM polysialylation during adherence transitions: Live cell monitoring using an antibody‐mimetic EGFP‐endosialidase and the viability dye DRAQ7</a><div class="gs_gray">PJ Smith, E Furon, M Wiltshire, S Chappell, LH Patterson, SD Shnyder, ...</div><div class="gs_gray">Cytometry Part A 83 (7), 659-671<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3699904630367142675" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:wLxue7F8ec0C" class="gsc_a_at">Pulmonary Targeting Crosslinked Cyclodextrin Metal–Organic Frameworks for Lung Cancer Therapy</a><div class="gs_gray">Y He, T Xiong, S He, H Sun, C Huang, X Ren, L Wu, LH Patterson, ...</div><div class="gs_gray">Advanced Functional Materials 31 (3), 2004550<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13433420344699764651" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:0aBXIfxlw9sC" class="gsc_a_at">Deuterated compounds and uses thereof</a><div class="gs_gray">S Ogrodzinski, P Smith, S McKeown, L Patterson, RJ Errington</div><div class="gs_gray">US Patent 10,385,009<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=969370085493843188" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:C33y2ycGS3YC" class="gsc_a_at">Rational development of novel activity probes for the analysis of human cytochromes P450</a><div class="gs_gray">JD Sellars, M Skipsey, S Gravell, H Abumansour, GJ Kashtl, J Irfan, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14241382611757283388" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:-6RzNnnwWf8C" class="gsc_a_at">Intramolecular thermal stepwise [2+ 2] cycloadditions: investigation of a stereoselective synthesis of [n. 2.0]-bicyclolactones</a><div class="gs_gray">A Throup, LH Patterson, HM Sheldrake</div><div class="gs_gray">Organic &amp; biomolecular chemistry 14 (40), 9554-9559<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5853724625725503422" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:SAZ1SQo2q1kC" class="gsc_a_at">An optimised assay for quantitative, high-throughput analysis of polysialyltransferase activity</a><div class="gs_gray">SM Elkashef, M Sutherland, LH Patterson, PM Loadman, RA Falconer</div><div class="gs_gray">Analyst 141 (20), 5849-5856<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5143860777759414270" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:UmS_249rOGwC" class="gsc_a_at">Probing cytochrome P450-mediated activation with a truncated azinomycin analogue</a><div class="gs_gray">V Vinader, M Sadiq, M Sutherland, M Huang, PM Loadman, L Elsalem, ...</div><div class="gs_gray">MedChemComm 6 (1), 187-191<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6034452845104129399" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:g5Ck-dwhA_QC" class="gsc_a_at">Compounds containing a vascular disrupting agent</a><div class="gs_gray">J Gill, P Loadman, R Falconer, L Patterson, J Atkinson, M Bibby</div><div class="gs_gray">US Patent 8,691,751<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10636189456359704705" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:uDGL6kOW6j0C" class="gsc_a_at">Minor structural modifications to alchemix influence mechanism of action and pharmacological activity</a><div class="gs_gray">QMA Abdallah, RM Phillips, F Johansson, T Helleday, L Cosentino, ...</div><div class="gs_gray">Biochemical pharmacology 83 (11), 1514-1522<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16228274598611153711" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:4aZ_i-5WJEQC" class="gsc_a_at">Growth factor</a><div class="gs_gray">J Gill, P Loadman, R Falconer, L Patterson, J Atkinson, M Bibby</div><div class="gs_gray">US Patent App. 12/595,482<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1882865743494383520" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:YohjEiUPhakC" class="gsc_a_at">Generation of a free radical from calphostin C by microsomal cytochrome P450 reductase in rat and human liver</a><div class="gs_gray">LH Patterson, S Jones, A Gescher</div><div class="gs_gray">Biochemical pharmacology 51 (5), 599-603<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13372368025468300970" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:bz8QjSJIRt4C" class="gsc_a_at">Rationalisation of the CS lyase activity of aspartate amino transferase</a><div class="gs_gray">PH Teesdale-Spittle, HJ Adcock, LH Patterson, LD Buckberry</div><div class="gs_gray">Biochemical Society Transactions 24 (1), 141S-141S<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15334988282688911035" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:4fGpz3EwCPoC" class="gsc_a_at">Cellular and molecular pharmacology of the anthrapyrazole antitumour agents</a><div class="gs_gray">LH Patterson, DR Newell</div><div class="gs_gray">Molecular aspects of anticancer drug-DNA interactions, 96-129<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16256628555535129754" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:_FM0Bhl9EiAC" class="gsc_a_at">Method for Analysis, and Distribution Profile, of Covalently‐linked Ferritin‐daunorubicin Conjugate in the Blood of Trypanosome‐infected Mice</a><div class="gs_gray">JE Brown, LH Patterson, J Williamson, JR Brown</div><div class="gs_gray">Journal of pharmacy and pharmacology 44 (1), 48-51<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4050452771622731387" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:H_jBuBxbQIAC" class="gsc_a_at">Wnt Signaling as a therapeutic target in cancer and metastasis</a><div class="gs_gray">R Morgan, R Ankrah, S El-Tanani, PM Loadman, L Pattterson, ...</div><div class="gs_gray">Introduction to cancer metastasis, 375-394<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1948778185275538675" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:c1e4I3QdEKYC" class="gsc_a_at">Compounds containing a vascular disrupting agent</a><div class="gs_gray">J Gill, P Loadman, R Falconer, L Patterson, J Xavier, M Bibby</div><div class="gs_gray">US Patent 9,358,303<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5906752606499711395" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:AYInfyleIOsC" class="gsc_a_at">Cytometry of Anticancer Prodrug OCT1002 Activation and Targeting Using In Vitro and In Vivo Models of Tumour Hypoxia</a><div class="gs_gray">P Smith, M Wiltshire, H Nesbitt, N Byrne, L Ming, D McKenna, ...</div><div class="gs_gray">CYTO 2015, the 30th Congress of the International Society for Advancement of&nbsp;…<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14002157095328256296" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:MpfHP-DdYjUC" class="gsc_a_at">Pyrrolo-indole and pyrrolo-quinoline derivatives as prodrugs for tumour treatment</a><div class="gs_gray">M Searcey, LH Patterson</div><div class="gs_gray">US Patent 7,626,026<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8821955838714583128" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:kw52XkFRtyQC" class="gsc_a_at">MMP activated vascular disrupting agents</a><div class="gs_gray">J Gill, P Loadman, R Falconer, L Patterson, J Atkinson, M Bibby</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16692996098446099918,18156584382340153755" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:-DxkuPiZhfEC" class="gsc_a_at">Membrane type 1-matrix metalloproteinase (MT1-MMP) targeted antitumor agents</a><div class="gs_gray">J Atkinson, R Falconer, C Pennington, S Martin, D Edwards, L Patterson, ...</div><div class="gs_gray">Cancer Research 67 (9 Supplement), 2453-2453<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17457717695321821899" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:anf4URPfarAC" class="gsc_a_at">CyTRAK™ probes: novel nuclear and cytoplasm discriminators compatible with GFP-based HCS and HTS assays</a><div class="gs_gray">RJ Errington, K Pors, LH Patterson, SJ Ogrodzinski, PJ Smith</div><div class="gs_gray">Poster presentation: Society for Biomolecular Sciences Annual Conference, USA<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14079096687996825282" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:6_hjMsCP8ZoC" class="gsc_a_at">Enhancement of cyclophosphamide anti-tumour activity with bioreductive drugs AQ4N and tirapazamine.</a><div class="gs_gray">SR McKeown, O Friery, R Gallagher, M Murray, C Clarke, LH Patterson, ...</div><div class="gs_gray">British Journal of Cancer 78, 14-14<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6256272916220214114" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:Ri6SYOTghG4C" class="gsc_a_at">Free radical formation by cytotoxic alkylaminoanthraquinones in liver microsomes</a><div class="gs_gray">LH Patterson, J Basra, JR Brown</div><div class="gs_gray">Oxygen Radicals in Biology and Medicine, 803-806<span class="gs_oph">, 1988</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2029900128078388959" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1988</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:FAceZFleit8C" class="gsc_a_at">Anthraquinone free-radical formation by mouse liver subcellular fractions</a><div class="gs_gray">MA OLDCORNE, JR BROWN, LH PATTERSON</div><div class="gs_gray">Biochemical Society Transactions 12 (4), 681-682<span class="gs_oph">, 1984</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10077141696332917196" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1984</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:JTqpx9DYBaYC" class="gsc_a_at">FREE-RADICAL FORMATION INVITRO BY CYTO-TOXIC ANTHRAQUINONE DERIVATIVES-COMPARISON WITH DOXORUBICIN</a><div class="gs_gray">J Basra, JR Brown, LH Patterson</div><div class="gs_gray">Investigational New Drugs 2 (1), 117-117<span class="gs_oph">, 1984</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1749781422686159508" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1984</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:9pM33mqn1YgC" class="gsc_a_at">Uptake, Elimination and Subcellular Distribution of Daunorubicin in Trypanosoma Rhodes Iense</a><div class="gs_gray">JE Brown, LH Patterson, J Williamson, JR Brown</div><div class="gs_gray">Journal of Pharmacy and Pharmacology 34 (Supplement_12), 42P-42P<span class="gs_oph">, 1982</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=153272607853500391" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1982</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:T_ojBgVMvoEC" class="gsc_a_at">Compounds containing a vascular disrupting agent</a><div class="gs_gray">J Gill, P Loadman, R Falconer, L Patterson, J Xavier, M Bibby</div><div class="gs_gray">US Patent 9,956,296<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5143838117778963496" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:-uzm3Y7AvW0C" class="gsc_a_at">Methods of treating cancer using compounds containing a vascular disrupting agent</a><div class="gs_gray">RA Falconer, J Gill, J Xavier, P Loadman, M Bibby, L Patterson</div><div class="gs_gray">US Patent 9,937,267<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8593439100003848685" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:c_xDhezhKKUC" class="gsc_a_at">The Effect of cRGDfV on Behaviour in 3D Spheroid Invasion Assay and 2D Models</a><div class="gs_gray">M Zraikat, S Shnyder, H Sheldrake, L Patterson</div><div class="gs_gray">Journal of Clinical Medicine and Therapeutics 2<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11710686839725196845" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:ZqE1mSdD_DYC" class="gsc_a_at">Tumour Dissemination And Assays Involved. Arch</a><div class="gs_gray">M Zraikat, S Shnyder, H Sheldrake, L Patterson</div><div class="gs_gray">Can. Res 5 (2), 144<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13841085789018104797" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:kJDgFkosVoMC" class="gsc_a_at">Tumor-selective bioactivation of duocarmycin bioprecursors by cytochrome P450 enzymes provides an opportunity to treat drug-resistant breast cancer cells</a><div class="gs_gray">SD Shnyder, PM Loadman, M Sutherland, HM Sheldrake, M Searcey, ...</div><div class="gs_gray">Cancer Research 75 (15 Supplement), 4541-4541<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14216640732254565072" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:WHdLCjDvYFkC" class="gsc_a_at">Method of analysing a cell or other biological material containing a nucleic acid</a><div class="gs_gray">PJ Smith, RJ Errington, LH Patterson</div><div class="gs_gray">US Patent 9,051,467<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2064689550657713300" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:zGdJYJv2LkUC" class="gsc_a_at">Design and synthesis of membrane type matrix metalloproteinase (MT-MMP) targeted anti-tumor agents.</a><div class="gs_gray">RA Falconer, AM Youssef, JG Warren, GR Morais, A Mitchell, SD Shnyder, ...</div><div class="gs_gray">Cancer Research 73 (8 Supplement), 5669-5669<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15181953200396818448" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:hvmnpdAuIbkC" class="gsc_a_at">Formulations of anthraquinone derivatives</a><div class="gs_gray">WA Denny, LH Patterson, GW Halbert, SJ Ford</div><div class="gs_gray">US Patent 7,276,537<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13683907863259892658" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:j7_hQOaDUrUC" class="gsc_a_at">Formulations of anthraquinone derivatives</a><div class="gs_gray">WA Denny, LH Patterson, GW Halbert, SJ Ford</div><div class="gs_gray">US Patent 7,074,835<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11423302619625325071" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:5ugPr518TE4C" class="gsc_a_at">Hydroxylation activated drug release</a><div class="gs_gray">GA Potter, LH Patterson, MD Burke</div><div class="gs_gray">US Patent App. 09/115,016<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5544062488217912723" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:LO7wyVUgiFcC" class="gsc_a_at">Comparative metal content profiling of parasitic helminths by electron paramagnetic resonance spectrometry: significance for metalloprotein content</a><div class="gs_gray">FA Taiwo, PM Brophy, DI Pritchard, A Brown, A Wardlaw, LH Patterson</div><div class="gs_gray">International journal for parasitology 30 (1), 29-33<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11955734685513918032" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:OR75R8vi5nAC" class="gsc_a_at">Treatment of arthritis in the rabbit with intra-articular daunorubicin linked to protein</a><div class="gs_gray">WC Foong, KL Green, LH Patterson, JE Brown, JR Brown</div><div class="gs_gray">Journal of Pharmacy and Pharmacology 37 (Supplement_12), 98P-98P<span class="gs_oph">, 1985</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7416979939842581196" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1985</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:pS0ncopqnHgC" class="gsc_a_at">LACK OF MITOXANTRONE FREE-RADICALS AND REDOX CYCLING IN RABBIT HEART SARCOPLASMIC-RETICULUM-COMPARISON WITH DOXORUBICIN</a><div class="gs_gray">LH Patterson, J Basra</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 52 (3), 416-416<span class="gs_oph">, 1985</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4976085921209044110" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1985</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:6yz0xqPARnAC" class="gsc_a_at">Computer graphics in rational anti-cancer drug design</a><div class="gs_gray">SA Islam, R Kuroda, S Neidle, JR Brown, BM Gandecha, LH Patterson</div><div class="gs_gray">Biochemical Society Transactions 10 (6), 501-501<span class="gs_oph">, 1982</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14297080543057339470" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1982</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:4hFrxpcac9AC" class="gsc_a_at">Some Aspects of the Metabolism of 4 Substituted N-Ethyl-N-Methylanilines.</a><div class="gs_gray">LH Patterson</div><div class="gs_gray">King's College London (University of London)<span class="gs_oph">, 1978</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7233140741107134743" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1978</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:eO3_k5sD8BwC" class="gsc_a_at">INVITRO C-OXIDATION AND N-OXIDATION OF 4 SUBSTITUTED UNSYMMETRICAL AROMATIC-AMINES</a><div class="gs_gray">LH Patterson, JW Gorrod</div><div class="gs_gray">NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY 297, R5-R5<span class="gs_oph">, 1977</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12455071656371550455" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1977</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:QVtou7C4vgoC" class="gsc_a_at">An efficient assay for identification and quantitative evaluation of potential polysialyltransferase inhibitors</a><div class="gs_gray">X Guo, JR Malcolm, MM Ali, GR Morais, SD Shnyder, PM Loadman, ...</div><div class="gs_gray">Analyst 145 (13), 4512-4521<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11769895624533697759" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:L_l9e5I586QC" class="gsc_a_at">Polysialyltransferase ST8SiaII as a target for neuroblastoma dissemination</a><div class="gs_gray">SM Elkashef, RF Saeed, GR Morais, X Guo, M Sini, VF Viprey, ...</div><div class="gs_gray">Cancer Research 76 (14 Supplement), 1270-1270<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2989307915602916335" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:ghEM2AJqZyQC" class="gsc_a_at">Polysialyltransferase ST8SiaII: A novel target for the treatment of neuroblastoma</a><div class="gs_gray">SM Elkashef, V Viprey, RF Saeed, BR Springett, M Sutherland, ...</div><div class="gs_gray">Cancer Research 75 (15 Supplement), 5431-5431<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16150289433929479683" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:zdjWy_NXXwUC" class="gsc_a_at">Compounds</a><div class="gs_gray">RA Falconer, J Gill, J Xavier, P Loadman, M Bibby, L Patterson</div><div class="gs_gray">US Patent App. 14/553,803<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16137505519185601188" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:Xl6nMSl579sC" class="gsc_a_at">Polysialyltransferase ST8SiaII: a new target for the treatment of metastatic tumors</a><div class="gs_gray">V Viprey, BR Springett, Y Al-Saraireh, M Northrop, M Sutherland, R Saeed, ...</div><div class="gs_gray">Cancer Research 74 (19 Supplement), 1774-1774<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6819460535615996510" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:sNmaIFBj_lkC" class="gsc_a_at">The use of pharmacokinetic and pharmacodynamic endpoints to determine dose of AQ4N given with radiotherapy (RT)</a><div class="gs_gray">A Benghiat, WP Steward, M Middleton, D Talbot, LH Patterson, SJ Ford, ...</div><div class="gs_gray">Journal of Clinical Oncology 23 (16_suppl), 2062-2062<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13315201053238342089" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:3htObqc8RwsC" class="gsc_a_at">Cytochrome P450 1B1 (CYP1B1) is expressed during the malignant progression of head and neck squamous cell carcinoma (HNSCC).</a><div class="gs_gray">ML Greer, PI Richman, PR Barber, GD Wilson, GI Murray, LH Patterson, ...</div><div class="gs_gray">Cancer Research 64 (7 Supplement), 854-854<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7447969612557511402" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:LPtt_HFRSbwC" class="gsc_a_at">Cytochrome P450CYP1B1 versus GLUT 1 protein expression during the development of head and neck squamous cell carcinomas (HNSCCs).</a><div class="gs_gray">ML Greer, FM Daley, P Barber, GI Murray, LH Patterson, SA Everett</div><div class="gs_gray">British Journal of Cancer 88, S33-S33<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14305383324312387416" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:WC9gN4BGCRcC" class="gsc_a_at">Cytochrome P450 and tumor selective drug activation</a><div class="gs_gray">LH Patterson</div><div class="gs_gray">DRUG METABOLISM REVIEWS 35, 12-12<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13987220692517157115" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:0izLItjtcgwC" class="gsc_a_at">A novel alkylating anthraquinone that is effective against resistant ovarian cancer cells</a><div class="gs_gray">LH Patterson, Z Paniwynk, K Pohrs, PH Teesdale-Spittle, JA Hartley, ...</div><div class="gs_gray">Proceedings of the American Association for Cancer Research 41, 2701-<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=349188705038319629" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:Ade32sEp0pkC" class="gsc_a_at">Increased expression of cytochrome P450 isoforms in mouse tumours and their role in the enhanced activation of the bioreductive drug, AQ4N</a><div class="gs_gray">MM Murray, T Robson, R Gallagher, LH Patterson, DG Hirst, ...</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 78, 22-22<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15923540951346343573" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:umqufdRvDiIC" class="gsc_a_at">Preparation and stability of liposome encapsulated dexorubicin and mitoxantrone and their internalisation by murine peritoneal macrophages</a><div class="gs_gray">JC Lilley, LH Patterson, MJ Taylor</div><div class="gs_gray">International journal of pharmaceutics 107 (2), 149-157<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12746177260832550653" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:NXb4pA-qfm4C" class="gsc_a_at">Uptake and intracellular distribution of anticancer drugs studied by direct imaging and flow cytometry</a><div class="gs_gray">PJ Smith, ME Fox, LH Patterson</div><div class="gs_gray">Bone marrow transplantation. Supplement (Basingstoke) 12 (4), S156-S157<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=699412250430916056" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:3NQIlFlcGxIC" class="gsc_a_at">COMPARISON OF UPTAKE, FREE-RADICAL GENERATION AND CYTO-TOXICITY OF C1941 WITH DOXORUBICIN IN MCF-7 HUMAN-BREAST CANCER-CELLS</a><div class="gs_gray">GR Fisher, LH Patterson</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 60 (3), 476-476<span class="gs_oph">, 1989</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5280373867989482859" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1989</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:hsZV8lGYWTMC" class="gsc_a_at">THE ROLE OF ANTHRAPYRAZOLE IRON COMPLEXES IN HYDROXYL RADICAL FORMATION DNA STRAND SCISSION AND CYTO-TOXICITY</a><div class="gs_gray">MA Graham, DR Newell, LH Patterson, C Qualmann, BK SINHA, ...</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 60 (3), 501-501<span class="gs_oph">, 1989</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9417644260071980666" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1989</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:rTD5ala9j4wC" class="gsc_a_at">Effect of doxorubicin on glutathione-depleted hepatocytes</a><div class="gs_gray">TJ LAVELLE, LH PATTERSON</div><div class="gs_gray">Biochemical Society Transactions 15 (3), 454-455<span class="gs_oph">, 1987</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11950564509690429076" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1987</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:AZju0d2GQJ0C" class="gsc_a_at">Methods of assessment of polysialyltransferase inhibitors for treatment of tumor cell dissemination</a><div class="gs_gray">X Guo, JR Malcolm, A Patel, MM Ali, GR Morais, SD Shnyder, ...</div><div class="gs_gray">Cancer Research 81 (13 Supplement), 2872-2872<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:BOlwja0KXvYC" class="gsc_a_at">Immunometabolomics: The metabolic landscape of immune cells in tumor microenvironment</a><div class="gs_gray">S Dhar, S Bose, G Sa, AA Elsharif, LH Patterson, SD Shnyder, ...</div><div class="gs_gray">Medknow Publications<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:wSy_KLzO7YEC" class="gsc_a_at">Probing cytochrome P450 (CYP) bioactivation with chloromethylindoline bioprecursors derived from the duocarmycin family of compounds</a><div class="gs_gray">N Ortuzar, K Karu, D Presa, GR Morais, HM Sheldrake, SD Shnyder, ...</div><div class="gs_gray">Bioorganic &amp; Medicinal Chemistry 40, 116167<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:ji7lAbPyDbYC" class="gsc_a_at">Fremgangsmåde til analyse af en celle eller andet biologisk materiale indeholdende nukleinsyre</a><div class="gs_gray">PJ Smith, RJ Errington, LH Patterson</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:sJPMR1oEGYQC" class="gsc_a_at">An assay for quantitative analysis of polysialic acid expression in cancer cells</a><div class="gs_gray">X Guo, SM Elkashef, A Patel, GR Morais, SD Shnyder, PM Loadman, ...</div><div class="gs_gray">Carbohydrate Polymers 259, 117741<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:G1UMdFYMoxkC" class="gsc_a_at">Methods of treating cancer using compounds containing a vascular disrupting agent</a><div class="gs_gray">R Falconer, J Gill, J Xavier, P Loadman, M Bibby, L Patterson</div><div class="gs_gray">US Patent 10,912,839<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:lYAcb2jw7qUC" class="gsc_a_at">The role of integrins in acute leukemias and potential as targets for therapy</a><div class="gs_gray">AA Elsharif, LH Patterson, SD Shnyder, HM Sheldrake</div><div class="gs_gray">Medknow Publications<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:naSTrk-c4S8C" class="gsc_a_at">Methods of treating cancer using compounds containing a vascular disrupting agent</a><div class="gs_gray">RA Falconer, J Gill, J Xavier, P Loadman, M Bibby, L Patterson</div><div class="gs_gray">US Patent App. 16/946,391<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:ijdKiLOsEJMC" class="gsc_a_at">Deuterated compounds and uses thereof</a><div class="gs_gray">S Ogrodzinski, P Smith, S McKeown, L Patterson, RJ Errington</div><div class="gs_gray">US Patent App. 16/543,790<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:qmtmRrLr0tkC" class="gsc_a_at">Composto, composição e complexo fluorescente compreendendo o mesmo, método de fabricação do composto e método de analisar uma célula ou outro material biológico compreendendo&nbsp;…</a><div class="gs_gray">SP James, RJ Errington, LH Patterson</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:s9ia6_kGH2AC" class="gsc_a_at">Compounds containing a vascular disrupting agent</a><div class="gs_gray">J Gill, P Loadman, R Falconer, L Patterson, J Xavier, M Bibby</div><div class="gs_gray">US Patent 10,556,014<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:nqdriD65xNoC" class="gsc_a_at">Acetalanthraquinone derivatives useful for cellular staining</a><div class="gs_gray">PJ Smith, RJ Errington, LH Patterson, K Pors, L Cosentino</div><div class="gs_gray">US Patent App. 16/312,652<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:jmjb1lOE9QIC" class="gsc_a_at">Quantitative profiling of Cytochrome P450 2S1 in colorectal cancer by PRM assay</a><div class="gs_gray">ul Shaheed, Sadr, LH Patterson, K Pors, CW Sutton</div><div class="gs_gray">CANCER RESEARCH 79 (13)<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:jtI9f0ekYq0C" class="gsc_a_at">Quantitative profiling of Cytochrome P450 2S1 in colorectal cancer by PRM assay</a><div class="gs_gray">S ul Shaheed, LH Patterson, K Pors, CW Sutton</div><div class="gs_gray">Cancer Research 79 (13 Supplement), 4545-4545<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:_AeoHAGD03cC" class="gsc_a_at">An efficient cell-based assay for quantification of cellular polysialic acid in neuroblastoma</a><div class="gs_gray">X Guo, FM Barnieh, J Malcolm, AD Race, GR Morais, SD Shnyder, ...</div><div class="gs_gray">Cancer Research 79 (13 Supplement), 241-241<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:4e5Qn2KL_jwC" class="gsc_a_at">MMP-ACTIVATED VASCULAR DESTRUCTIVE AGENTS</a><div class="gs_gray">RA Falconer, J Gill, J Atkinson, P Loadman, M Bibby, L Patterson</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:jlhcAiayVhoC" class="gsc_a_at">Mmp aktyvinti kraujagysles ardantys agentai</a><div class="gs_gray">R Falconer, J Gill, J Atkinson, P Loadman, M Bibby, L Patterson</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:wUn16MOA3RoC" class="gsc_a_at">New connections and applications thereof</a><div class="gs_gray">S Ogrodzinski, P Smith, S Mckeown, L Patterson, RJ Errington</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:n3vGvpFsckwC" class="gsc_a_at">Mmp activated vascular disrupting agents</a><div class="gs_gray">RA Falconer, J Gill, J Atkinson, P Loadman, M Bibby, L Patterson</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:eI34FqJmdUoC" class="gsc_a_at">New compounds and uses thereof</a><div class="gs_gray">S OGRODZINSKI, P Smith, S Mckeown, L Patterson, RJ Errington</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:iyewoVqAXLQC" class="gsc_a_at">Specifinė mmp-14 skaldymo seka</a><div class="gs_gray">J Gill, P Loadman, R Falconer, L Patterson, J Atkinson, M Bibby</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:JWITY9-sCbMC" class="gsc_a_at">Method of analysis of a cell or other biological material that contains a nucleic acid</a><div class="gs_gray">PJ Smith, RJ Errington, LH Patterson</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:NMlhSUseqAsC" class="gsc_a_at">Expression of cytochrome P450 in head and neck cancer cell lines</a><div class="gs_gray">DF Presa, GR Morais, M Sutherland, J McCaul, J Robert, L Patterson, ...</div><div class="gs_gray">Cancer Research 77 (13 Supplement), 5234-5234<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:N4u4nq0IxgcC" class="gsc_a_at">VESSEL DESTROYERS ACTIVATED BY MMP</a><div class="gs_gray">J Gill, P Loadman, R Falconer, L Patterson, J Atkinson, M Bibby</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:tHtfpZlB6tUC" class="gsc_a_at">Probing cytochrome P450 activity with benzofuran-based duocarmycins in a panel of head and neck cancer cell lines and CYP1A1, 1B1 and CYP2W1 transfected cell lines</a><div class="gs_gray">D Presa, PM Loadman, G Nigro, HM Sheldrake, M Sutherland, ...</div><div class="gs_gray">Cancer Research 76 (14 Supplement), 3105-3105<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:isU91gLudPYC" class="gsc_a_at">Professor John William Gorrod PhD, DSc, MPS (hon), FKC, FSP, FRCPath, 1931–2015</a><div class="gs_gray">M Smith, L Patterson</div><div class="gs_gray">Xenobiotica 46 (7), 571-572<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:sfnaS5RM6jYC" class="gsc_a_at">MMP-ACTIVATED vascular damaging FUNDS</a><div class="gs_gray">J Gill, P Loadman, R Falconer, L Patterson, J Atkinson, M Bibby</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:1r-w4gtu6w8C" class="gsc_a_at">Agentes de interrupción vascular activados por MMP</a><div class="gs_gray">J Gill, P Loadman, R Falconer, L Patterson, J Atkinson, M Bibby</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:ymY9cBF3mdcC" class="gsc_a_at">MMP-activated vascular damaging agents</a><div class="gs_gray">J Gill, P Loadman, R Falconer, L Patterson, J Atkinson, M Bibby</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:pYKElYtJMmwC" class="gsc_a_at">Agentes disruptores vasculares activados por MMP</a><div class="gs_gray">J Gill, P Loadman, R Falconer, L Patterson, J Atkinson, M Bibby</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:qE4H1tSSYIIC" class="gsc_a_at">New models for investigating integrin antagonists</a><div class="gs_gray">A Elsharif, H Sheldrake, L Patterson, S Shnyder</div><div class="gs_gray">European Journal of Cancer 1 (61), S56<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:RuPIJ_LgqDgC" class="gsc_a_at">Method of analysing a cell or other biological material containing a nucleic acid</a><div class="gs_gray">PJ Smith, RJ Errington, LH Patterson</div><div class="gs_gray">US Patent App. 14/731,647<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:aIdbFUkbNIkC" class="gsc_a_at">CYP2W1 as a novel therapeutic target in colon cancer</a><div class="gs_gray">K Pors, PM Loadman, S Travica, SD Shnyder, M Sutherland, H Sheldrake, ...</div><div class="gs_gray">Cancer Research 74 (19 Supplement), 1779-1779<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:qe6vwMD2xtsC" class="gsc_a_at">289 Progress in drugging CYP1A1, 1B1 and CYP2W1 overexpressed in cancer</a><div class="gs_gray">K Pors, V Le Morvan, S Travica, SD Shnyder, M Sutherland, ...</div><div class="gs_gray">European Journal of Cancer, 95<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:UuEBAcK4md4C" class="gsc_a_at">520: Investigation of the expression and the role of avβ3, avβ5 and a5β1 integrins in head and neck cancers</a><div class="gs_gray">H Ahmedah, L Patterson, S Shnyder, H Sheldrake</div><div class="gs_gray">European Journal of Cancer, S125<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:jSAVyFp_754C" class="gsc_a_at">Re-engineering of the duocarmycin structural architecture enables tumour-selective CYP2W1-mediated drug activation in human colon cancer xenografts.</a><div class="gs_gray">K Pors, S Travica, PM Loadman, SD Shnyder, M Sutherland, ...</div><div class="gs_gray">Cancer Research 73 (8 Supplement), 2224-2224<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:IsPWOBWtZBwC" class="gsc_a_at">Inhibition of cell surface polysialic acid biosynthesis modulates tumor cell migration.</a><div class="gs_gray">BR Springett, YMJ Al-Saraireh, V Viprey, M Sutherland, M Begouin, ...</div><div class="gs_gray">Cancer Research 73 (8 Supplement), 4410-4410<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:LdasjJ6CEcoC" class="gsc_a_at">204 Modulation of Tumour Cell Migration by Inhibition of Polysialic Acid Biosynthesis</a><div class="gs_gray">BR Springett, YMJ Al-Saraireh, M Sutherland, LH Patterson, SD Shnyder, ...</div><div class="gs_gray">European Journal of Cancer, 61-62<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:4Yq6kJLCcecC" class="gsc_a_at">Method of analysing a cell or other biological material containing a nucleic acid</a><div class="gs_gray">PJ Smith, RJ Errington, LH Patterson</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:ubry08Y2EpUC" class="gsc_a_at">Benz-indole and benzo-quinoline derivatives as prodrugs for tumor treatment</a><div class="gs_gray">M Searcey, LH Patterson</div><div class="gs_gray">US Patent 8,017,640<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:CYCckWUYoCcC" class="gsc_a_at">Instability of ABCG2-associated side population expression in human A549 lung cancer cells and its contribution to drug resistance</a><div class="gs_gray">L Cosentino, M Wiltshire, S Chappel, P Burns, LH Patterson, K Pors, ...</div><div class="gs_gray">Cancer Research 71 (8 Supplement), 503-503<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:DyXnQzXoVgIC" class="gsc_a_at">Design and development of ICT2700: A proof-of-concept agent demonstrating the therapeutic potential in targeting cytochromes P450 for tumor-selective activation</a><div class="gs_gray">K Pors, SD Shnyder, A Sharma, AC Rigby, MA Grant, M Sutherland, ...</div><div class="gs_gray">Cancer Research 71 (8 Supplement), 3247-3247<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:m92CDrhVnKEC" class="gsc_a_at">Compounds</a><div class="gs_gray">RA Falconer, J Gill, J Atkinson, P Loadman, M Bibby, L Patterson</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:Xz60mAmATU4C" class="gsc_a_at">Combination of decitabine and the tumor-selective CYP450-activated compound ICT2700 produces a synergistic effect in HeLa cells</a><div class="gs_gray">L Cosentino, M Sutherland, H Sheldrake, LH Patterson, K Pors</div><div class="gs_gray">Cancer Research 70 (8 Supplement), 5424-5424<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:7BrZ7Jt4UNcC" class="gsc_a_at">Analogues of the Azinomycins as Anti-Tumour Agents and as Prodrugs</a><div class="gs_gray">M Searcey, LH Patterson, K Pors, M Casely-Hayford</div><div class="gs_gray">US Patent App. 11/886,505<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:jgBuDB5drN8C" class="gsc_a_at">Anthraquinone compounds as anti cancer compounds</a><div class="gs_gray">LH Patterson, K Pors, PH Teesdale-Spittle</div><div class="gs_gray">US Patent 7,557,215<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:X9ykpCP0fEIC" class="gsc_a_at">Abstract# 673: Development of a novel class of tumor-selective CYP1A1-activated chloromethylindolines</a><div class="gs_gray">K Pors, H Sheldrake, S Shnyder, M Sutherland, P Loadman, A Gordon, ...</div><div class="gs_gray">Cancer Research 69 (9 Supplement), 673-673<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:Ic1VZgkJnDsC" class="gsc_a_at">Anthraquinone and its derivatives</a><div class="gs_gray">PJ Smith, L Patterson</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:c59VksA5Vz4C" class="gsc_a_at">Gel formulations and uses thereof</a><div class="gs_gray">PJ Smith, L Patterson, RJ Errington</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:GFxP56DSvIMC" class="gsc_a_at">CYP1A1 activation and pharmacokinetics of a novel chloromethylpyrrollolindoline with potential as a tumour selective prodrug</a><div class="gs_gray">AD Race, K Pors, SD Shnyder, TC Cooper, HM Sheldrake, M Searcey, ...</div><div class="gs_gray">Ejc Supplements 6 (12), 105-105<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:WJVC3Jt7v1AC" class="gsc_a_at">24 INVITED The evolution of CYPs from metabolising enzymes to potential targets in cancer therapy development</a><div class="gs_gray">LH Patterson, K Pors, PM Loadman, M Sutherland, J Gill, H Sheldrake, ...</div><div class="gs_gray">Ejc Supplements 12 (6), 11<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:Zh0EY9V9P6UC" class="gsc_a_at">Potent cytotoxicity and inhibition of pan-cell cycle progression by an alkylating anthraquinone</a><div class="gs_gray">A Epenetos, K Pors, P Smith, L Patterson</div><div class="gs_gray">US Patent App. 11/655,043<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:27LrP4qxOz0C" class="gsc_a_at">Use of a modified hollow fibre assay to evaluate vascular-targeting agents.</a><div class="gs_gray">S Shnyder, P Cooper, S Al-Islam, E Pilarinou, J Hassan, G Jayson, ...</div><div class="gs_gray">Cancer Research 67 (9 Supplement), 489-489<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:hSRAE-fF4OAC" class="gsc_a_at">Cytotoxicity of novel alkylating anthraquinones in cells with DNA nucleotide excision repair and DNA mismatch repair defects</a><div class="gs_gray">K Pors, F Johansson, T Helleday, E Matheson, A Hall, L Patterson</div><div class="gs_gray">Cancer Research 67 (9 Supplement), 3206-3206<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:U4n9YNQMCAIC" class="gsc_a_at">Indoline and tetrahydro-quinolines as prodrugs for tumour treatment</a><div class="gs_gray">M Searcey, LH Patterson</div><div class="gs_gray">US Patent 7,179,921<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:silx2ntsSuwC" class="gsc_a_at">Comparative cytochrome P450 proteomics in the livers of immunodeficient mice using 18O stable isotope labeling.</a><div class="gs_gray">LH Patterson, WJ Griffiths, CS Lane, Y Wang, R Betts</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:wMgC3FpKEyYC" class="gsc_a_at">Development of Methods to Profile Cytochrome P 450 s from Normal and Tumour Tissues</a><div class="gs_gray">CW Sutton, LH Patterson</div><div class="gs_gray">55 th ASMS Conference Proceedings<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:unp9ATQDT5gC" class="gsc_a_at">PA. 023 EXPLOITING HYPOXIA-ACTIVATED AQ4N AND VASCULAR DISRUPTING AGENTS TO KILL THE EWING'S SARCOMA FAMILY OF TUMOURS (ESFT)</a><div class="gs_gray">C Whistler, S Dalal, L Patterson, M Bibby, N Hurst, I Lewis, S Burchill</div><div class="gs_gray">Pediatric Blood &amp; Cancer 47 (4)<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:KbBQZpvPDL4C" class="gsc_a_at">Potent cytotoxicity and inhibition of pan-cell cycle progression by Alchemix, a novel alkylating anthraquinone</a><div class="gs_gray">AA Epenetos, K Pors, PJ Smith, LH Patterson</div><div class="gs_gray">Journal of Clinical Oncology 24 (18_suppl), 12030-12030<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:2VqYfGB8ITEC" class="gsc_a_at">Development of DNA-affinic aminoanthraquinones with alkylating potential that exhibit potent cytotoxicity against resistant ovarian carcinoma cell lines</a><div class="gs_gray">K Pors, S Shnyder, MC Bibby, JA Hartley, M Zloh, M Searcey, ...</div><div class="gs_gray">Cancer Research 66 (8 Supplement), 263-263<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:8xutWZnSdmoC" class="gsc_a_at">Screening far red probes for use on optical biochip devices</a><div class="gs_gray">KL Njoh, LH Patterson, K Pors, M Zloh, S Ameer-Beg, H Summers, ...</div><div class="gs_gray">Imaging, Manipulation, and Analysis of Biomolecules, Cells, and Tissues IV&nbsp;…<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:SIv7DqKytYAC" class="gsc_a_at">Synthesis of DNA-Directed Pyrrolidinyl and Piperidinyl Confined Alkylating Chloroalkylaminoanthraquinones: Potential for Development of Tumor-Selective N-Oxides</a><div class="gs_gray">LH Patterson, K Pors, SD Shnyder, PH Teesdale-Spittle, JA Hartley, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:yxmsSjX2EkcC" class="gsc_a_at">ORGN 741-Total synthesis of duocarmycin prodrugs</a><div class="gs_gray">M Guino, LH Patterson, M Searcey</div><div class="gs_gray">Abstracts of Papers of the American Chemical Society 232, 741-ORGN<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:sJsF-0ZLhtgC" class="gsc_a_at">312 POSTER Preclinical evaluation of a rationally designed novel class of non-hydroxamate Histone Deacetylase inhibitors (HDACi)</a><div class="gs_gray">JH Gill, CWG Fishwick, V Androutsopoulos, A Mohanarajah, T Khamnaen, ...</div><div class="gs_gray">EJC Supplements 12 (4), 98<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:LhH-TYMQEocC" class="gsc_a_at">417 POSTER Membrane Type 1-Matrix Metalloproteinase (MT1-MMP) is overexpressed in lung cancer and can cleave peptide-conjugates</a><div class="gs_gray">J Atkinson, R Falconer, C Pennington, S Martin, V Anikin, A Mearns, ...</div><div class="gs_gray">EJC Supplements 12 (4), 128<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:HeT0ZceujKMC" class="gsc_a_at">N-oxides of alkylating anthraquinones as hypoxia-targeting prodrugs.</a><div class="gs_gray">K Pors, RM Phillips, JA Hartley, LH Patterson</div><div class="gs_gray">AMER ASSOC CANCER RESEARCH 11 (24), 9053S-9053S<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:lgwcVrK6X84C" class="gsc_a_at">NCAM polysialylation and the small-cell lung carcinoma cell-adherence phenotype</a><div class="gs_gray">RA Falconer, LH Patterson, R Errington, M Wiltshire, PJ Smith</div><div class="gs_gray">Cancer Research 65 (9 Supplement), 455-455<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:gVv57TyPmFsC" class="gsc_a_at">Potent cytotoxicity and inhibition of pan-cell cycle progression by Alchemix, a novel DNA alkylating anthraquinone</a><div class="gs_gray">K Pors, PJ Smith, AA Epenetos, LH Patterson</div><div class="gs_gray">Cancer Research 65 (9 Supplement), 564-565<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:QYdC8u9Cj1oC" class="gsc_a_at">A new paradigm in the development of anticancer drugs: Agents with increased potency against cisplatin resistant cells</a><div class="gs_gray">K Pors, J Plumb, P Teesdale-Spittle, R Brown, A Epenetos, PJ Smith, ...</div><div class="gs_gray">Cancer Research 65 (9 Supplement), 565-565<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:EsEWqaRxkBgC" class="gsc_a_at">Development of nonsymmetrical 1, 4-disubstituted anthraquinones that are potently active against cisplatin-resistant ovarian cancer cells</a><div class="gs_gray">PH Teesdale-Spittle, K Pors, R Brown, LH Patterson, JA Plumb</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:sA9dB-pw3HoC" class="gsc_a_at">Design and synthesis of a DNA-crosslinking azinomycin analogue</a><div class="gs_gray">K Pors, MA Casely-Hayford, JA Hartley, LH Patterson, M Searcey</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:6bLC7aUMtPcC" class="gsc_a_at">Prodrug analogs of the duocarmycins activated by CYP-oxidation</a><div class="gs_gray">M Searcey, K Karu, SS Grewal, NO Kerr, W Griffith, LH Patterson</div><div class="gs_gray">Abstracts of Papers of the American Chemical Society 229, 414-MEDI<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:XUvXOeBm_78C" class="gsc_a_at">Influence of the stereoisomeric position of azinomycin epoxide on DNA binding and sequence selectivity</a><div class="gs_gray">MH David-Cordonnier, M Casely-Hayford, LH Patterson, C Bailly, ...</div><div class="gs_gray">Clinical Cancer Research 11 (24), 9013S-9013S<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:Ak0FvsSvgGUC" class="gsc_a_at">Design and synthesis of bio-oxidatively activated prodrugs based upon the duocarmycins: Routes to Boc-CI and CI-MI prodrugs</a><div class="gs_gray">NO Kerr, SS Grewel, BGO Martin, K Karu, LH Patterson, M Searcey</div><div class="gs_gray">Abstracts of Papers of the American Chemical Society 229, 413-MEDI<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:ODE9OILHJdcC" class="gsc_a_at">Design, synthesis and biological evaluation of potential anticancer agents based on the azinomycins</a><div class="gs_gray">MA Casely-Hayford, K Pors, LH Patterson, M Searcey</div><div class="gs_gray">Abstracts of Papers of the American Chemical Society 229<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:TaaCk18tZOkC" class="gsc_a_at">Phase 1 dose escalation study of AQ4N, a selective hypoxic cell cytotoxin, with fractionated radiotherapy (RT): First report 2091</a><div class="gs_gray">A Benehiat, W Steward, P Loadman, M Middleton, D Talbot, L Patterson, ...</div><div class="gs_gray">Journal of Clinical Oncology 22<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:5MTHONV0fEkC" class="gsc_a_at">The proteomic identification of cytochrome P450 isoforms in liver and tumors from patients with metastatic colorectal cancer</a><div class="gs_gray">CS Lane, WJ Griffiths, BJ Fuller, BR Davidson, KJ Welham, LH Patterson</div><div class="gs_gray">Cancer Research 64 (7 Supplement), 1302-1302<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:fbc8zXXH2BUC" class="gsc_a_at">Use of the Alkaline Comet Assay as an indicator of AQ4N metabolism in excised tumor biopsies; a strategy for indicating tumor sensitivity</a><div class="gs_gray">SR McKeown, V McErlane, R Gallagher, C Dunk, LH Patterson</div><div class="gs_gray">Cancer Research 64 (7 Supplement), 259-259<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:65Yg0jNCQDAC" class="gsc_a_at">Manipulation of p450 gene expression in tumours; a novel approach for targeted activation of bioreductive prodrugs</a><div class="gs_gray">T Robson, A Yakkundi, H McCarthy, V McErlane, CM Hughes, DG Hirst, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:mlAyqtXpCwEC" class="gsc_a_at">Preface [Hot topic: Tumour-Selective Drug Activation (Executive Editor: LH Patterson)]</a><div class="gs_gray">LH Patterson</div><div class="gs_gray">Current Pharmaceutical Design 9 (26), i-i<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:mel-f30kHHgC" class="gsc_a_at">Manipulation of P450 gene expression in tumours; a novel approach for targeted activation of bioreductive prodrugs</a><div class="gs_gray">T Robson, A Yakkundi, H McCarthy, V McErlane, CM Hughes, DG Hirst, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:Br1UauaknNIC" class="gsc_a_at">DMU135: A CYP1B1 activated tyrosine kinase inhibitor prodrug with tumour selective activity.</a><div class="gs_gray">ML Greer, FM Daley, P Barber, GI Murray, LH Patterson, SA Everett</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 88, S33-S33<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:jU7OWUQzBzMC" class="gsc_a_at">Tumour-Selective Drug Activation</a><div class="gs_gray">LH Patterson</div><div class="gs_gray">Current pharmaceutical design 9 (26)<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:0CzhzZyukY4C" class="gsc_a_at">Nanoelectrospray ionisation tandem mass spectrometric identification of cytochrome P450s in human liver and hepatocytes</a><div class="gs_gray">S Nisar, C Lane, A Wilderspin, K Welham, S Orr, LH Patterson</div><div class="gs_gray">JOURNAL OF PHARMACY AND PHARMACOLOGY 55, 11-11<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:4X0JR2_MtJMC" class="gsc_a_at">Design and synthesis of duocarmycins as potential prodrugs</a><div class="gs_gray">SS Grewal, LH Patterson, M Searcey</div><div class="gs_gray">JOURNAL OF PHARMACY AND PHARMACOLOGY 55, 41-41<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:cWzG1nlazyYC" class="gsc_a_at">Erratum: The chemopotentiation of cisplatin by the novel bioreductive drug AQ4N</a><div class="gs_gray">R Gallagher, CM Hughes, MM Murray, OP Friery, LH Patterson, DG Hirst, ...</div><div class="gs_gray">British Journal of Cancer 87 (11), 1339-1339<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:CdxZDUztZiMC" class="gsc_a_at">Validation of cytochrome P450CYP1B1 as a target for cancer therapeutics</a><div class="gs_gray">ML Greer, GI Murray, GD Wilson, LH Patterson, SA Everett</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 86, S107-S107<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:yY3RG6sOEgwC" class="gsc_a_at">Short Papers in Pharmaceutical Analysis</a><div class="gs_gray">CS Lane, LH Patterson, C Lenz, KJ Welham</div><div class="gs_gray">J. Pharm. Pharmacol, 54<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:PVgj2kMGcgYC" class="gsc_a_at">Novel inhibitor of topo II is effective against resistant ovarian cancer cells.</a><div class="gs_gray">Z Paniwnyk, K Pors, PH Teesdale-Spittle, GA Potter, J Plumb, JA Hartley, ...</div><div class="gs_gray">British Journal of Cancer 80, 46-46<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:2vr6o8x5NLkC" class="gsc_a_at">Enhancement of chemotherapy of murine tumours by AQ4N, a bioreductively activated anti-tumour agent.</a><div class="gs_gray">LH Patterson, SR McKeown, K Ruparelia, J Double, M Bibby, MA Graham, ...</div><div class="gs_gray">British Journal of Cancer 82<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:bnK-pcrLprsC" class="gsc_a_at">Clinical Pharmacokinetics and Metabolism-Rat cytochromes P450 (CYP) specifically contribute to the reductive bioactivation of AQ4N, an alkylaminoanthraquinone-di-N-oxide anti&nbsp;…</a><div class="gs_gray">SM Raleigh, E Wanogho, MD Burke, LH Patterson</div><div class="gs_gray">Xenobiotica 29 (11), 1115-1122<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:YTuZlYwrTOUC" class="gsc_a_at">BIOREDUCTIVE THERAPIES-Involvement of Human Cytochromes P450 (CYP) in the Reductive Metabolism of AQ4N, A Hypoxia Activated Anthraquinone di-N-oxide Prodrug</a><div class="gs_gray">SM Raleigh, E Wanogho, MD Burke, SR McKeown, LH Patterson</div><div class="gs_gray">International Journal of Radiation Oncology Biology Physics 42 (4), 763-768<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:1yWc8FF-_SYC" class="gsc_a_at">Involvement of human and murine tumour cytochrome P450 in bioreduction of AQ4N</a><div class="gs_gray">SM Raleigh, MM Murray, T Robson, R Gallagher, S McKeown, ...</div><div class="gs_gray">ANNALS OF ONCOLOGY 9, 134-134<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:r_AWSJRzSzQC" class="gsc_a_at">CHEMOTHERAPY AND METABOLIC INHIBITORS-Reduction of the indoloquinone anticancer drug EO9 by purified DT-diaphorase A detailed kinetic study and analysis of metabolites</a><div class="gs_gray">SM Bailey, AD Lewis, RJ Krwx, LH Patterson, GR Fisher, P Workman</div><div class="gs_gray">Biochemical Pharmacology 56 (5), 613-622<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:yqoGN6RLRZoC" class="gsc_a_at">DNA Damage in the T50/80 Tumour Following Combination of Radiation With the Bioreductive Drugs Aq4n or Tirapazamine</a><div class="gs_gray">OP Friery, MV Hejmadi, LH Patterson, SR McKeown</div><div class="gs_gray">IRISH JOURNAL OF MEDICAL SCIENCE 166, 167-167<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:L1USKYWJimsC" class="gsc_a_at">Interaction of the novel bioreductive drug AQ4N with radiation in BDF mice implanted with the T50/80 tumour</a><div class="gs_gray">OP Friery, MV Hejmadi, IA McIntyre, JJA McAleer, LH Patterson, ...</div><div class="gs_gray">IRISH JOURNAL OF MEDICAL SCIENCE 165 (4), 310-310<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:prdVHNxh-e8C" class="gsc_a_at">Comparison of the cardiotoxicity of new anthraquinone antitumour agents and their N-oxides prodrugs with doxorubicin and epirubicin using isolated rat cardiac myocytes</a><div class="gs_gray">MK Rahal, G Irving, LH Patterson, JE Brown</div><div class="gs_gray">BRITISH JOURNAL OF PHARMACOLOGY 117, P274-P274<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:CaZNVDsoPx4C" class="gsc_a_at">INTERACTION OF THE NOVEL BIOREDUCTIVE DRUG AQ4N WITH RADIATION AS MEASURED BY THE COMET ASSAY.</a><div class="gs_gray">SR McKeown, MV Hejmadi, OP Friery, LH Patterson</div><div class="gs_gray">Irish Journal of Medical Science 165, 5<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:HtS1dXgVpQUC" class="gsc_a_at">A COMPARISON OF THE INTERACTION OF AQ4N and a range of bioreductive drugs with a single dose of radiation (12 Gy).</a><div class="gs_gray">OP Friery, MV Hejmadi, IA Mclntyre, JJA McAleer, LH Patterson, ...</div><div class="gs_gray">Irish Journal of Medical Science 165, 1-1<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:5icHVeHT4IsC" class="gsc_a_at">THE NOVEL BIOREDUCTIVE DRUG, AQ4N, SHOWS A SUBSTANTIAL RADIATION DOSE SPARING EFFECT: IN VIVO AND EX VIVO STUDIES IN BDF MICE WITH T50/80 TUMOUR IMPLANTS.</a><div class="gs_gray">SR McKeown, MV Hejmadi, JJA McAleer, LH Patterson</div><div class="gs_gray">Irish Journal of Medical Science 164 (4), 318-318<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:9DLIHnF0jcYC" class="gsc_a_at">Anti-cancerforbindelser</a><div class="gs_gray">LH Patterson</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:M0leSnx2MbUC" class="gsc_a_at">Anthrapyrazole derivatives and pharmaceutical compositions.</a><div class="gs_gray">LH Patterson</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:tzM49s52ZIMC" class="gsc_a_at">Relationship between DNA binding affinity, inhibition of Topoisomerase II and cytotoxicity of some novel alkylaminoanthraquinone antitumour agents: development of prodrugs</a><div class="gs_gray">P Teesdale-Spittle, Y Giles, MR Craven, K Ruparelia, PJ Smith, ...</div><div class="gs_gray">Journal of Pharmacy and Pharmacology 46 (2), 1063-1063<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:DBa1UEJaJKAC" class="gsc_a_at">Miller, DM</a><div class="gs_gray">JW Allis, A Armario, K Brendel, A Brouwer, M Delnomdedieu, JL Farber, ...</div><div class="gs_gray">Chem.-Biol 88 (231), 231<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:artPoR2Yc-kC" class="gsc_a_at">Decreased toxicity in-vitro of liposome encapsulated mitoxantrone and macrophage phagocytosed liposome-encapsulated mitoxantrone</a><div class="gs_gray">JC Lilley, LH Patterson, MJ Taylor</div><div class="gs_gray">Journal of Pharmacy and Pharmacology 45 (2), 1120<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:R-LXmdHK_14C" class="gsc_a_at">Anthraquinone derivatives containing at least one n'-disubstituted n'-oxide alkylamino substituent; preparatory processes and intermediates</a><div class="gs_gray">LH Patterson</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:hNSvKAmkeYkC" class="gsc_a_at">Anti-cancer coumpounds</a><div class="gs_gray">LH Patterson</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:m4fbC6XIj1kC" class="gsc_a_at">Anti-cancer antracene derivatives</a><div class="gs_gray">LH Patterson</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:dBIO0h50nwkC" class="gsc_a_at">Short papers in pharmaceutical analysis</a><div class="gs_gray">G Baker, AC Taylor, TS Gill, GD Allen, M Nash, CC Davie, A Allen, ...</div><div class="gs_gray">Analytical Proceedings 29 (5), 171-183<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:nPTYJWkExTIC" class="gsc_a_at">Anti-cancer compounds</a><div class="gs_gray">LH Patterson</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:Ehil0879vHcC" class="gsc_a_at">DNA Binding Affinity and MCF-7 Breast Tumour Cytotoxicity of Anthrapyrazoles: Comparison with Doxorubicin and Mitoxantrone</a><div class="gs_gray">SK AI-Kareem, D Cairns, LH Patterson, JE Brown</div><div class="gs_gray">Journal of Pharmacy and Pharmacology 42 (Supplement_1), 171P-171P<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:-mN3Mh-tlDkC" class="gsc_a_at">UPTAKE, DNA-BINDING AND CYTO-TOXICITY OF DIETHYLAMINOALKYLAMINOANTHRAQUINONES IN MCF-7 HUMAN-BREAST CANCER-CELLS</a><div class="gs_gray">JE MAINE, D CAIRNS, JR BROWN, LH PATTERSON</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 60 (3), 502-502<span class="gs_oph">, 1989</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1989</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:DkZNVXde3BIC" class="gsc_a_at">Degradation of doxorubicin by myoglobin</a><div class="gs_gray">TJ LAVELLE, DA COWAN, LH PATTERSON</div><div class="gs_gray">Biochemical Society Transactions 15 (5), 958-958<span class="gs_oph">, 1987</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1987</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:69ZgNCALVd0C" class="gsc_a_at">INHIBITION OF ADRIAMYCIN SUPEROXIDE FORMATION AND LIPID-PEROXIDATION BY THE ANTHRAPYRAZOLONE CI941</a><div class="gs_gray">MA GRAHAM, DR NEWELL, LH PATTERSON</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 56 (2), 203-204<span class="gs_oph">, 1987</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1987</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:mWEH9CqjF64C" class="gsc_a_at">THE EFFECT OF MITOXANTRONE ON VIABILITY AND DIFFERENTIATION OF HUMAN PROMYELOCYTIC LEUKEMIA (HL60) CELLS</a><div class="gs_gray">LH PATTERSON, M RUFFET, MA AULTON, JK SUGDEN, MJ TAYLOR</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 56 (2), 200-200<span class="gs_oph">, 1987</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1987</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:QUX0mv85b1cC" class="gsc_a_at">INTERACTION OF DOXORUBICIN AND MITOXANTRONE WITH MYOGLOBIN</a><div class="gs_gray">TJ LAVELLE, LH PATTERSON</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 56 (2), 204-204<span class="gs_oph">, 1987</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1987</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:SGW5VrABaM0C" class="gsc_a_at">EFFECT OF BIANTHRAZOLE (CI-941), AN AMINOANTHRAPYRAZOLE ANTITUMOR AGENT, ON LIVER MICROSOMAL FREE-RADICAL FORMATION</a><div class="gs_gray">LH PATTERSON, MA GRAHAM, DR NEWELL</div><div class="gs_gray">INVESTIGATIONAL NEW DRUGS 5 (1), 116-116<span class="gs_oph">, 1987</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1987</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:buQ7SEKw-1sC" class="gsc_a_at">Oxidation of Oxymyoglobin by Doxorubicin and its Effect on Heart Sarcosomal Lipid Peroxidation</a><div class="gs_gray">TJ Lavelle, LH Patterson</div><div class="gs_gray">Journal of Pharmacy and Pharmacology 38 (Supplement_12), 64P-64P<span class="gs_oph">, 1986</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1986</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:AHdEip9mkN0C" class="gsc_a_at">Doxorubicin Free Radical Formation and Lipid Peroxidation in Rat Hepatocytes</a><div class="gs_gray">TJ Lavelle, J Basra, JR Brown, LH Patterson</div><div class="gs_gray">Journal of Pharmacy and Pharmacology 37 (Supplement_12), 20P-20P<span class="gs_oph">, 1985</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1985</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:bKqednn6t2AC" class="gsc_a_at">Effect of Free Radical Scavengers on the In-Vitro Cytotoxicity of Mitozantrone</a><div class="gs_gray">MBR Partridge, J O'Neill, LH Patterson</div><div class="gs_gray">Journal of Pharmacy and Pharmacology 37 (Supplement_12), 21P-21P<span class="gs_oph">, 1985</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1985</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:mNrWkgRL2YcC" class="gsc_a_at">Mitozantrone Induced Dna Strand Breaks in the Presence of Cytochrome P450 Reductase</a><div class="gs_gray">MA Oldcorne, MC Conder, PM Cullis, LH Patterson</div><div class="gs_gray">Journal of Pharmacy and Pharmacology 37 (Supplement_12), 17P-17P<span class="gs_oph">, 1985</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1985</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:SnGPuo6Feq8C" class="gsc_a_at">HUMAN-LIVER MICROSOMAL GENERATION OF DOXORUBICIN AND MITOXANTRONE FREE-RADICALS</a><div class="gs_gray">J BASRA, CR WOLF, LH PATTERSON</div><div class="gs_gray">BRITISH JOURNAL OF CANCER 52 (3), 423-424<span class="gs_oph">, 1985</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1985</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:TlpoogIpr_IC" class="gsc_a_at">Evidence for Two Distinct Tertiary Amine Oxidases</a><div class="gs_gray">JW Gorrod, LA Damani, L Patterson</div><div class="gs_gray">Deutsche Pharmakologische Gesellschaft, 10-10<span class="gs_oph">, 1978</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1978</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:NxmKEeNBbOMC" class="gsc_a_at">Potential of a novel CXCR4 chemokine receptor antagonist for the treatment of metastatic cancer</a><div class="gs_gray">MS Ahmed, D Ahmet, HAD Basheer, SD Shnyder, MV Vinader, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:A8cqit5AE6sC" class="gsc_a_at">Materials and Instrumentation</a><div class="gs_gray">A Throup, LH Patterson, HM Sheldrake</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=wGRCWGAAAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=wGRCWGAAAAAJ:2v_ZtQDX9iAC" class="gsc_a_at">Cu/Zn superoxide dismutase in excretoryąsecretory products of the human hookworm Necator americanus</a><div class="gs_gray">FA Taiwo, PM Brophy, DI Pritchard, A Brown, A Wardlaw, LH Patterson</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr></tbody></table><div id="gsc_a_sp" class=""></div><div id="gsc_a_err" class="gs_alrt">The system can't perform the operation now. Try again later.</div></div><div id="gsc_lwp"><span id="gsc_a_nn">Articles 1–297</span><div id="gsc_bpf"><button type="button" id="gsc_bpf_more" class="gs_btnPD gs_in_ib gs_btn_flat gs_btn_lrge gs_btn_lsu" disabled=""><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl">Show more</span></span></button></div></div></form></div></div></div></div><div id="gs_ftr_sp" role="presentation"></div><div id="gs_ftr" role="contentinfo"><div id="gs_ftr_rt"><a href="/intl/en/scholar/about.html">Help</a><a href="//www.google.com/intl/en/policies/privacy/">Privacy</a><a href="//www.google.com/intl/en/policies/terms/">Terms</a></div></div></div></body></html>